Bioprospecting for bioactive polysaccharides from marine algae endemic to South Africa by January, Grant Garren
  
Bioprospecting for bioactive 
polysaccharides from marine algae 
endemic to South Africa 
 
 
 
 
 
Grant Garren January 
 
 
 A thesis submitted in partial fulfilment of the requirements for the 
degree of Magister Scientiae (MSc) in the Faculty of Natural 
Sciences, Department of Biotechnology, University of the Western 
Cape 
   
4
th
 January 2016 
 
Supervisors: Dr. Rolene Bauer and Dr. Bronwyn Kirby 
 
Co-supervisor: Dr. Renè Naidoo  
 
 
 
 
 
  
ii 
 
 
Bioprospecting for bioactive polysaccharides from marine algae endemic to 
South Africa 
 
Grant Garren January 
Keywords (10) 
 
Polysaccharide 
Fucoidan 
Heterogeneity 
Extractions 
Chemical composition 
Fractionation 
Purification 
Bioactivity 
Anti-oxidant 
Anti-cancer 
  
 
 
 
 
  
iii 
 
Plagiarism Declaration 
 
I, Grant Garren January, hereby declare that ―Bioprospecting for bioactive polysaccharides 
from marine algae endemic to South Africa‖ is my own original work, that it has not been 
submitted before for any degree or examination in any other university, and that all sources I 
have used or quoted have been accurately reported and acknowledged by means of complete 
references. 
Full name: Grant Garren January  
Date: 4
th
 January 2016 
 
 
Signed: …………………. 
 
 
Witness: ........................ 
  
 
 
 
 
  
iv 
 
Acknowledgments 
 
I would like to first and foremost acknowledge and thank my creator and Heavenly Father, 
Jesus Christ.  It is only by His strength, guidance, love and grace upon my life that any of my 
achievements would be possible. 
I would like to thank the National Research Foundation of South Africa for funding this 
research project. 
I would like to gratefully and wholeheartedly thank Prof. Mervin Meyer for hosting me in the 
DST/Mintek NIC and Animal Cell Culture Laboratories at the University of the Western 
Cape even though I was not officially his student. Thank you for your support and motivation 
with all aspects of my research and career path Prof. 
To Dr. Bronwyn Kirby, thank you for your academic support, for tending to all my 
administrative issues, the motivational talks, and for the critical reviewing of my thesis.  
To Dr. Rolene Bauer, your motherly nature and excellent advisory abilities make you the 
perfectly balanced supervisor. I cannot begin to thank you for all your academic support. You 
allowed me to present my work internationally with the leaders in our field in Australia, you 
also granted me to the opportunity expand my scientific knowledge by allowing me to take 
up a scholarship to study bioinformatics in Italy, and you allowed me to work independently 
throughout most of my Master‘s degree. Thank you for having me as part of your research 
group, for preparations with conference presentations, sampling trips, for the critical 
reviewing of my thesis, but most importantly for believing in my research capabilities.  
To Dr. Renè Naidoo, the best co-supervisor a student can ask for! Thank you wholeheartedly 
for everything you have done for me through the course of my Master‘s degree. Including, 
but not limited to, project guidance, assistance with experimental design, thesis editing, 
conference presentation preparations, allowing me to pick your brain (almost daily), and for 
the many motivational talks. Mostly thank you for sharing your passion of research (and 
seaweed) with me. You‘re an inspiration and a role model.  
Thank you to Dr. Mark Rothman and Mr. Chris Boothroyd of the Department of Agrictural, 
Forestry, and Fisheries (DAFF) for sampling expeditions as well as identification of species 
and diving training. 
 
 
 
 
  
v 
 
To Dr. Ebrahim Mohamed and The Biovac Institute thank you for analysing my samples on 
your HPLC system and for your expertise on polysaccharide purification and willingness to 
assist with my research project. 
To Mr. Halford Dace at Molecular and Cell Biology Department, University of Cape Town, 
thank you for all the troubleshooting, and analysing my samples on GC-MS MS. Many have 
tried before but only you have succeeded! 
To the UWC Proteomics Unit thank you analysing my irradiated samples on your 
MALDI-TOF system. 
Thank you to the Medical Research Council of South Africa Indigenous Knowledge Systems 
(MRC IKS) for access to your facilities and equipment, and for the willingness to collaborate 
on research projects. 
To the Algae Research Group of UWC thank you for being my academic family. We were a 
new group and learnt by trial, error, and bouncing ideas off each other. You have all played a 
significant role in my Master‘s degree. To Aisha, Fatima, Hannibal, Renè, Mouna, Monique, 
Rolene, and Tanya may the success of research be ever in your favour.  
To all the staff and students of the DST/ Mintek NIC Laboratory it has been real adventure. I 
have to show appreciation to my lab mates/friends/peers with special mention to Phathu, 
Nicole, Monray, Mustafa, Yancke, Fatima, Abdul, and Bridget for your support and 
motivation. Thank you. 
To all the staff and students of the Department of Biotechnology the last 4 years as a 
post-graduate student has been an amazing experience which all of you have contributed to. 
Thank you to Yo-Neal, Reyghana, Stacey, Relebohile, Michael, and Timothy; our journey 
has finally come to an end!  
Last but far from least, to my family, and my friends, you are my support system without 
which I would not function.  Thank you for being a part of my journey into academia. And to 
my dearest Lauren, I thank you for your enduring love, support, and unconditional belief in 
me. This accomplishment would not have been possible without you by my side. 
 
 
 
 
  
vi 
 
Dedication 
 
This thesis is dedicated to my parents: Jonathan and Christina January, who instilled in me 
from a very young age the love for lifelong-learning, the value and power of knowledge, and 
amongst trying circumstances afforded me the opportunity to pursue my dreams through 
education. 
Thank you. 
  
 
 
 
 
  
vii 
 
 
Table of Contents 
 
Keywords (10)........................................................................................................................... ii 
Plagiarism Declaration .......................................................................................................... iii 
Acknowledgments ................................................................................................................... iv 
Dedication ................................................................................................................................ vi 
List of Figures ........................................................................................................................... x 
List of Tables ......................................................................................................................... xiv 
List of Nomenclature ............................................................................................................ xvi 
Research outputs .................................................................................................................. xxii 
Abstract ............................................................................................................................... xxiii 
Chapter 1. General introduction and project aims............................................................... 1 
1.1) Introduction ............................................................................................................................. 1 
1.2) Project aims ............................................................................................................................. 3 
1.3) Literature cited ........................................................................................................................ 4 
Chapter 2. Literature review .................................................................................................. 7 
2.1) Marine resources ..................................................................................................................... 7 
2.2) Taxonomy of the brown seaweed ........................................................................................... 8 
2.3) Anatomy and physiology ........................................................................................................ 9 
2.4) Distribution and habitat of brown macroalgae ...................................................................... 10 
2.5) South African brown macroalgae ......................................................................................... 11 
2.5.1) Ecklonia maxima ................................................................................................................ 12 
2.5.2) Laminaria pallida ............................................................................................................... 13 
2.5.3) Splachnidium rugosum ....................................................................................................... 14 
2.6) Marine sources of bioactive compounds ............................................................................... 15 
2.6.1) Marine biotechnology: Bioprospecting for marine natural products .................................. 16 
2.6.2) Bioprospecting marine macroalgae .................................................................................... 17 
2.6.3) Marine bioactive compounds .............................................................................................. 18 
2.6.4) Genomic approaches to elucidating marine bioactive compounds ..................................... 19 
2.7) Fucoidan: Sulphated polysaccharides from the seas ............................................................. 21 
2.7.1) Structure and chemistry ...................................................................................................... 21 
 
 
 
 
  
viii 
 
2.7.2) Biological function in macroalgae ...................................................................................... 25 
2.7.3) Bioactive properties ............................................................................................................ 27 
2.7.4) Fucoidan and cancer: specificity and efficacy .................................................................... 29 
2.7.5) Fucoidan as a natural anti-oxidant ...................................................................................... 34 
2.8) Concluding Remarks: Towards isolating and chemically characterising an endemic fucoidan 
molecule ............................................................................................................................................ 37 
2.9) Literature cited ...................................................................................................................... 38 
Chapter 3. Assessing the effect of extraction method on fucoidan heterogeneity ............ 57 
Abstract ............................................................................................................................................. 57 
3.1)  Introduction .......................................................................................................................... 58 
3.2) Methods and materials .......................................................................................................... 60 
3.2.1) Sampling and processing .................................................................................................... 60 
3.2.2) Fucoidan extraction methods .............................................................................................. 61 
3.2.3) Chemical composition of fucoidan ..................................................................................... 63 
3.2.4) Acid hydrolysis of fucoidan ................................................................................................ 67 
3.2.5) High Performance Liquid Chromatography analysis of fucoidan ...................................... 67 
3.2.6) Gas chromatography mass spectrometry ............................................................................ 68 
3.2.7) Statistical analysis ............................................................................................................... 69 
3.3)  Results ................................................................................................................................... 70 
3.3.1) Colorimetric analyses ......................................................................................................... 70 
3.3.2) Fucoidan compositional analysis by gas chromatography mass spectroscopy ................... 77 
3.4) Discussion ............................................................................................................................. 79 
3.4.1) Fucoidan extraction from brown seaweeds ........................................................................ 79 
3.4.2) Sulphate content in native and acid-hydrolysed fucoidan .................................................. 81 
3.4.3) Fucoidan compositional analysis by gas chromatography mass spectroscopy ................... 82 
3.5) Conclusion ............................................................................................................................ 86 
3.6) Literature cited ...................................................................................................................... 88 
Chapter 4. Fractionation and purification of fucoidan ...................................................... 93 
Abstract ............................................................................................................................................. 93 
4.1) Introduction ........................................................................................................................... 94 
4.2)  Methods and material ........................................................................................................... 97 
4.2.1) Fucoidan samples and compositional analysis ................................................................... 97 
4.2.2) Anion exchange/silica column chromatography ................................................................. 98 
4.2.3) Gamma-irradiated fucoidan mucilage ................................................................................ 99 
4.2.4) Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry ................. 100 
4.2.5) Statistical analysis ............................................................................................................. 101 
 
 
 
 
  
ix 
 
4.3) Results ................................................................................................................................. 102 
4.3.1) Assessing ion exchange eluate fractions for fucoidan content ......................................... 102 
4.3.2) Compositional analyses of crude fucoidan extracts before and after ion exchange 
chromatography .......................................................................................................................... 103 
4.3.3) Gamma-irradiated fucoidan .............................................................................................. 105 
4.4) Discussion ................................................................................................................................ 109 
4.4.1) Assessing ion exchange eluates for fucoidan content ....................................................... 109 
4.4.2) Assessment of fucoidan purity .......................................................................................... 110 
4.4.3) Fucoidan content of Splachnidium rugosum mucilage ..................................................... 112 
4.4.4) Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis of 
gamma-irradiated fucoidan ......................................................................................................... 114 
4.5)  Conclusion ......................................................................................................................... 117 
4.6)  Literature cited ................................................................................................................... 118 
Chapter 5. Bioactivity of fucoidan ...................................................................................... 124 
Abstract ........................................................................................................................................... 124 
5.1)  Introduction ......................................................................................................................... 126 
5.2)  Methods and material ......................................................................................................... 129 
5.2.1) Fucoidan samples.............................................................................................................. 129 
5.2.2) Anti-oxidant screening...................................................................................................... 129 
5.2.3) Anti-cancer and cytotoxic screening ................................................................................. 130 
5.3.3) Assay for cellular proliferation ......................................................................................... 132 
5.3)  Results ................................................................................................................................ 134 
5.3.1) Anti-oxidant activity of fucoidan ...................................................................................... 134 
5.3.2) Anti-cancer and cytotoxicity screening of fucoidan ......................................................... 135 
5.4)  Discussion ........................................................................................................................... 138 
5.4.1) Anti-oxidant activity of fucoidan by 2,2-Diphenyl-1-picrylhydrazyl assay ..................... 138 
5.4.2) Anti-oxidant capacity of fucoidan by Cupric Reducing Antioxidant Capacity assay ...... 139 
5.4.3) Anti-cancer and cytotoxicity screening of fucoidan ......................................................... 140 
5.5)  Conclusion ......................................................................................................................... 143 
5.6)  Literature cited .................................................................................................................... 144 
Chapter 6. General Conclusion .......................................................................................... 148 
 
  
 
 
 
 
  
x 
 
List of Figures 
 
Chapter 2   
   
Figure 2.1. Map of South Africa showing the coasts of which algal species have 
been observed and studied. 
12 
   
Figure 2.2. Adult sporophyte of Ecklonia maxima in the wild. 13 
   
Figure 2.3. Adult sporophyte of Laminaria pallida in the wild. 14 
   
Figure 2.4. Adult sporophyte of Splachnidium rugosum in the wild. 15 
   
Figure 2.5. The total number of new marine natural products from macroalgal 
phyla over four decades (1965-2012). 
18 
   
Figure 2.6. Diagram of the metabolic network of the sulphated fucans of 
Ectocarpus siliculosus. 
20 
   
Figure 2.7. Structures of the main polysaccharides typical of brown algae: (a) 
alginate; (b) sulphated fucan from Fucales; (c) sulphated fucan from 
Ectocarpales. (d) Hypothetical model of the biochemical organization 
of cell walls of brown algae. 
22 
   
Figure 2.8. Metabolic map of the biosynthesis of sulphated fucans in brown algae. 27 
   
Figure 2.9. Representation of fucoidan mechanisms of action against cancer by 
cell cycle arrest and apoptosis. 
31 
   
Figure 2.10. Extrinsic and intrinsic pathways of apoptosis. 33 
   
Figure 2.11. Fucoidan action in growth signalling molecules and their pathways in 
cancer. 
34 
 
 
 
 
  
xi 
 
Chapter 3   
   
Figure 3.1. Sampling sites of brown macroalgae in the Western Cape, South 
Africa. 
60 
   
Figure 3.2. Species of brown macroalgae harvested from South African coastline.  61 
   
Figure 3.3. Lyophilised Splachnidium rugosum fucoidan after hot water extraction. 61 
   
Figure 3.4. Splachnidium rugosum fucoidan after acid extraction. 62 
   
Figure 3.5. Lyophilised Splachnidium rugosum fucoidan after salt extraction.  63 
   
Figure 3.6. Microtitre plate assay for L-fucose content.  64 
   
Figure 3.7. Microtitre plate assay for sulphate content. 
 
65 
Figure 3.8. Microtitre plate assay for uronic acid content. 66 
   
Figure 3.9. Microtitre plate assay for protein content.  67 
   
Figure 3.10. Chemical profile of fucoidan extracted from Ecklonia maxima using 
hot water, acid or salt. 
71 
   
Figure 3.11. Chromatogram of molecular weight estimation of intact and 
fractionated fucoidan compounds analysed by HPLC. 
73 
   
Figure 3.12. Chemical profile of fucoidan isolated from Laminaria pallida using 
hot water, acid, or salt. 
74 
   
Figure 3.13. Chemical profile of fucoidan isolated from Splachnidium rugosum 
using hot water, acid, or salt. 
75 
   
 
 
 
 
  
xii 
 
Figure 3.14. Sulphate content of native and acid hydrolysed fucoidan from several 
brown macroalage. 
76 
   
Chapter 4   
   
Figure 4.1. Splachnidium rugosum mucilage isolated from algal tissue.  97 
   
Figure 4.2. Fucoidan purification columns. 98 
   
Figure 4.3. L-fucose content of fucoidan extracted from Splachnidium rugosum 
tissue with a hot water method. 
 
102 
Figure 4.4. L-fucose content of fucoidan extracted from Splachnidium rugosum 
tissue with an acid method.  
 
103 
Figure 4.5. Chemical profile of Splachnidium rugosum fucoidan extracts.  104 
   
Figure 4.6. L-fucose content of fucoidan in Splachnidium rugosum mucilage and 
cellular tissue.  
105 
   
Figure 4.7. Molecular weight of gamma-irradiated fucoidan. 106 
   
Figure 4.8. L-fucose content of gamma-irradiated and non-irradiated fucoidan.  107 
   
Figure 4.9. Sulphate content of gamma-irradiated fucoidan. 107 
   
Figure 4.10. Uronic acid content of gamma-irradiated fucoidan. 108 
   
Figure 4.11. Comparative profile of Splachnidium rugsoum gamma-irradiated 
fucoidan.  
108 
   
   
   
 
 
 
 
  
xiii 
 
   
Chapter 5   
   
Figure 5.1. Confluent culture of  cells visualized and captured by light microscope 
(200X magnification). 
131 
   
Figure 5.2. Anti-oxidant capacity of crude fucoidan extracts as measured by the 
CUPRAC assay. 
135 
   
Figure 5.3. MCF-7 cell viability after 24 hr treatment with Splachnidium rugosum 
fucoidan. 
136 
   
Figure 5.4. Schematic illustrating the conversion of WST-1 to formazan. 141 
 
 
 
 
 
  
xiv 
 
List of Tables 
 
Chapter 2   
   
Table 2.1. Global aquaculture production of aquatic algae by continent over the last 
decade (million tonnes). 
 
7 
Table 2.2. Bioactive polysaccharides from marine algae. 
 
19 
Table 2.3. Brown algal fucoidans from different species displaying the compounds 
heterogeneity. 
 
23 
Table 2.4. Chemical compositional analysis of algal extracts from brown seaweeds 
produced using different extraction methods. 
 
24 
Chapter 3   
   
Table 3.1. Fucoidan profile of brown seaweed extracts. 71 
   
Table 3.2. Monosaccharide composition of hot water fucoidan extracts by GC-MS 
analysis. 
78 
   
Chapter 4   
   
Table 4.1. Yield of fucoidan constituents gained (+) or lost (-) after ion exchange 
chromatography. 
104 
   
Chapter 5   
   
Table 5.1. Anti-oxidant activity of seaweeds as defined by ability to scavenge free 
radicals. 
134 
   
 
 
 
 
  
xv 
 
Table 5.2. Optimal WST 1 assay conditions for cytotoxicity screening of fucoidan from 
this study. 
136 
   
Table 5.3. IC50 values and selectivity index of fucoidan compounds against various cell 
lines. 
137 
 
 
 
 
  
xvi 
 
List of Nomenclature 
 
Acronyms and abbreviations 
 
°C Degrees Celsius 
α Lowercase alpha 
β Uppercase beta 
µ Micro 
μg/mL Microgram per millilitre  
µL Microlitre  
€ Euro 
x g Relative centrifugal force 
ANOVA Analysis of variance 
(AP)-1 Activator protein  
Apaf-1 Apoptotic protease activating factor 1  
ATIII Anti-thrombin  
ATP Adenosine triphosphate 
BaCl2 Barium Chloride 
BHA Butylates hydroxyanisole  
BHT Butylatedhydroxytoluene  
Bid Bcl-2 interacting protein  
BSA Bovine serum albumin 
C12H9N Carbazole  
CaCl2 Calcium chloride 
 
 
 
 
  
xvii 
 
CHCA α-Cyano-4-hydroxycinnamic acid  
CO2 Carbon dioxide 
CTAB Hexadecyltrimethylammoniumbromide 
CUPRAC Cupric Reducing Antioxidant Capacity 
Da Dalton 
DCs Dendritic cells  
ddH2O Distilled deionized water 
DHB 2,5-dihydroxybenzoic acid  
DMEM/F12 Dulbecco's Modified Eagle's Medium and Ham's F-12 Nutrient Mixture  
DMSO Dimethyl sulfoxide  
DNA Deoxyribonucleic acid 
DNase Deoxyribonuclease 
DPPH 2,2-Diphenyl-1-picrylhydrazyl 
EDTA Ethylenediaminetetraacetic acid  
EGFR Epidermal growth factor receptors  
ERK Extracellular regulated kinase 
ESI Electrospray ionization 
EtOH Ethanol 
FAO The Food and Agriculture Organization of the United Nations 
FADD Fas-associated death domain  
FBS fetal bovine serum  
FCSPs Fucose-containing–sulphated-polysaccharides 
FGF Fibroblast growth factor  
g gram 
γ-irradiation Gamma-irradiation 
 
 
 
 
  
xviii 
 
GC-MS Gas chromatography mass spectroscopy 
H2SO4 Sulphuric acid 
HCl Hydrochloric acid 
HCMV Human cytomegalovirus  
HIV Human immunodefiency virus 
HSV-1 Herpes simplex virus 1 
HSV-2 Herpes simplex virus 2 
HMEC Human mammalian epithelial cells  
HMW High molecular weight 
HMWF High Molecular Weight Fucoidan 
HSD Honest significant difference  
IEC Ion exchange chromatography 
K2SO4 Potassium sulphate 
kDa Kilodalton 
kGy Kilogray 
kV Kilovolt 
L Litre 
LMW Low molecular weight 
LMWF Low molecular weight fucoidan 
MALDI-TOF Matrix assisted laser desorption/ionization time-of-flight 
MAPK Mitogen activated protein kinase  
Mbp Mega base pairs 
MEK Mitogen activated kinase/ERK-kinase  
m Metre 
mg/mL Milligram per millilitre  
 
 
 
 
  
xix 
 
min minutes 
mL Millilitre 
MMWF Medium molecular weight fucoidan  
MNPs Marine natural products 
MPA Marine protected areas 
MWCO Molecular weight cut off 
M Molar 
MS Mass spectroscopy 
MSTFA N-Methyl-N-(trimethylsilyl)trifluoroacetamide  
N Normal solution 
Na2B4O7 Sodium tetraborate  
NaCl Sodium chloride 
NaOAc Sodium acetate 
NaI Sodium Iodide 
NaOH Sodium hydroxide 
NH₄Ac Ammonium acetate 
nm Nanometre 
NPs Natural products 
NGS Next generation sequencing 
NK Natural killer cells  
NMR Nuclear magnetic resonance 
PARP Poly ADP-ribose polymerase  
PBS Phosphate-buffered saline  
PDGFR Platelet-derived growth factor receptor  
PENSTREP Penicillin-streptomycin  
 
 
 
 
  
xx 
 
pmol Picomole 
RNA Ribonucleic acid 
rpm Revolutions per minute 
ROS Reactive oxygen species 
RT Room temperature 
RTKs Receptor tyrosine kinases  
SA Sinapinic acid  
SD Standard deviation 
SE Standard error 
SI Selectivity index 
SO4
2-
 Sulphate ion 
t Metric tonnes 
tBid  Truncated Bid 
TBHQ Butyl hydroquinone  
TFA Trifluroacetic acid  
TFPI Tissue factor pathway inhibitor  
THAP 2,4,6-trihydroxyacetophenone  
TNFR-1 Tumour necrosis factor receptor-1  
USD United States Dollar 
UV Ultraviolet 
VEGF Vascular endothelial growth factor 
vol Volume 
v/v Volume per volume 
w/v Weight per volume 
WST Water-soluble tetrazolium salts 
 
 
 
 
  
xxi 
 
WST-1 4-[3-(4-Iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate 
 
 
 
 
  
 
 
 
 
  
xxii 
 
Research outputs 
 
Publications 
 
The following articles are in preparation for publication based on the research derived from 
this study:  
 
January G.G., Naidoo, R.K., Kirby, B., and Bauer, R. 2016. Assessing the effect of 
extraction method on fucoidan extraction from brown macroalage of South Africa. 
January G.G., Naidoo, R.K., Kirby, B., and Bauer, R. 2016. Fractionation, purification, and 
bioactivity assessment of low molecular weight fucoidan from South African brown 
macroalgae. 
 
Presentations 
 
January G.G., Naidoo, R.K., and Bauer, R.  Bioprospecting for bioactive polysaccharides 
from marine brown algae. 28
th 
Congress of the Phycological Society of Southern Africa, 
Western Cape, South Africa, 13-17 January 2014. 
January G.G., Naidoo, R.K., and Bauer, R.  Bioprospecting for bioactive polysaccharides 
from marine brown algae. 5
th
 International Symposium of Applied Phycology, Sydney, 
Australia, 22-27 June 2014. 
January G.G., Naidoo, R.K., and Bauer, R.  Anti-cancer potential of fucoidan isolated from 
South African brown seaweeds. 24th biennial congress of the South African Society for 
Biochemistry and Molecular Biology, Western Cape, South Africa, 6-9 July 2014. 
  
 
 
 
 
  
xxiii 
 
Abstract 
 
Bioprospecting for bioactive polysaccharides from marine algae endemic to South Africa 
G.G. January 
MSc Thesis, Faculty of Natural Sciences, Department of Biotechnology, University of the 
Western Cape, South Africa 
 
Fucoidan is a marine-derived sulphated polysaccharide with bioactive properties ideal for the 
food, chemical and pharmaceutical industries. The polysaccharide consists largely of 
L-fucose, has a highly heterogeneous structure and is of diverse origin. Fucoidan was 
extracted from Ecklonia maxima, Laminaria pallida and Splachnidium rugosum and the 
effect of different extraction methods on fucoidan heterogeneity was assessed. Extraction 
methods employed hot water, hydrochloric acid or calcium chloride salt. Fucoidan yield and 
purity were determined by various colorimetric assays. Highest fucoidan yield was obtained 
with the hot water extraction method as seen by highest L-fucose content. Splachnidium 
rugosum extracts contained ~5 times more L-fucose than Ecklonia maxima and 
Laminaria pallida extracts. The salt extraction method yielded extracts free of contaminants, 
however L-fucose content in all extracts was >20 times lower. Acid extraction yielded 
highest levels of uronic acid contamination and liberated sulphate from the fucoidan 
polysaccharide. The fucose-to-sulphate ratio for Ecklonia maxima was approximately 1:5, 
whilst the ratios for Splachnidium rugosum and Laminaria pallida were approximately 1:1 
and 1:2, respectively. The acid and salt extraction methods removed all traces of protein 
contaminants, while the hot water method retained very low levels of protein. The extraction 
method used to isolate fucoidan was a determining factor in yield and purity.  
Chemical compositional analyses of hot water extracts were assessed by gas chromatography 
mass spectroscopy. Splachnidium rugosum and Laminaria pallida extracts consisted largely 
of L-fucose, while Ecklonia maxima fucoidan was characterized with high glucose 
abundance. Crude hot water and acid extracts from Splachnidium rugosum tissue were 
fractionated and purified by (anionic) ion exchange chromatography as bioactivity has been 
correlated to lower molecular weight forms. In water extracts, ion exchange chromatography 
resulted in close to 90% decrease in L-fucose, sulphate and uronic acid, while protein content 
 
 
 
 
  
xxiv 
 
increased by 57%. Similar results were reported for acid extracts; however protein content 
did not change significantly. These results show that method of extraction may affect the 
composition of fucoidan post-purification. Hot water extraction is recommended due to 
higher fucoidan yield, as reflected by L-fucose content, and higher sulphate-to-fucose ratio. 
High protein content after ion exchange chromatography was however of concern. Since 
mucilage in Splachnidium rugosum thallus was free of protein, fucoidan was precipitated 
from mucilage with ethanol. Fucoidan yield of mucilage was >15-fold higher than content in 
purified hot water extracts with a sulphate-to-fucose ratio of ~1:1. The average molecular 
weight of native fucoidan in mucilage was estimated at 2367 kDa. The polysaccharide was 
hydrolysed by gamma-irradiation levels of 10-50 kGy to fractions ranging between 60 and 
15.5 kDa.  
Hot water crude fucoidan extracts from Ecklonia maxima, Laminaria pallida, and 
Splachnidium rugosum were assessed for anti-oxidant activity by measuring the ability to 
scavenge free radicals and the capacity to reduce copper ions with 
2,2-Diphenyl-1-picrylhydrazyl and Cupric Reducing Anti-oxidant Capacity assays, 
respectively. Ecklonia maxima crude fucoidan displayed highest anti-oxidant activity and 
capacity, having the potential to scavenge reactive oxygen species as well as the capacity to 
reduce copper to less toxic forms in mammalian systems. Splachnidium rugosum showed 
weakest anti-oxidant activity and lowest reducing capacity. The anti-cancer activity of crude 
and purified hot water Splachnidium rugosum extracts, as well as non-irradiated (native) and 
gamma-irradiated fucoidan, and commercially procured fucoidan were assessed for anti-
cancer activity against MCF-7 breast cancer cells. Splachnidium rugosum crude and purified 
fucoidan displayed a half maximal inhibitory concentration of 0.7 mg/mL and 0.029 mg/mL, 
respectively. Low cytotoxicity of crude and purified Splachnidium rugosum fucoidan against 
non-cancerous breast epithelial cell line MCF-12A was observed, as seen by half maximal 
inhibitory concentration values of 2 mg/mL and 0.663 mg/mL, respectively. The cancer 
specific selectivity of purified Splachnidium rugosum fucoidan was therefore much higher as 
reflected by 10-fold higher selectivity index than that of crude fucoidan. Native and low 
molecular weight gamma-irradiated fucoidan also showed bioactive properties including anti-
cancer activity as seen by the reduction of cell proliferation in vitro, whereas crude fucoidan 
showed the ability to scavenge free radicals, and the capacity to reduce copper ions.  
January 2016
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Chapter 1. General introduction and project 
aims 
 
 
1.1) Introduction 
 
Marine macroalgae (seaweeds) are a unique group of photosynthetic organisms that appear 
similar to land plants, but are molecularly distinct (Yoon et al., 2004). Seaweeds are crucial 
species in marine ecosystems as they provide food, and shelter for fish and invertebrates, and 
act as substrata for epiphytic smaller algae (Connell, 2003). Seaweeds are comprised of 
photosynthetic primary producers, which are pivotal to the food supply chain in marine 
environments, as well as giant under-water kelp forests which offer protection and habitat to 
marine life (Reed and Foster, 1984; Tegner and Dayton, 2000). Moreover, they contribute 
approximately 70-80% of oxygen in the atmosphere required by terrestrial organisms. 
Macroalgae can be broadly categorised into brown, green, and red seaweeds, and possess a 
plethora of natural products (NPs), vitamins, and minerals (De Clerck et al., 2013). Brown 
macroalgae are particularly interesting as they possess unique characteristics which have 
evolved over time leading to the development of novel bioactive compounds (Cock et al., 
2010). One such compound is fucoidan, a sulphated polysaccharide found within the 
mucilage of brown seaweeds. Fucoidan has been shown to exhibit several bioactivities in 
mammalian cells including anti-oxidant and anti-cancer activity (Jiao et al., 2011). 
South Africa possesses the third highest biodiversity globally with 80% of its flora not being 
found anywhere else in the world (Griffiths et al., 2010). This is due mainly to its unique 
geographic location and physical features (Bolton et al., 2009). In this study our interest lies 
with three seaweed species found along the South Western coast of South Africa. Ecklonia 
maxima and Laminaria pallida are two kelp species endemic to South Africa with large 
industrial and agro-economical value (Troell et al., 2006; Rothman et al., 2015). 
Splachnidium rugosum is a unique species of brown seaweed that possesses internal and 
external mucilage that could potentially consist of high yields of fucoidan (Clayton, 1985; 
Harden et al., 2009). S. rugosum is found only in parts of the Southern Hemisphere, with 
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most species studied originating on the Australian or New Zealand coastline (Clayton, 1987; 
Hurd et al., 2004). These three algae species hold enormous commercial importance as a 
source of fucoidan, however they have not been well studied or characterised with respect to 
fucoidan content or composition. 
Fucoidan compounds are difficult to extract and characterize but remains of interest due to 
several potent bioactivities that it presents in mammalian systems (Ale et al., 2013). The 
pharmaceutical industry is particularly interested because of its organic nature, intense 
bioactivity and low cytotoxicity, as well as opportunities for sustainable harvesting from 
seaweeds (Fitton et al., 2015). Fucoidan compounds have a proposed common structure 
consisting of an α-L-fucose backbone, with varying degrees of sulphation, glycosidic 
linkages, minor monosaccharides, short discrete uronic acid branches, proteins and other 
macromolecule contaminants (e.g. lipids, carbohydrates, acetates, acids, & polysaccharides) 
(Fitton et al., 2011). The common structure of fucoidan is similar at a Phylum ranking but 
becomes more complex at species level. The fucoidan extraction method adds significantly to 
diversity, introducing a certain amount of bias which can lead to changes in structure, charge, 
molecular weight and chemical composition (Ale and Meyer, 2013). This makes research on 
each individually isolated fucoidan molecule unique. Currently a standardised fucoidan 
extraction technique is currently not available. The establishment of a simple, cost-effective, 
standardised procedure would enable the exploitation of fucoidan providing an opportunity 
for the development of a commercially viable algae industry in South Africa.  
Today, breast cancer is the most common cancer affecting women worldwide (Siegel et al., 
2015) and despite tremendous advances in screening, diagnosis, and treatment, the causes of 
this disease remain elusive and complex (Hanahan, 2014). Teas et al. (2013) has presented a 
proof of principle manuscript wherein they correlate the consumption of (daily) seaweed rich 
diets, in Japan, to lower postmenopausal breast cancer incidence and mortality rates. 
Research has shown that fucoidan possess anti-cancer activity by inhibiting proliferation of 
cancerous cells in vitro (Yamasaki-Miyamoto et al., 2009) and in vivo (Kwak et al., 2014), 
with a few clinical trials in humans showing potential as an adjunct to current cancer therapy 
(Ikeguchi et al., 2011). However, fucoidan molecules are generally large, heterogeneous, 
complex compounds (Choi and Kim, 2013). The purification and/or fractionation of the 
compound (for increased absorption and drug delivery) is therefore required for enhanced 
efficacy. However, no study has evaluated fucoidan from highly diverse, brown seaweeds of 
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South Africa. Thus, this study will assess the feasibility of isolating fucoidan from endemic 
species for potential use as a cancer therapeutic drug.  
 
1.2) Project aims 
 
This research project aims to:  
(I)  Isolate fucoidan compounds from three species of brown macroalgae from South 
Africa using three independent extraction methods, and assess yield and purity of 
crude extracts;  
(II)  Develop a novel, effective, purification and fractionation technology for fucoidan 
compounds;  
(III)  Chemically characterise the composition of native, fractionated, and purified fucoidan 
compounds;  
(IV)  Evaluate the bioactivity of crude, purified, and fractionated fucoidan against 
cancerous and non-cancerous cell lines by screening for anti-oxidant and anti-cancer 
properties. 
  
 
 
 
 
  
4 
 
1.3) Literature cited 
 
Ale, M.T., and Meyer, A.S. 2013. Fucoidans from brown seaweeds: an update on structures, 
extraction techniques and use of enzymes as tools for structural elucidation. The Royal 
Society of Chemistry, 3: 8131-8141. 
Bolton, J.J., Robertson-Andersson, D.V., Shuuluka, D., and Kandjengo, L. 2009. Growing 
Ulva (Chlorophyta) in integrated systems as a commercial crop for abalone feed in South 
Africa: a SWOT analysis. Journal of Applied Phycology, 21 (5): 575-583. 
Choi, J.-I., and Kim, H.-J. 2013. Preparation of low molecular weight fucoidan by 
gamma-irradiation and its anticancer activity. Carbohydrate Polymers, 97: 358– 362. 
Clayton, M.N., 1985. A critical investigation of the vegetative anatomy, growth and 
taxonomic affinities of Adenocystis, Scytothamnus, and Splachnidium (Phaeophyta). British 
Phycological Journal, 20 (3): 285-296. 
Clayton, M.N. and Shankly, C.M., 1987. The apical meristem of Splachnidium rugosum 
(Phaeophyta) 1. Journal of Phycology, 23 (s2): 296-307. 
Cock, J. M., Sterck, L., Rouzé, P., Scornet, D.,  Allen, A.E., Amoutzias, G., Anthouard, V., 
Artiguenave, F., Aury, J.,-M., Badger, J.H., Beszteri, B., Billiau, K., Bonnet, E., Bothwell, 
J.H., Bowler, C., Boyen, C., Brownlee, C., Carrano, C.J., Charrier, B., Cho, G.Y., Coelho, 
S.M., Collén, J., Corre, E., Da Silva, C.,  Delage, L., Delaroque, N., Dittami, S.M., Doulbeau, 
S.,  Elias, M., Farnham, G., Gachon, C.M.M., Gschloessl, B., Heesch, S., Jabbari, K., Jubin, 
C., Kawai, H., Kimura, K.,Kloareg, B., Küpper, F.C.,Lang, D.,Le Bail, A., Leblanc, C., 
Lerouge, P.,Lohr, M., Lopez, P.J.,Martens, C., Maumus, F., Michel, G., Miranda-Saavedra, 
D., Morales, J., Moreau, H., Motomura, T., Nagasato, C., Napoli, C.A., David Nelson, D.R., 
Nyvall-Collén, P., Peters, A.F., Pommier, C., Potin, P.,Poulain, J., Quesneville, H., Read, 
B.,Rensing, S.A., Ritter, A., Rousvoal, S., Samanta, M.,Samson, G., Schroeder, D.C., 
Ségurens, B., Strittmatter, M.,Tonon, T., Tregear, J.W., Valentin, K.,von Dassow, P., 
Yamagishi, T.,Van de Peer, Y., and Wincker, P. 2010. The Ectocarpus genome and the 
independent evolution of multicellularity in brown algae. Nature, 465: 617-621. 
Connell, S.D. 2003. Negative effects overpower the positive of kelp to exclude invertebrates 
from the understorey community. Oecologia, 137 (1): 97-103.  
 
 
 
 
  
5 
 
De Clerck, O., Guiry, M.D., Leliaert, F., Samyn, Y., and Verbruggen, H. 2013. Algal 
taxonomy: A road to nowhere? Journal of Phycology, 49: 215–225. 
Fitton, J.H. 2011. Therapies from Fucoidan; Multifunctional Marine Polymers. Marine 
Drugs, 9: 1731-1760. 
Fitton, J.H., Stringer, D.N., and Karpiniec, S.S. 2015. Therapies from Fucoidan: An Update 
Multifunctional Marine Polymers. Marine Drugs, 13: 5920-5946. 
Griffiths, C.L., Robinson, T.B., Lange, L., and Mead, A. 2010. Marine biodiversity in South 
Africa: An evaluation of current states of knowledge. Public Library of Science, 5 (8): 1-13. 
Hanahan, D. 2014. Rethinking the war on cancer. The Lancet, 383 (9916): 558-563. 
Harden, E.A., Falshaw, R., Carnachan, S.M., Kerna, E.R., and Prichard, M.N. 2009. 
Virucidal activity of polysaccharide extracts from four algal species against herpes simplex 
virus. Antiviral Research, 83: 282–289. 
Hurd, C.L., Nelson, W.A., Falshaw, R. and Neill, K.F., 2004. History, current status and 
future of marine macroalgal research in New Zealand: Taxonomy, ecology, physiology and 
human uses. Phycological Research, 52 (2): 80-106. 
Ikeguchi, M., Yamamoto, M., Arai, Y., Maeta, Y., Ashida, K., Katano, K., Miki, Y. and 
Kimura, T. 2011. Fucoidan reduces the toxicities of chemotherapy for patients with 
unresectable advanced or recurrent colorectal cancer. Oncology Letters, 2 (2): 319-322. 
Jiao, G., Yu, G., Zhang, J., and Ewart H.S. 2011. Chemical Structures and Bioactivities of 
Sulfated Polysaccharides from Marine Algae. Marine Drugs, 9: 196-223. 
Kwak, J.-Y. 2014. Fucoidan as a Marine Anticancer Agent in Preclinical Development. 
Marine Drugs, 12: 851-870. 
Reed, D.C. and Foster, M.S. 1984. The effects of canopy shadings on algal recruitment and 
growth in a giant kelp forest. Ecology, 65(3): 937-948.  
Rothman, M.D., Mattio, L., Wernberg, T., Anderson, R.J., Uwai, S., Mohring, M.B., and 
Bolton, J.J. 2015. A molecular investigation of the genus Ecklonia (Phaeophyceae, 
Laminariales) with special focus on the Southern Hemisphere. Journal of Phycology, 51 (2): 
236-246. 
 
 
 
 
  
6 
 
Siegel, R.L., Miller, K.D. and Jemal, A. 2015. Cancer Statistics, 2015. CA: A Cancer Journal 
for Clinicians, 65 (1): 5-29. 
Teas, J., Vena, S., Cone, D.L. and Irhimeh, M. 2013. The consumption of seaweed as a 
protective factor in the etiology of breast cancer: proof of principle. Journal of Applied 
Phycology, 25 (3): 771-779. 
Tegner, M.J. and Dayton, P.K. 2000. Ecosystem effects of fishing in kelp forest communities. 
ICES Journal of Marine Science: Journal du Conseil, 57 (3): 579-589. 
Troell, M., Robertson-Andersson, D., Anderson, R.J., and Bolton, J.J., Maneveldt, G., 
Halling, C., and Probyn, T. 2006. Abalone farming in South Africa: An overview with 
perspectives on kelp resources, abalone feed, potential for on-farm seaweed production and 
socio-economic importance. Aquaculture, 257: 266–281. 
Yamasaki-Miyamoto, Y., Yamasaki, M., Tachibana, H., and Yamada, K. 2009. Fucoidan 
induces apoptosis through activation of caspase-8 on human breast cancer MCF-7 cells. 
Journal of Agricultural and Food Chemistry, 57 (18): 8677-8682. 
Yoon, H.S., Hackett, J.D., Ciniglia, C., Pinto, G., and Bhattacharya, D. 2004. A Molecular 
Timeline for the origin of Photosynthetic Eukaryotes. Molecular Biology and Evolution, 21 
(5): 1-10.  
 
  
 
 
 
 
  
7 
 
Chapter 2. Literature review 
 
 
2.1) Marine resources  
 
Aquaculture is the aquatic component of agriculture, wherein freshwater and marine 
organisms are farmed for food or industrial uses (Alexander et al., 2015; Martínez-Espiñeira 
et al., 2015). The global aquaculture industry has increased exponentially over the last 
half-century, with the production of 52.5 million metric tonnes (t) of marine derived products 
in 2008, at an estimated value of USD 98.5 billion (Bostock et al., 2010). Marine resources 
are not limited to nutrients, animal feed, or food supply (accounting for 50% of the global 
fish food supply), but also include pharmaceutical, cosmetics, and industrial compounds 
derived from the ocean (Martinez-Porchas and Martinez-Cordova, 2012). The Food and 
Agricultural Organization of the United Nations (FAO) strictly manages these marine 
resources. Globally, aquaculture production has steadily increased over the last decade (Table 
2.1).  
 
Table 2.1. Global aquaculture production of aquatic algae by continent over the last decade (million 
tonnes). 
Location Year    
 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
Africa 0.08 0.12 0.11 0.08 0.08 0.09 0.10 0.12 0.11 0.14 0.14 
Americas 0.07 0.07 0.04 0.02 0.02 0.04 0.03 0.03 0.09 0.01 0.02 
Asia 9.55 10.40 11.25 12.56 13.41 13.95 14.87 15.73 17.14 18.84 20.80 
Europe 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
Oceania 0.01 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.01 0.01 0.01 
Total 9.7 10.6 11.4 12.7 13.5 14.1 15.0 15.9 17.4 19.0 21.0 
Year-on-year growth rate 4.4% 9.1% 7.6% 11.1% 6.7% 4.2% 6.4% 5.9% 9.3% 9.5% 10.4% 
*Adapted from FAO Department of Aquaculture and Fisheries. 
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Marine aquaculture, or mariculture, is a specific branch of aquaculture reserved for the 
farming of marine organisms such as marine algae, fish, and plants (Troell et al. 2003; 
Edwards, 2015). According to the FAO Fisheries and Aquaculture Department‘s global 
statistics (2011), farmed aquatic algae production reached 21 million t with total revenue of 
USD 5.5 billion. Seaweed mariculture has a long history of importance in Asian countries 
where they are used for food and medicinal purposes (Zaneveld, 1959). The farming of 
seaweed originated in Japan and today produces more than 92% of the market demand 
(Chopin and Sawhney, 2009). Recently Europe has taken a much greater interest in seaweed 
mariculture as the prospect of using algae for biofuels, bioremediation, and commercially 
valuable marine natural products (MNPs) gains favour (Bixler and Porse, 2011; Handå et al., 
2013).  
Mariculture in South Africa is important in the agro-economic sector, with tons of cultivated 
seaweed (e.g. Ulva, Gracilaria, and Ecklonia) being produced as abalone (Haliotis midae) 
feed annually (Bolton et al., 2009). South Africa is the second largest producer of cultivated 
abalone outside of Asia and this herbivorous marine mollusc is considered a delicacy in many 
Asian countries. In 2002, over 22 600 t of abalone were produced globally, of which 8600 t 
were farmed to a value of USD 0.8 billion (Troell et al., 2006). Commercial companies such 
as Afrikelp
®
, Kelpak, and Dermikelp
® 
(Lamicare Health) use extracts of South African kelp 
for cosmetic (e.g. dermatological conditions) and agricultural purposes (e.g. fertilizer and 
plant growth regulators). Since the 1950‘s beach-cast Ecklonia maxima has been shipped to 
Europe and North America for alginate production (Anderson, 1989). Thus, maintaining and 
cultivating macroalgae in South Africa is important for sustainable and profitable 
mariculture.  
 
2.2) Taxonomy of the brown seaweed 
 
Macroalgae are a unique group of aquatic organisms, evolutionary diverse from land plants 
but with distinct phenotypical similarities (Yoon et al., 2004). They can exist in both fresh 
water and marine environments (Simons, 1994; Cole et al., 2013; and Lawton et al., 2013). 
Macroalgae can be taxonomically classified into three major Classes, namely, the Phaeophyta 
(brown algae), the Rhodophyta (red algae), and the Chlorophyta (green algae) (Rindi et al., 
2012; De Clerck et al., 2013). Macroalgae are not taxonomically classified by their 
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pigmentation but rather by variations at a molecular and physiological level, including 
flagella morphology and anatomy; reproductive cell ultrastructure and motility; 
deoxyribonucleic nucleic acid (DNA) or ribonucleic acid (RNA) analysis, as well as plastid 
origin and endosymbiotic properties (Martin et al., 1992; Bhattacharya and Medlin, 1998). 
These traits are evolutionarily more conserved compared to the vegetative cell classifications 
used in the past (Bhattacharya and Medlin, 1998). 
The brown macroalgae, or Phaeophyceae, are a Class of macroalgae that belong to the 
Phylum Stramenopiles (Heterokonts) (Charrier et al., 2008). These seaweeds are mostly 
found within marine ecosystems, with less than 1% of its species found in freshwater 
environments (McCauley and Wehr, 2007; Tonon et al., 2011). The Phaeophyceae have 
developed complex multicellularity over the course of evolution via secondary 
endosymbioses and horizontal gene transfer (Bhattacharya and Medlin, 1998; Raymond and 
Blankenship, 2003). Taxonomic classification of these species were further validated and 
expanded through the advancement of the whole genome sequencing of a model brown 
macroalgal species, Ectocarpus siliculosus (Cock et al., 2010). The data revealed fascinating 
genetic detail, such as light-acquiring and pigment biosynthesis gene clusters, signal 
transduction genes and receptor kinases, halogen metabolising complexes, and an integrated 
DNA viral genome (Cock et al., 2010). 
 
2.3) Anatomy and physiology 
 
The Phaeophyceae are complex multicellular seaweeds that are much more diverse than their 
red and green seaweed relatives, with respect to biochemical, genetic, anatomical, and 
physiological profile (Hajibabaei et al., 2007; Rodrigues et al., 2015; Zardi et al., 2015). The 
brown colour of these algae are partially accounted for by the pigments they carry, such as 
chlorophyll a and c, and fucoxanthin, but their habitat and the physics of light absorption and 
surface chemistry play a major role too (Branch and Branch, 1981; Branch  et al,. 1994; 
Stegenga et al,. 1994). Fucoxanthin is found exclusively in brown seaweeds and other 
Heterokonts. Morphologically brown algae are extremely diverse, consisting of large kelp 
forests, to hanging wracks, and polysaccharide filled ―dead man‘s fingers‘‘ (Branch and 
Branch, 1981; Branch et al,. 1994; Stegenga et al,. 1994). 
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Brown algae are mostly found in rocky tidal pools or closely related intertidal regions, when 
not washed up on shore (Tonon et al., 2011). Consequently, they are constantly exposed to a 
wide range of environmental stresses and have evolved molecular mechanisms of survival 
(Cock et al., 2010; Silberfeld et al., 2010). These stressors include fluctuations in abiotic 
factors such as light intensity, pH, salinity, temperature and wave action (Hurd, 2000). Biotic 
stresses are caused by epibiotic organisms and herbivorous marine life, and can often lead to 
infections and fatal diseases (Hurd, 2000). The sequencing of the E. siliculosus genome – the 
first model brown macroalgae - in 2010 was a significant development as it allowed 
researchers to elucidate physiologic adaptations from a molecular evolutionary perspective 
for the first time (Cock et al., 2010). 
The genome of E. siliculosus revealed that the Phaeophyceae adapt to changes in light 
intensities with the aid of light harvesting gene clusters and processes white light into a 
carbon source via photosynthesis by complex pigment biosynthesis genes and their resultant 
proteins (Cock et al., 2010). This seaweed overcomes damage caused by ultraviolet (UV) 
light and reactive oxygen species (ROS) by using phenolic compounds and anti-oxidant 
enzymes, respectively (Rozema et al., 2002; Cock et al., 2010). Halide metabolism genes 
were also found to help in warding off halogenated defensive compounds secreted by other 
brown macroalgae, allowing E. siliculosus to symbiotically grow on these larger kelp species 
(Russell, 1983a; Russell, 1983b; and La Barre et al., 2010; Thomas et al., 2011). 
Physiological adaptations to mechanical stress caused by wave action include the 
incorporation of polysaccharides, such as fucose-containing-sulphated-polysaccharides 
(FCSPs) and alginates, in the cell wall of these algae (Kloareg and Quatrano, 1988; Ale and 
Meyer, 2013). These polysaccharides aid in structural rigidity of the algae as well as 
protection against predators (Skriptsova et al., 2015). 
 
2.4) Distribution and habitat of brown macroalgae 
 
The brown macroalgae‘s geographical diversity extends into marine ecosystems in the 
Northern and Southern Hemispheres (Kantachumpoo et al., 2014; Neiva et al., 2015; Yesson 
et al., 2015). The Phaeophyceae of the south include the kelps, wracks, Sargassums, 
Dictyota, Zonaria, and other unique macroalgae (Bolton and Stegenga, 2002; Mattio et al., 
2015; Rothman et al., 2015). Species that have some form of commercial or 
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eco-conservational importance include: S. rugosum (brown macroalgae), E. maxima (kelp), 
L. pallida (kelp), Sargassum species, Macrocystis angustifolia (kelp), Ecklonia biruncinata 
(kelp), Bifucaria brassicaeformis (wrack), Dictyopteris species, and Pandina boryana 
(Zonaria group). Most of the research conducted on macroalgae inhabiting the coast of South 
Africa has been limited to conservation studies (Griffiths et al., 2010) and there is a need for 
more molecular biology and biotechnological studies to explore the biotechnological 
potential of these macroalgae (Zardi et al., 2015). 
 
2.5) South African brown macroalgae 
 
Seaweeds of South Africa are extremely diverse containing some of the richest global 
diversity of seaweed flora (Bolton and Stegenga, 2002). The South African coastline consists 
of approximately 800 species, with the South Coast containing the highest species diversity 
between 250-300 species per section, and the West Coast boasting the second highest 
diversity with 140 species per section (Figure 2.1). The commercial use of South African 
seaweeds began amidst the Second World War, when the export of agar from Japan to Britain 
ceased (Rothman et al., 2006). This lead to a boom of the South African seaweed industry 
which started in the 1950‘s and died down around 1980‘s. Several species of brown, green, 
and red seaweeds are cultivated in South Africa and are used both locally and exported 
abroad (Bolton et al., 2009). The average dry seaweed biomass exported annually varies 
between 100-1500 t, however South Africa has observed a sharp decline in exports with the 
highest recorded export amount of 4000 t per year reported between 1972 to 1977 (Troell et 
al., 2006). In South Africa, seaweeds have been collected and exported for use as feeds, or 
raw materials for the extractions of agricultural (e.g. fertilizer), food (e.g. stabilizing agents), 
industrial (e.g. alginate extractions), pharmaceutical (e.g. capsule formulations and bioactive 
substrates) and cosmetic agents (e.g. dermatological creams) (Griffiths et al., 2010; Mwangi 
et al., 2013). Bolton and Stegenga (2002) reported that brown seaweeds along the South 
African coastline consist of 101 known species. Locally, brown seaweeds are currently being 
used as feedstock for mariculture and in the pharmaceutical and research industries for 
extraction of bioactive compounds (Davies-Coleman, 2010).  
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Fig. 2.1. Map of South Africa showing the coasts of which algal species have been observed and studied. 
The numbers on the map indicate positions of the coastal sections for which detailed species data were analysed; 
13: Langebaan to Postberg, 19: Rooi Els to Kleinmond, 24: Koppie Alleen to Cape Infanta, 32: Storms River to 
Skuinsklip, 45: Mncwasa River, to Sharks Point, and 50: Scottburgh to Ispingo Beach (Taken from Bolton and 
Stegenga, 2002). 
 
2.5.1) Ecklonia maxima 
 
The order Laminariales contains brown macroalgae that are more generally referred to as 
kelps. Kelps are the most efficient primary producers in the coastal inshore ecosystems and 
play an important role in the food-web of this ecosystem (Troell et al., 2006; Rothman et al., 
2015). Kelps can grow up to 50 m in length, forming beds or underwater-forests that act as 
both habitats and food sources for numerous marine organisms. E. maxima (also known as 
sea bamboo) is a split fan kelp of the Southern Hemisphere (Figure 2.2). Ecklonia species are 
abundant in the Northern Hemisphere; with E. maxima and Ecklonia radiata being the only 
two endemic species in South Africa (Lane et al., 2006; Rothman et al., 2015). E. maxima 
have a strap resembling frond that has been reported to grow a stipe (stem) up to 9 m in 
length (Troell et al., 2006). These fronds hold beneath them a gas containing bulb, which 
keeps the kelp buoyant, making the fronds visible from above the water surface. E. maxima 
have been observed from Cape Agulhas to Cape Columbine, being the dominant inshore kelp 
species in this environment. E. maxima play an important role in the South African 
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mariculture sector, as it is exported to Europe, North America and Asia for alginate 
extraction. Locally, it is sustainably cultivated and used as abalone feed, an agricultural 
fertilizer, and as an active ingredient in dermatological products. 
 
 
Fig. 2.2. Adult sporophyte of Ecklonia maxima in the wild.  (Source: www.algaebase.org) 
 
2.5.2) Laminaria pallida 
 
L. pallida is the other dominant kelp second to E. maxima in the inshore coastline 
environment of South Africa (Troell et al., 2006). The morphology of the adult L. pallida is 
phenotypically represented by a digitate frond, a hollow stipe that can grow up to 2 m in 
length, and the absence of the hollow bulb which is characteristic of E. maxima (Figure 2.3). 
L. pallida also differs morphologically from that of E. maxima, as it has warty stipes and 
E. maxima has smooth stipes. The split-fan-like blades of L. pallida can grow up to 5 m in 
length, and droop over in the deeper waters, sweeping the seafloor. L. pallida has been found 
between the Agulhas and Columbine region. In the deeper inshore environment (north of 
Columbine) L. pallida appears as a sub canopy and gradually starts to replace E. maxima as 
the dominant inshore kelp species. Unlike E. maxima which appears at the water-surface 
L. pallida is submerged beneath the surface, often forming extensive kelp-beds in deeper 
waters (up to 30 m). Beach-cast L. pallida has been harvested since 1950‘s and exported for 
use in the food and chemical industries. L. pallida is also harvested locally for abalone feed, 
where it is either mixed with E. maxima or used by itself, and fed to the abalone in dry or in 
pellet form.  
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Fig. 2.3. Adult sporophyte of Laminaria pallida in the wild.  (Source: www.algaebase.org) 
 
2.5.3) Splachnidium rugosum 
 
S. rugosum is a brown macroalgal species with unique characteristics. This alga is the sole 
species in its genus as well as the sole genus in its family (Clayton, 1985). There have been 
no molecular systematic studies on this species and as such its taxonomic ranking has not 
been confirmed. S. rugosum occurs only in the Southern Hemisphere and has been observed 
on the coastlines of Australia, South Africa, and New Zealand (Hurd et al., 2004; Mwangi, 
2014). It has a distinctive morphology when compared to other brown seaweeds as it does not 
possess a stipe-like holdfast characteristic of many kelp species (Figure 2.4) (Price and 
Ducker, 1966). Instead S. rugosum has a disc-like holdfast which is attached to rocks or 
limpets, and from this holdfast monopodial thalli branch. The alga consists of finger-like 
thalli filled with sticky mucilage and it is from this phenotypic trait that the alga derives its 
common name ―dead man‘s fingers‖ (Clayton and Shankly, 1985). It is postulated that this 
mucilage keeps the alga buoyant as well as providing structural rigidity (e.g. from harsh 
intertidal wave action) (Skriptsova et al., 2015). The sticky mucilage inside and around the 
brown algae‘s thallus is thought to mostly consist of a sulphated polysaccharide commonly 
known as fucoidan (Black, 1954). Fucoidans play a role in protecting brown algae from harsh 
intertidal wave actions and other extrinsic environmental stressors such as fluctuations in 
salinity and heavy metals, UV-radiation, and predation (Skriptsova, 2015).  
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Fig. 2.4. Adult sporophyte of Splachnidium rugosum in the wild.   
 
2.6) Marine sources of bioactive compounds 
 
The Earth‘s surface is covered by approximately 70% water, of which 95% are considered to 
be marine environments (Ellis, 2001; Jimeno et al., 2004). These statistics alone highlight the 
extent to which marine ecosystems overshadow terrestrial environments. However, it was 
only during the late 20
th
 century that aquatic-exploration-technologies such as deep-sea 
diving and scuba diving paved the way for economically and scientifically feasible marine 
exploration studies (Ramirez-Llodra et al., 2011). These technological advances allowed 
biological resources from marine ecosystems to be more readily accessed. 
Marine organisms outnumber their terrestrial counterparts in terms of diversity mainly due to 
their ability to adapt to constantly changing aquatic habitats. This has allowed for better 
proliferation and altered biochemistry through molecular adaptations over the course of 
evolution which ensures growth and survival (Pörtner et al., 2001; Pörtner et al., 2002; Wu, 
2002; Pörtner 2006; Bichego et al., 2007; Tomanek, 2014; Jebbar et al., 2015; Yancey and 
Siebenaller, 2015). Thus, for marine organisms water essentially equals life. Mankind, being 
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the resourceful species that we are, have since exploited these aquatic mechanics for our own 
gain — giving birth to the field of marine biotechnology. 
 
2.6.1) Marine biotechnology: Bioprospecting for marine natural products 
 
 Marine biotechnology entails the exploitation of biological systems from marine and other 
aquatic ecosystems for commercial gain (Burgess, 2012). Since the late 1980‘s the marine 
environment has been the leading biological resource for the discovery of novel genes, 
antibiotics, and other biotechnologically important compounds (Hu et al., 2011; Imhoff et al., 
2011). Marine biotechnology is not a new scientific discipline but has garnered research 
interest, and an increase in commercial funding recently, as modern technologies for 
bioprospecting have improved (Ritchie et al., 2013). Enhancements in technologies such as 
metagenomic and next generation sequencing (NGS) are showcasing the true biodiversity 
from these extreme environments; however a large amount of this biodiversity remains 
largely untapped (Kennedy et al., 2010). Marine biodiversity, a causative effect of a history 
of molecular adaptations to biotic and abiotic stresses, gave rise to unique organisms from 
which novel bioactive compounds could be extracted, modelled against, or co-synthesised 
from (Tomanek, 2014). Other driving forces that are boosting the marine biotechnology 
industry include the need for novel pharmaceuticals and sustainable fuel, food, and chemical 
products (Zemke-White and Ohno, 1999; Bixler and Porse, 2011; Freitas et al., 2012). 
Research conducted on marine organisms has migrated away from the traditional taxonomy 
and conservation studies and more focus has been placed on elucidating the mechanisms 
behind defensive strategies of these deep-sea organisms (Ritter et al., 2008; Thomas et al., 
2011; Tonon et al., 2011; Goulitquer et al., 2012). Marine or ―Blue‖ biotechnology involves 
the search and extraction of commercially valuable compounds from aquatic organisms 
residing in the sea (Burgess, 2012). Many highly valuable MNPs used in the pharmaceutical, 
food, cosmetic, and chemical industries have already been extracted from marine sources 
(Blunt et al., 2013). The majority of MNPs are bioactive compounds which display useful 
properties in mammalian systems (Gerwick and Moore, 2012; Blunt et al., 2013). These 
bioactive compounds can be isolated from organisms such as invertebrates, algae, and 
microbial associated symbionts (Proksch et al., 2003; Jimeno et al., 2004). Several of the 
currently identified bioactivities from MNPs include: anti-cancer, anti-viral, anti-coagulant, 
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anti-microbial, anti-oxidant, anti-bacterial, anti-protozoal, anti-inflammatory and 
anti-metastatic properties, as well as lifestyle associated diseases (Bhakuni and Rawat, 2005). 
Algal biotechnology dates back as early as the 18
th
 and 19
th
 centuries where kelp were burnt 
for iodine, potash, and soda, as well as being used as a fertiliser (Tseng, 2001). Algae contain 
numerous bioactive active compounds, or NPs, that includes polyunsaturated fatty acids 
(PUFAs), B-vitamins, carotenoid, polyphenols, dietary fibre, polysaccharides, proteins, plant 
growth hormones auxins, gibberellins, and cytokinins.  
Macroalgal biotechnology is of enormous industrial importance because of their phycocolloid 
substances such as agar, alginate and carrageen, which are harvested at large scale for 
commercial exploits (Michalak and Chojnacka, 2015). Similarly, microalgal biotechnology is 
a multibillion dollar industry, where microalgae are cultured and harvested at an industrial 
scale (Wijffels et al., 2013). The biomass is refined through downstream processes and sold 
as food and dietary supplements, nutraceuticals, or processed as pigments or speciality 
chemicals.  
 
2.6.2) Bioprospecting marine macroalgae 
 
In contrast to land plants and microalgae, macroalgae (seaweed) are unique in terms of their 
anatomy, physiology and metabolism (La Barre et al., 2010). Seaweed encounter numerous 
environmental stresses including varying light intensities, high salinity, rapid fluctuations in 
pH and osmotic pressure, and harsh intertidal ocean currents (Hurd, 2000; Cock et al., 2010). 
Macroalgae also encounter biotic attacks, such as those by pathogenic microorganisms and 
larger predators, which are successfully evaded by immune responses and chemical defences 
(Küpper 2002; Küpper 2006; Thomas et al., 2011). The course of evolution has led to 
adaptive mechanisms of survival, which include natural products such as halogenated 
compounds, secondary metabolites, and sulphated polysaccharides (La Barre et al., 2010; 
Shalaby, 2011). The macroalgae are particularly interesting because of the sulphated fucans 
and galactan polymers found within their cell walls, known as FCSPs (Ale et al., 2011). 
These compounds display several bioactivities against microbial pathogens; viruses; systemic 
disorders; and anti-proliferative effects against numerous cancers and tumours in mammalian 
cells (Ale et al., 2011). The major FCSPs isolated from macroalgae are fucoidans, which are 
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mainly found in brown algae, hypothesised to play a role in the structural rigidity and 
survival of the seaweed (Pomin and Mourão, 2008; Skriptsova et al., 2015).   
 
2.6.3) Marine bioactive compounds  
 
The bioactive compounds found within macroalgal extracts are as diverse as the species they 
originate from. These compounds produced by brown, red, and green algae include 
polysaccharides, pigments, anti-oxidant compounds, plant growth promoting 
substances/hormones and a range of other bioactive compounds (Michalak and Chojnacka, 
2015). Macroalgae are an important source of MNPs as discussed by Leal et al (2013). They 
reported that between 1965 and 2012 red, brown, and green seaweeds have been the source of 
3129 MNPs (reds, 53% of the total; browns, 39%; green, 8%) (Figure 2.5). Historically, 
MNPs from macroalgae have been significant in marine drug progression, with 28% of novel 
MNPs originating between 1970 and 1980. Therapeutically, macroalgae have been used in 
traditional and folk medicine for hundreds of years.  
 
 
*Ochrophyta referred to in this study is synonymous with Phaeophyta (brown seaweed) 
Fig. 2.5. The total number of new marine natural products from macroalgal phyla over four decades 
(1965-2012). (Taken from Leal et al., 2013). 
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According to the Dictionary of Marine Natural Products (Blunt and Munro, 2008), MNPs are 
categorised into the following groups: aliphatic, alkaloids, simple aromatic, amino acids and 
peptides, carbohydrates, oxygen heterocycles, polyketide, polypyrroles, steroids, and 
terpenoids. One of the categories of brown macroalgal MNPs that has received a considerable 
amount of interest are sulphated polysaccharides (e.g. fucans, laminarans, galactans, 
sargassans) (Table 2.2). 
 
Table 2.2. Bioactive polysaccharides from marine algae. (Adapted from Michalak and Chojnacka, 2015). 
 Brown  
algae (Phaeophyta)  
Red  
algae 
(Rhodophyta) 
Green  
algae (Chlorophyta) 
Polysaccharides Alginate 
Cellulose 
Fucoidan 
Laminarin 
Sargassan 
Agar 
Carrageenan 
Cellulose 
Fucellaran 
Mannan 
Porphyran 
Xylan 
Amylose 
Amylopectin 
Cellulose 
Inulin 
Mannan 
Pectin 
Xylan 
Ulvan 
 
2.6.4) Genomic approaches to elucidating marine bioactive compounds 
 
E. siliculosus represents the first model organism for the brown algae and has helped to 
elucidate the underlying genetics that govern the production of compounds of interest 
(Michel et al., 2010). E. siliculosus was chosen based on a multifactorial set of characteristics 
such as an extensive history of experimental research (diversity and taxonomy studies), 
complex multicellularity, global distribution, compact genetic profile (214 Mbp), physical 
size, high fertility and growth rates, and extensive knowledge of its life cycle (which can be 
completed in vitro in three months) (Charrier et al., 2008). E. siliculosus genome data 
allowed researchers to hypothesise how molecular adaptations to intertidal environments and 
evolution of multicellularity arose (Michel et al., 2010). The genomic data also delivered a 
detailed interpretation of the carbohydrate metabolism of brown algae. Michel et al. (2010), 
reported that cell walls of brown algae share components with terrestrial plants (e.g. 
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cellulose) and with animals (e.g. sulphated fucans), but also contain exclusive 
polysaccharides such as alginates. Analysis of the Ectocarpus genome allowed researchers to 
gain insight into molecular basis of these metabolic pathways. Bioinformatic tools were used 
to determine which enzymes are involved in the biogenesis and remodelling of alginates, 
cellulose, and fucans and a phylogenetic tree of the key enzymes involved was constructed. 
They discovered that Ectocarpus metabolic networks are lacking known families of 
cellulases, and expansins, which are enzymes involved in cell wall expansion that are 
commonly found in metabolic pathways of terrestrial plants. Thus, it can be inferred that 
novel mechanisms and/or proteins must exist in this alga for cell wall expansion. This data 
describes a multifaceted evolutionary history of the cell wall components of brown algae, 
many of which are bioactive compounds of interest. Furthermore, it was determined that 
cellulose synthesis was passed along from a red algal endo-symbiont, and that the final steps 
of the alginate biosynthesis pathway were acquired through horizontal gene transfer (HGT) 
from an Actinobacterium species. The HGT transaction also resulted in the acquisition of 
genes for the hemicellulose pathway. Contrary to this, the metabolic pathway for sulphated 
fucans is thought to be ancestral; and conserved within animals (Figure 2.6).  
 
 
Fig. 2.6. Diagram of the metabolic network of the sulphated fucans of Ectocarpus siliculosus. (Taken from 
Michel et al., 2010). FK, L-fucokinase; GFPP, GDP-fucose pyrophosphorylase; GFS, GDP-L-fucose 
synthetase; GM46D, GDP mannose4,6-dehydratase. 
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2.7) Fucoidan: Sulphated polysaccharides from the seas 
 
2.7.1) Structure and chemistry 
 
The largest constituent of algal polysaccharides are found within their cell walls, thereby 
aiding in structural rigidity, and offering protection against mechanical stress caused by 
intertidal wave currents (Skriptsova et al., 2015). Similar to green plants, brown algae also 
produce crystalline cellulose (fibres) but this accounts for only 1-8% of the dry weight of the 
thallus (Michel et al., 2010). The main cell wall components are anionic polysaccharides such 
as alginate and fucoidan. These polysaccharides (alginate:fucoidan:cellulose) are found at an 
average weight ratio of 3:1:1 in mature brown macroalgae (Figure 2.7). Most of the 
polysaccharides within brown marine algae are sulphated, such as fucoidan, which consists of 
a pentose sugar backbone comprising of (1-3) and (1-4) α-L- fucopyranose residues and also 
contain side chains of sulphate and/or acetyl groups (Ale et al., 2011). Monosaccharides 
sugars such as mannose, galactose, xylose and rhamnose, as well as protein and uronic acid 
moieties complete the structure. Sargassum species are slightly different as their 
polysaccharides are composed of sulphated galactofucans known as ‗sargassans‘, and consist 
of (1-6)-β-D-galactose and/or (1-4)-α-D-glucuronic acid, ending in either β-D-xylose or (1-
4)-α-D-glucose (Duarte et al., 2001; Ale et al., 2011a). 
Marine derived sulphated polysaccharides of algal origin, such as fucans and galactans, are 
often heterogeneous, displaying different chemical structures‘ at species level (Pomin and 
Mourão, 2008). However, these chemical compounds show a degree of conserved structural 
similarity at the Phylum level (Pomin and Mourão, 2008). Fucoidans from brown algae differ 
from fucoidans isolated from marine invertebrates, such as sea urchins and sea cucumbers, 
which display a regularity in structure with respect to linearity of sugar backbone; degree of 
sulphation and lacks branching, even when isolated from different species (Berteau and 
Mulloy, 2003). Brown algal fucoidans display extremely branched fucoidans ranging from 
high uronic acid, low sulphate containing polysaccharides, with noteworthy amounts of 
D-xylose, D-galactose, and D-mannose (xylofuco-glucuronan and xylo-fuco-glucans) to 
highly sulphated homofucan compounds (Michel et al., 2010). The sulphated fucans from the 
order Fucales contain extensive repeat units of the disaccharide ( → 4)-α-l-fucose-2,3-
disulfate-(1 → 3)-α-l-fucose-2-sulfate-(1 → ) (Figure 1.7b). Whereas, the sulphated fucans 
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from the order Laminariales and Ectocarpales exhibit a structure primarily consisting of 
3-linked α-l-fucose residues mostly sulphated at C-4 position. (Figure 2.7c). As illustrated 
below, brown macroalgal fucoidans have a common structure, but show a large level of 
structural diversity at the species level (Table 2.3) (Ale et al., 2013). 
The chemical composition of the extracted sulphated polysaccharide may be subject to bias 
due to factors such as method of extraction, origin of the compound (e.g., species or 
geographical location), seasonal or climatic conditions, and/or maturity of the seaweed (e.g., 
juvenile or adult life cycle). Purification of sulphated fucans, such as fucoidan, is proposed to 
be necessary for optimal bioactivity of the compound. The heterogeneity of these highly 
complex polysaccharides are problematic and are hypothesised to be caused by fucose branch 
lengths; scattered sulphation around the core structure; different glycosidic bonds and other 
chemical characteristics such as acetylation, methylation, and pyruvilation (Pomin and 
Mourão, 2008). Techniques such as partial acid hydrolysis, desulphation, or deacetylation 
have been utilised prior to chemical analysis by mass spectroscopy (MS), matrix assisted 
laser desorption/ionization time-of-flight (MALDI-TOF), or nuclear magnetic resonance 
(NMR), in attempt to resolve the complex heterogeneity of these compounds (Bilan et al., 
2002; Berteau and Mulloy, 2003; Bilan et al., 2006; and Anastyuk et al., 2009). However, 
with every pre-treatment step employed the original structure of the compound is altered 
(Table 2.4). 
 
 
Fig. 2.7. Structures of the main polysaccharides typical of brown algae: (a) alginate; (b) sulphated fucan 
from Fucales; (c) sulphated fucan from Ectocarpales. (d) Hypothetical model of the biochemical 
organization of cell walls of brown algae. (Taken from Michel et al., 2010). 
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Table 2.3. Brown algal fucoidans from different species displaying the compounds heterogeneity. 
(Adapted from Ale et al., 2013). 
Seaweed species Order Fucoidan structural element Characteristics 
 
Chorda filum 
 
Laminariales 
 
 
 
Contains a poly-a(1A3)-fucopyranose 
backbone with a high degree of 
branching, mainly of a(1A2)-linked 
single units. Sulphated at O-4 (mainly) 
and O-2 positions. Some a(1A3)-linked 
fucose residues are 2-O-acetylated. 
 
Laminaria 
saccharina 
Laminariales 
 
Mainly made up of 4-sulfated a(1A3)-
linked a-L-fucopyranose residues, some 
of which are additionally 2-sulfated or 
carry a 2-O-a-L-
fucopyranosylsubstituent. 
 
 
Fucus serratus L. 
 
 
Fucales 
 
 
 
Contains a backbone built of alternating 
3- and4-linked a-L-fucopyranose 
moieties, with about half of the 3-linked 
residues being substituted at C-4 by 
trifucoside units a-L-Fucp-(1A4)-a-
LFucp-(1A3)-a-L-Fucp-(1A (not 
shown)). Sulphate groups have been 
shown to be substituted mainly on C-2 
and sometimes C-4, although some 
terminal fucose residues may be non-
sulphated. 
 
Cladosiphono 
kamuranus 
 
Chordariales 
 
 
 
The main structure is a linear backbone 
of a(1A3)-fucopyranose with half of the 
sulphate substitutions at C-4, and a 
portion of the fucose residues are O-
acetylated. The a-glucuronic acid 
residues are linked to the C-2 positions 
of the fucose residues which are not 
substituted by a sulphate group. 
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Ascophyllum 
nodosum 
Fucales 
 
An a(1A3)-linked fucose backbone and 
a high proportion of a(1A4) linkages 
mainly sulphated atO-2, to a lesser 
extent at O-3, and only slightly atO-4, 
and fucose 2, 3-O-disulfate residues 
were observed. Anticoagulant activity 
appears related to 2-O-sulfation and 2,3-
O-disulfation levels. 
    
 
Table 2.4. Chemical compositional analysis of algal extracts from brown seaweeds produced using 
different extraction methods. (Adapted from Ale et al., 2013). 
Seaweed species Order Extraction method Composition 
 
Cladosiphono 
kamuranus 
 
Chordariales 
 
Seaweed-H2O suspension was treated with 30% HCl 
(pH 3) at 100 °C for 15 min. The supernatant was 
neutralized with NaOH, precipitated with CaCl2 and 
ethanol for 20 h at 4 °C, precipitate was dissolved 
with H2O and subsequently dried. 
 
 
Fucose, glucose, 
uronic acid and 
sulphate. 
 
Sargassum 
stenophyllum 
 
 
 
 
Fucales 
 
Extracted with water 7% (w/v), 12 h, 3x. Precipitated 
with ethanol and CaCl2 and cetylpyridiniumchloride. 
Soluble fraction (SF) was 
then fractionated (F1-F6). 
 
 
Fucose, xylose, 
mannose, galactose, 
glucose, sulphate and 
uronic acid. 
 
Fucus evanescens; 
Fucus distichus 
 
Fucales 
 
Pre-treatment: MeOH-CHCl3-H2O (4 : 2 : 1), then 
extracted with 2% CaCl2 for 5 hr at 85 °C, 
precipitated and the precipitate was washed with 
water, stirred with 20% ethanolic solution and 
dissolved with water. 
 
Fucose, xylose, 
galactose, uronic acid 
and sulphate. 
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Fucus serratus 
 
Fucales 
 
Pre-treatment: MeOH-CHCl3-H2O(4 :2 : 1), then 
extracted with 2% CaCl2 for 5 hr at 85 °C, the 
extracts were collected by centrifugation, combined, 
dialyzed and lyophilized. 
 
Fucose, xylose, 
mannose, glucose, 
galactose, uronic acid 
and sulphate. 
 
Chorda filum 
 
Laminariales 
 
Extracted with CHCl3-MeOH-H2O (2 : 4 : 1) 
followed by 80% ethanol, then extracted successively 
with 2% CaCl2 at 20 and 70 °C, then with 
HCl (pH 2) and 3% Na2CO3, precipitated with 
calcium salt. 
 
Fucose, xylose, 
mannose, glucose, 
galactose, uronic acid 
and sulfate. 
 
Adenocystis 
utricularis 
 
 
Ectocapales 
 
80% ethanol, 24 hr, 70 °C pre-treatment, then 
extracted with water (or 2% CaCl2; or HCl) for 7 hr, 
RT, followed by exhaustive extraction at 70 °C. 
 
Fucose, xylose, 
mannose, glucose, 
galactose, uronic acid 
and sulfate. 
 
Undaria 
pinnatifida 
 
Laminariales 
 
Ground seaweed extracted twice at RT for 6 hr with 
1% H2SO4, neutralized with 10% NaOH and 
lyophilized. 
 
Fucose, mannose, 
xylose, rhamnose, 
galactose, glucose and 
sulfate. 
 
Laminaria 
religiosa 
 
Laminariales 
 
Water extraction at boiling temperature for 4 hr, 
fucoidan fraction was obtained by using 0.09 HCl at 
4 °C for 2 hr, then precipitated with 85% ethanol and 
dried. 
 
Fucose, mannose, 
xylose, rhamnose, 
galactose, glucose and 
sulfate. 
 
2.7.2) Biological function in macroalgae 
 
The elusive nature of fucoidan is not only limited to its bioactive properties in mammalian 
systems but also to the physiology of its host. The function of fucoidan in marine organisms 
has only been proposed to date. It has been deduced that fucoidan plays a role in protection 
 
 
 
 
  
26 
 
against desiccation, as the amount of fucoidan found in intertidal algal species is higher than 
that found in sublittoral species (Skriptsova et al., 2012). Another hypothesis is that fucoidan 
plays a role in the structural rigidity of the cell wall of algae as seasonal shifts in fucoidan 
content mirrors the seasonal shift from winter to summer which results in more sunlight 
exposure. Sulphated fucans of brown macroalage are biologically synthesised in the 
dictyosomes of Golgi bodies, and this includes the synthesis of fucoidan chains (Skriptsova et 
al., 2015). The common, active form of L-fucose, GDP-fucose is regarded as the fucan 
precursor. GDP-fucose is synthesised in most bacteria, mammals, and plants produced from 
GDP-mannose by a de novo pathway (Figure 2.8). Thereafter, the precursor GDP-mannose is 
enzymatically converted into GDP-4-keto-6-deoxymannose (Figure 2.8). This 
keto-intermediate is then converted into GDP-fucose in two steps, catalysed by a bifunctional 
epimerase/reductase, GDP-l-fucose synthetase which has been found in the E. siliculosus. 
There is an alternate proposed pathway in brown macroalgae whereby GDP-fucose is 
synthesised from L-fucose through fucose-1-phosphate (Figure 2.8). This is achieved when 
cytosolic fucose is phosphorylated by L-fucokinase, followed by the enzymatic reversible 
reaction of fucose-1-phosphate with GDP to form GDP-fucose. However, these enzymes 
have not been found in brown algae so this pathway remains putative. 
Skriptsova et al. (2015) established that fucoidan compounds are involved in construction of 
cell walls and physical support of alga structure. Other significant physiological roles of 
fucoidan in brown algae include release of spores and gametes from their reproductive organs 
as well as the morphogenesis of zygotes of fucoid algae. Fucoidan also serves to facilitate the 
polarity of the cell, as well as fixing the cell division axis, which is responsible for the 
development of the rhizoidal and apical poles of juvenile thalli. The sulphated nature of 
fucoidan compounds are also vital in capturing divalent ions such as K
+,
 Na
+
, Ca
2+
, Mg
2+
ions 
from the ecosystem. This form of ion exchange with its environment allows for the adaption 
of algae to environmental stressors such as rapid fluctuations in pH, salinity, and lethal heavy 
metal compounds.  
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Fig. 2.8. Metabolic map of the biosynthesis of sulphated fucans in brown algae. Fuc, fucose; Gal, galactose; 
Xyl, xylose; UDP, uridine diphosphate; GDP, guanosine diphosphate. Enzymes whose existence remains 
unconfirmed are highlighted in bold italics. (Taken from Skriptsova et al., 2015) 
 
2.7.3) Bioactive properties 
 
Fucoidan isolated from brown macroalgae have been shown both in vitro and in vivo to have 
bioactive properties in mammalian systems, with some compounds currently undergoing 
clinical trials (Kwak, 2014; Fitton et al., 2015). These bioactive properties include: anti-viral; 
anti-microbial; anti-cancer; anti-metastatic; immunomodulatory; anti-thrombic; 
anti-inflammatory; and anti-oxidant activity. The precise mechanisms of action of these 
compounds in mammalian systems are not fully understood. However, partial elucidation of 
the structure of these compounds has led researchers to infer that the following are key 
contributors: molecular weight, structural make-up, sulphation pattern and content, charge 
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density, purity, and monosaccharide composition (Haroun-Bouhedja et al., 2000; Pomin and 
Mourão, 2008; Usov and Bilan, 2009; Jiao et al., 2011; Senthilkumar et al., 2013). 
Previous studies have reported that the bioactivity of fucoidan in mammalian systems is both 
size- and dose-dependent (Yamasaki-Miyamoto et al., 2009; Cho et al., 2010; Lee et al., 
2012; Morya et al, 2012; Kimura et al., 2013; Zhang et al., 2013; Kwak, 2014). The average 
reported size of fucoidan is ~20 kDa with low molecular weight fucoidan (LMWF) ranging in 
size from <10 kDa, medium molecular weight fucoidan (MMWF) between 10-10,000 kDa, 
and high molecular weight fucoidan (HMWF) is categorised as >10,000 kDa (Senthilkumar 
et al., 2013). 
LMWF can be produced by several experimental techniques including enzymatic, 
gamma-irradiation, acidolysis, ultrasound, electronic beam and mechanical shearing (Choi et 
al., 2009; Cho et al, 2011; and Jo and Choi, 2014). LMWF has been found to have 
anti-thrombic (Chabut et al., 2003; Chabut et al., 2004), anti-cancer (Ozawa et al., 2006; 
Choi and Kim, 2013; Kimura et al., 2013; Mak et al., 2014), and anti-oxidant (Wang et al., 
2010; Mak et al., 2013; Lim et al., 2015) bioactivities (Morya et al., 2012). LMWF also show 
endothelial cell migration (Matsubara et al., 2005; Lake et al., 2006), and 3D culture 
stimulant abilities (Changotade et al., 2008), as well as alloimune injury protective activity 
(Alkhatib et al. 2006), and cardiovascular disease therapeutic activities (Bachelet et al., 2009; 
Yu et al., 2014).  
Similarly, HMWF could be quite useful as an anti-coagulant or anti-thrombic compound in 
mammalian systems (Jiao et al., 2011). The structure of HMWF fucoidan is similar to that of 
heparin, an anti-coagulant, which binds to blood coagulating protein thrombin. Both fucoidan 
and heparin are heavily sulphated and contain high molecular weight sugar chains. The exact 
mechanism of this bioactivity is not fully understood, but several investigations have reported 
that direct and indirect inhibition of thrombin by the activation of thrombin inhibitors such as 
anti-thrombin (ATIII) and heparin cofactor II could potentially be its mechanism of action 
(Grauffel et al., 1989; Mauray et al., 1995; Kuznetsova et al., 2003; Ustyuzhanina et al., 
2015). Fucoidan has also been shown to promote coagulation by obstructing tissue factor 
pathway inhibitor (TFPI) (Zhang et al., 2015).  
Sulphated polysaccharides, such as fucoidan, exhibit immunomodulatory properties that 
could potentially trigger the immune response or control cellular immune activity which 
alleviates undesirable effects such as inflammation (Chen et al., 2008). Fucoidans may have 
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several targets in both immune and inflammatory systems which can affect the progression of 
diseases as well as the development of tumours and metastasis (Groth et al., 2009). The 
immune related activities of algal fucoidan include its ability to interfere with the movement 
of leukocytes to sites of inflammation. 
Fucoidan has been reported to show anti-viral activity against enveloped viruses, including 
human cytomegalovirus (HCMV), human immunodeficiency virus (HIV), herpes simplex 
virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) and tobacco mosaic virus, a plant 
pathogen (Ponce et al., 2003; Usov and Bilan, 2009). Active extracts have been isolated from 
brown algal species such as Undaria pinnatifida, Adenocystis utricularis, Sargassum horneri, 
Sargassum patens, Stoechospermum marginatum and Cystoseira indica (Ponce et al., 2003; 
Hayashi et al., 2008; Ermakova et al., 2011). Researchers have postulated that the anti-viral 
activity can be linked to the degree of sulphation, with increasing degrees of sulphation 
having higher efficacies against viral penetration and adsorption to host cells (Harden et al., 
2009; Wozniak et al., 2015). Although other researchers have reported that an alternative 
mode of action involves the early blocking of viral entry, as shown in the case of shielding 
off the positively charged amino acids present in the viral envelope glycoprotein gp120 of 
HIV (Thuy et al., 2015). 
Fucoidans have also exhibited several anti-microbial activities against pathogenic bacteria, 
such as Pseudomonas aeruginosa. Fucoidan extracts prohibited biofilm formation, inhibited 
toxic metabolites, inhibited secretion of virulence factors, supressed expression of quorum 
sensing genes, and motility in P. aeruginosa (Kandasamy et al., 2015). These FCSPs also 
protected Caenorhabditis elegans from P. aeruginosa infection by altering immune gene 
expression in the presence of the pathogen and by altering functional pathways in the 
presence of the pathogen.  
 
2.7.4) Fucoidan and cancer: specificity and efficacy 
 
Cancerous cells or tumours are the uncontrolled growth or proliferation of abnormal cells that 
should have been destroyed by cellular regulation mechanisms such as apoptosis or other 
immune responses but have evaded these cellular mechanisms (Hanahan and Weinberg, 
2000). The economic cost of cancer is a pandemic problem with the estimated cost on the 
European economy being approximately more than 50 billion euros (€) in care, treatment, 
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and lost productivity (Hanahan, and Weinberg, 2011). The hunt for cancer therapeutics have 
led to a vast range of therapies, ranging from chemical, radiation treatment, surgery, NPs, and 
holistic therapies. However, every cancer is different in terms of growth, mechanism of 
proliferation, and metastasis (Weinberg, 2007). Finding a cancer therapy that is effective in 
destroying tumours, possesses a low cytotoxicity (not affecting non-cancerous cells), and 
selectively only targeting the cancerous growth has focussed research toward MNPs 
(Hanahan, 2014). Fucoidan, the sulphated polysaccharide, is one such bioactive compound 
possessing these unique abilities. For years fucoidan has been sold as a dietary or 
nutraceutical product with various therapeutic properties (Kwak et al., 2014). Fucoidan or 
FCSPs have advantages such as low toxicity, oral bioavailability, and multiple mechanisms 
of action. Therefore, in Asian countries such as China, Japan, and Korea, fucoidan derived 
foods and drinks are administered to cancer patients as an oral adjunct. Fucoidan has several 
pharmacological actions which affect carcinogenesis, inflammation, oxidative stress, and 
vascular physiology (Fitton et al., 2011). While the underlying mechanism of action of 
fucoidan as an anti-cancer agent has not been fully elucidated, it has been proven that it 
includes cytotoxicity and apoptosis of cancer cells. Fucoidan can also act as an 
anti-angiogenic agent preventing the metastasis of cancer by supressing signalling molecules 
such as vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) (Ye et 
al., 2005; Ustyuzhanina et al., 2015). Additionally, fucoidan can stimulate dendritic cells 
(DCs) (Jin et al., 2009; Cheng et al., 2010) and natural killer cells (NK) (Ale et al., 2011b; 
Azuma et al., 2012) improving anti-cancer immunity by means of immune cell activation and 
the production of anti-cancer cytokines. 
The central processes of development of the cell cycle and of apoptosis involve the complex 
interaction of several co-ordinated cascades of protein families (e.g. the caspases) in a 
systematic manner (Kwak et al., 2014). These processes are related and are key factors 
during the communication of malignant cells to chemotherapeutic treatments. The cell cycle 
is a large energy requiring process by which cells act to divide. If the series of phases in the 
cell cycle are not ordered, or are hindered in some way, the duplication and segregation of 
that organism‘s genome will be incorrectly inherited by future generations. The cell cycle‘s 
ordered series of events starts with quiescence (G0 phase) and progresses to proliferation 
(G1, S, G2, and M phases) and back to quiescence (Norbury and Nurse, 1992). With the 
advancement of knowledge of cell cycle deregulation in cancers, research into marine 
compounds as anti-cancer agents has been accelerated. Studies have shown that MNPs can 
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modulate signalling pathways leading to cell cycle regulation or directly modify cell cycle 
regulatory molecules in cancer therapies (Figure 2.9) (Kwak et al., 2014). Fucoidan has been 
reported to dose-dependently increased G0/G1-phase in a hepatocarcinoma cell line (Huh7) 
accompanied by a decrease in the S phase, which inferably suggests that fucoidan may cause 
the cell cycle arrest at the G0/G1 phase  (Senthilkumar et al., 2003; Nagamine et al., 2009). 
 
 
Fig. 2.9. Representation of fucoidan mechanisms of action against cancer by cell cycle arrest and 
apoptosis. Fucoidan arrest cell cycle at G1/S or G2/M phase. Apoptosis occurs via extrinsic and intrinsic 
pathways. Fucoidan can activate both pathway mediated apoptosis processes. Black colour small arrow indicates 
downregulation and upper arrow indicates upregulation of protein activation by fucoidan. (Taken from 
Senthilkumar et al., 2003). 
 
Programmed cell death, or apoptosis is facilitated through two major pathways, i.e. the 
extrinsic (death receptor) pathway and the intrinsic (mitochondrial) pathway (Sprick et al., 
2004; Duprez et al., 2009). In the extrinsic pathway stimulation of the death receptors Fas 
and tumour necrosis factor receptor-1 (TNFR-1), leads to the gathering and formation of a 
death inducing signalling complex, which includes the adaptor protein Fas-associated death 
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domain (FADD) and initiator caspases, caspase-8 (Figure 2.10). Once caspase-8 is activated, 
a cascade of downstream events occur, which include activation of effector caspases, 
caspase-3 and caspase-7 (Ashkenazi and Dixit, 1998) (Figure 2.10). Caspase-8 also functions 
to cleave Bcl-2 interacting protein (Bid) into truncated Bid (tBid) and interacts with 
pro-apoptotic protein Bax (Figure 2.10). The build-up of Bax in the mitochondria of the cell 
aids in the release of cytochrome c into the cytosol (Desagher et al., 1999; Eskes et al., 2000; 
Li and Yuan, 2008). In the intrinsic pathway the death receptors communicate death signals 
to mitochondria, consequently releasing several mitochondrial intermembrane space proteins 
such as cytochrome c (Figure 2.10). These mitochondrial intermembrane space proteins then 
associate with apoptotic protease activating factor 1 (Apaf-1) and procaspase-9 (intact 
enzyme) to form the apoptosome (Figure 2.10). Once caspase-9 is activated (by enzymatic 
cleavage) it can fulfil its function to cleave and activate effector caspases, caspase-3 and 
caspase-7 (Hengartner, 2000).  
Research of brown algal fucoidan as an anti-cancer agent has shown strong anti-proliferative 
and apoptotic effects on human breast cancer cell line MCF-7 in a dose-dependent manner 
(Yamasaki-Miyamoto et al., 2009). However, this fucoidan showed no cytotoxicity to human 
mammalian epithelial cells (HMEC). Apoptotic cell death has unique characteristics such as 
induction of chromatin condensation, fragmentation of nuclei and DNA; and cleavage of 
apoptotic specific proteins. Fucoidan trigged clustering of sub-G1 population, chromatin 
condensation, and internucleosomal fragmentation of DNA. The effector caspases caspase-3 
and caspase-7 activate deoxyribonuclease (DNase), which results in the cleavage of DNA in 
response to apoptotic stimuli. Interestingly, MCF-7 cells do not express functional caspase-3 
but does express caspase-7. Caspase-7 is an executioner caspase which cleaves poly ADP-
ribose polymerase (PARP) which is a hallmark of apoptotic cell death in the MCF-7 cell line 
(Kaufmann et al., 1993; Liang et al., 2001). Another study showed that PARP was cleaved 
and caspase-7 activated in MCF-7 cells treated with fucoidan and fucoidan-induced apoptosis 
can be inhibited in the presence of caspase-7 inhibitor z-DEVD-fmk (Aisa et al., 2005). A 
hallmark of fucoidan-induced apoptosis is the activation of caspase 3 (Teruya et al., 2007). 
Thus, caspase-7 is required for fucoidan-induced apoptosis in MCF-7 cell lines but not 
caspase-3. Mitochondrial depolarization is another hallmark of apoptosis in MCF-7 cells, and 
Zhang et al. (2011) showed that a fucoidan extract increased mitochondrial depolarization by 
up-regulating the expression of pro-apoptotic proteins Bax and Bad, and down-regulating the 
expression of anti-apoptotic proteins Bcl-2 and Bcl-x. 
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Fig. 2.10. Extrinsic and intrinsic pathways of apoptosis. (Taken from Duprez et al., 2009). 
 
MNPs have been shown to have chemopreventive and chemotherapeutic properties by the 
inhibition of phosphorylation of membrane receptors such as receptor tyrosine kinases 
(RTKs), epidermal growth factor receptors (EGFR) and platelet-derived growth factor 
receptor (PDGFR) (Senthilkumar et al., 2013). These membrane receptors are involved in the 
transduction of mitogenic signals across the plasma membrane and in the facilitation of cell 
growth and propagation. Certain MNPs, such as fucoidan, effectively disrupt growth factor 
stimulated pathways, generally initiating a pathway consisting of Ras to Raf extracellular 
regulated kinase (ERK) to mitogen activated kinase/ERK-kinase (MEK) to activator protein 
(AP)-1 pathway (Figure 2.11). Mitogen activated protein kinase (MAPK) pathways are 
associated with in cellular propagation, differentiation, and apoptosis (Chang and Karin, 
2001; Wada and Penninger, 2004). Whereas, the ERK1/2 pathway is implicated in the 
invasive or migratory behaviour of several malignancies. 
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Fig. 2.11. Fucoidan action in growth signalling molecules and their pathways in cancer. PI3K/AKT 
mediated pathway and EGR-R pathways are important in cancer progression. Fucoidan controls growth 
signalling molecules involved in the cell existence, propagation, apoptosis, invasion, metastasis and 
angiogenesis. Downward black colour arrow indicates that decreased activity of the molecules caused by 
fucoidan. Fucoidan (Taken from Senthilkulmar et al., 2013). 
 
2.7.5) Fucoidan as a natural anti-oxidant 
 
One of fucoidans most extensively researched bioactive properties is its ability to scavenge 
free radicals. Fucoidan acts as an anti-oxidant by neutralising ROS (Mak et al., 2013). The 
food and pharmaceutical industry are constantly seeking natural anti-oxidants that can act as 
preservatives as well as therapeutic agents (Wang et al., 2010) as chemically synthesised 
anti-oxidants are not stable and have potential environmental and health risks (Ito et al., 
1989). The consumption of fruits and vegetables that contain natural anti-oxidants has also 
been correlated to a lower risk of cardiovascular diseases and cancer (Thaipong et al., 2006). 
Rupérez et al. (2002) showed that fucoidan extracts from Fucus vesiculosus displayed 
significant ferric iron reducing anti-oxidant action, whereas de Souza et al. (2007) showed 
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that F. vesiculosus fucoidan exhibited superoxide radical scavenging ability. Fucan fractions 
from Laminaria japonica exhibited anti-oxidant properties in superoxide radical and 
hydroxyl radical scavenging assays (Wang et al., 2009; Wang et al., 2010; Zhao et al., 2012). 
An investigation of the properties of fucoidan compounds which make it an effective anti-
oxidant revealed that the sulphate content of the polysaccharide was positively correlated 
with superoxide radical scavenging activity (de Souza et al., 2007; Wang et al., 2010). 
Polysaccharide extracts from red and green seaweeds such as carrageenans (de Souza et al., 
2007) and ulvans (Zhang et al., 2012) also display anti-oxidant properties that are related to 
their sulphate content. Other polysaccharide specific anti-oxidant properties such as metal 
chelating, free radical, and hydroxyl radical scavenging activities appear to be linked to 
sulphate:fucose ratios (Jiao et al., 2011). 
 
In normal cells, ROS acts as secondary cell signalling messengers for several regular 
biological processes. However, under cellular homeostasis, physiologically produced ROS is 
eliminated through free radical scavenging systems. A hallmark of cancerous cell growth is 
the increase in the rate of production of ROS and a modified redox environment compared to 
cells in homeostasis (Glasauer and Chandel, 2014). Additionally, redox regulation and redox 
signalling have a pivotal part in the formation of tumours (tumorigenesis) and in the response 
to anti-cancer drugs. In the biology of cancer, ROS takes on two-part, contradictory roles. 
These implications for tumorigenesis are significant, especially with respect to cancer 
therapeutics that aim to modulate cellular redox levels. ROS has a fundamental role in cancer 
development and progression by inducing genetic mutations, genome stability, and abnormal 
pro-tumorigenic signalling. Conversely, high levels of ROS can also be toxic to cancer cells 
and may destroy cancer cells. To bring the state of oxidative stress to equilibrium, cancer 
cells intensify their anti-oxidant capacity, which suggests that high ROS levels may have the 
potential to block tumorigenesis. The two-sided role (a double-edged sword) of ROS in 
cancer development is seen when ROS contributes to cancer initiation, progression and 
metastasis, through instigation and modulation of signalling pathways, which control cell 
proliferation, survival, angiogenesis and metastasis (Weinberg et al., 2010; Wallace, 2012). 
This pro-tumorigenic cell signalling cascade is the oncogenic role of ROS. However, the anti-
cancer role is seen when excessive amounts of ROS in cancer cells induce cell death 
signalling, senescence, and cell cycle arrest. Wang et al. (2015) reported on the anti-oxidant 
properties of aqueous and ethanolic fucoidan extracts from Sargassum cristaefolium and how 
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it showed potential anti-cancer activity against HT-29 (human colon cancer cell line) cells by 
scavenging ROS, an important determinant in cancer progression.  
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2.8) Concluding Remarks: Towards isolating and chemically characterising an 
endemic fucoidan molecule 
 
Fucoidans are natural compounds from brown seaweeds that possess several potent 
bioactivities. However, these bioactive properties have not been elucidated due to the 
heterogeneity of the compounds. These polysaccharides differ from species to species, and 
the variability in structure and chemical composition is subject to several biases. Age, 
life-cycle, sexual maturity and geochemistry are intrinsic factors that affect the complex 
structural identity and complexity of these compounds. Extrinsic factors include extraction 
method, temperature, pH and time. Numerous studies have explored optimal extraction 
strategies for fucoidan from species from Europe, Asia, Australia, and New Zealand of 
commercial, environmental, and agronomical importance. However, to the best of our 
knowledge this is the first study investigating the extraction and characterisation of fucoidan 
from endemic brown seaweeds of South Africa. In order to possibly characterize 
heterogeneous fucoidan compounds a unified approach is required to holistically study these 
polysaccharides. A standardised extraction technique is needed to account for biodiversity of 
fucoidan from different seaweeds and to retain structural features, which are the key to 
understanding fucoidans bioactivities. Therefore, this study aims to identify a standardised 
fucoidan extraction technique, establish an effective purification and fractionation platform, 
and assess the bioactivity of these fucose-containing-sulphated-polysaccharides with 
emphasis on anti-cancer and cytotoxicity screening against human cancerous cell lines. This 
study will also assess the variability of fucoidan with respect to extraction method; 
comparatively analyse the chemical composition between crude and fractionated, and 
purified fucoidan; and assess if these factors influence overall bioactivity. 
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Chapter 3. Assessing the effect of extraction 
method on fucoidan heterogeneity 
 
 
Abstract 
 
Fucoidan is a marine-derived sulphated polysaccharide with useful properties ideal for food, 
chemical and pharmaceutical industries. The polysaccharide consists largely of L-fucose, has 
a highly heterogeneous structure and is of diverse origin. In this study different extraction 
methods were assessed for effect on fucoidan heterogeneity from Ecklonia maxima, 
Laminaria pallida and Splachnidium rugosum. Extraction methods employed hot water, 
hydrochloric acid or calcium chloride. Extracts were assessed for fucoidan yield and purity 
by colorimetric assays. The highest fucoidan yield was obtained with the hot water method as 
seen by highest L-fucose content. Splachnidium rugosum extracts contained ~5 times more 
L-fucose (265 ± 49.2 µg/mL) than Ecklonia maxima and Laminaria pallida extracts. The salt 
method yielded extracts free of contaminants, however L-fucose content in all extracts was 
>20 times lower. Acid extraction yielded the highest levels of uronic acid contamination and 
liberated sulphate from the fucoidan polysaccharide. The fucose-to-sulphate ratio for 
Ecklonia maxima was approximately 1:5, whilst the ratios for Splachnidium rugosum and 
Laminaria pallida were approximately 1:1 and 1:2, respectively. The acid and salt method 
removed all traces of protein contaminants, while the hot water method retained very low 
levels of protein (<40 µg/mL). The extraction method used to isolate fucoidan was a 
determining factor in yield and purity. Chemical compositional analyses of hot water extracts 
were assessed by gas chromatography mass spectroscopy. Splachnidium rugosum and 
Laminaria pallida extracts consisted largely of L-fucose, while Ecklonia maxima fucoidan 
was characterized by an abundance of glucose. Other neutral sugars present at low amounts 
were galactose, mannose, rhamnose, xylose and fructose. The L-fucose ratio in crude and 
purified fucoidan extracts was highest in Splachnidium rugosum (79-98%) which was 
comparable to the ratio determined for the commercial Fucus vesiculosus control (86%). 
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3.1)  Introduction 
 
Fucoidan, laminarin, and alginic acid are the most concentrated water-soluble 
polysaccharides in brown macroalgae (seaweeds) (Skriptsova et al., 2012). Unique 
rheological properties offer commercial value to medical, biotechnological, agricultural and 
food industries. Caution is required when isolating these polysaccharides from brown 
macroalgae as more abundant polysaccharides (or even unwanted contaminants) with similar 
properties are often co-extracted (Ale et al., 2012). 
Over the past century, fucoidan and other sulphated polysaccharides have been extracted 
from brown macroalgae with a myriad of extraction techniques (Ale et al., 2011). Fucoidan 
compounds have been shown to possess enormous commercial and pharmaceutical value 
(Michalak and Chojnacka, 2015). However, to the best of our knowledge, fucoidan 
compounds from indigenous South African brown macroalgae have not been characterised or 
studied. The South African coastline is characterized by high biodiversity (Griffiths et al., 
2010) which has been largely untapped, primarily because of the large number of pristine 
marine protected areas (MPA). The pharmaceutical and biotechnology sector could benefit 
greatly by exploiting marine algal resources, which are currently mostly being used for 
mariculture (e.g. abalone feed). Moreover, abundant amounts of seaweed wash onto the shore 
where it decays. Thus, seaweed species are ideal candidates for bioprospecting studies geared 
towards the identification of bioactive compounds such as fucoidan. 
The method used for algal polysaccharide extraction should be governed by the application of 
the end-point use of the compound (e.g. application in food industry or as a potential 
therapeutic agent). For example, the food industry requires good emulsifying agents, whereas 
in the pharmaceutical industry natural product derived drug targets should be of high purity, 
high bioactivity, bioavailability and have low cytotoxicity (Tseng, 2001; Pulz and Gross, 
2004; Fitton et al., 2015). 
Fucoidan compounds have a high degree of structural diversity, with studies showing 
inter-compositional variation between different species of brown macroalgae, as well as 
intra-compositional variations of fucoidan within the same species (Lee et al., 2006; Ale et 
al., 2013). The fucoidan extraction method adds significantly to its diversity, introducing a 
certain amount of bias which can lead to changes in structure, charge, molecular weight and 
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chemical composition (Ale and Meyer, 2013). Extraction methods typically employ hot 
water, hydrochloric acid (HCl) or sulphuric acid (H2SO4), or salt such as calcium chloride 
(CaCl2) (Ale et al., 2011). A consensus has yet to be reached as to which extraction method 
yields the highest quality fucoidan, while retaining the compound‘s natural chemistry and 
structural traits. This chapter will assess the effect of various extraction methods on the 
variability of fucoidan extracts from South African brown algae. 
 
3.1.1) Aim and objectives of this chapter 
 
The aim of this Chapter was to identify an extraction method for the isolation of high quality 
fucoidan from brown macroalgal species of South Africa. Factors to be considered when 
extracting good quality fucoidan are fucoidan yield, purity, and desired chemical 
characteristics. The aim was broken down into two objectives: 
1. Assessment of water, acid, and salt extraction methods on fucoidan yield, as well as 
analyses of sulphate, protein, and uronic acid content using spectrophotometric 
assays. 
2. Determination of the chemical composition of fucoidan extracts by gas 
chromatography mass spectroscopy (GC-MS) and spectrophotometric analysis. 
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3.2) Methods and materials 
 
3.2.1) Sampling and processing 
 
Brown macroalgae species E. maxima, L. pallida and S. rugosum were harvested from three 
locations in the Western Cape, South Africa: Betty‘s Bay (34° 21' 20.16 "S; 18° 55' 42.96"E), 
Rooi Els (34° 18'05"S; 18° 48' 59"E) and Oudekraal (33°59'0"S; 18° 21'0"E) (Figure 3.1). 
S. rugosum was harvested from rocks outside the intertidal zone (Figure 3.2 A). E. maxima 
and L. pallida were collected by scuba diving a few metres offshore from intertidal zones 
(Figure 3.2 B and C). Three biological replicates of sporophytes from each species were 
collected and processed in the laboratory. 
Seaweed was rinsed with distilled water and left to dry at room temperature (RT). Samples to 
be processed immediately were further dried at 45°C for 3 days and the remainder was frozen 
at -80°C. Dried samples were milled to a fine powder by grinding with a mortar and pestle. 
 
A. B.  C.  
Fig. 3.1.Sampling sites of brown macroalgae in the Western Cape, South Africa. A. Betty‘s Bay; B. Rooi 
Els; C. Oudekraal. 
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A. B.  C.  
Fig. 3.2. Species of brown macroalgae harvested from South African coastline. A. Splachnidium rugosum; 
B. Ecklonia maxima; C. Laminaria pallida. Seaweed was collected and immediately transported to the 
laboratory for processing. Seaweed species were identified by Mark Rothman and Chris Boothroyd of the 
Department of Agrictural, Forestry, and Fisheries (DAFF). 
 
3.2.2) Fucoidan extraction methods 
 
3.2.2.1) Water extraction 
 
Fucoidan was extracted from dried seaweed samples using the hot water extraction method 
described by Lee et al. (2012) with slight modifications. Dried biomass (0.5 g) from three 
biological replicates were dissolved in 50 mL distilled deionized water (ddH2O), respectively. 
Samples were incubated overnight at 70°C with agitation, filtered through Whatman
®
 Filter 
Paper 42 (Sigma-Aldrich), frozen at -80°C, and lyophilised to a dry powder (Figure 3.3). 
 
 
Fig. 3.3. Lyophilised Splachnidium rugosum fucoidan after hot water extraction. 
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3.2.2.2) Acid extraction 
 
Fucoidan was extracted from S. rugosum, L. pallida and E. maxima using an acid extraction 
method as described by Lee et al. (2004) with slight modifications. Dried biomass from three 
biological replicas was washed by dissolving 0.5 g in 0.15M HCl at 65°C for 2 hours. 
Samples were centrifuged at 7,500 x g for 40 min at RT. The supernatant was neutralized 
with 3M sodium hydroxide (NaOH) (Merck) and stored at 4°C. Fucoidan was precipitated 
from solution by the addition of 4 volumes (vol) absolute ethanol (EtOH) (Kimix Chemicals 
& Laboratory Suppliers) at 4°C, overnight. Polysaccharides were recovered by centrifugation 
at 7,500 x g for 40 min at RT. Fucoidan pellets were washed with absolute EtOH, dried 
overnight at 40°C, and milled by grinding in a mortar and pestle to a fine powder (Figure 
3.4). Dried fucoidan samples were stored at RT in conical tubes (SDL).  
 
 
Fig. 3.4. Splachnidium rugosum fucoidan after acid extraction. 
 
3.2.2.3) Salt extraction 
 
Fucoidan was extracted from S. rugosum, L. pallida and E. maxima using a modified salt 
extraction method as described by Bilan et al. (2002) and Mak et al. (2013). Dried biomass 
(0.5 g) from three biological replicates were incubated overnight at RT in 5 mL 
methanol-chloroform-water (4:2:1), with regular stirring, to remove macromolecule 
contaminants such as pigments, lipids, and proteins. Supernatants were decanted and defatted 
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biomass was washed with acetone and dried overnight in a fume hood. Dried biomass was 
mixed with 5 mL of 2% (w/v) CaCl2 and incubated at 85°C for 5 hours with mechanical 
stirring to extract polysaccharides. The supernatant was mixed with 1.5 mL of 10% (w/v) 
hexadecyltrimethylammoniumbromide (CTAB) (Merck) and stored at 4°C overnight to 
precipitate fucoidan. The CTAB-supernatant complex was centrifuged at 7,500 x g for 40 
min at RT, rinsed with ddH2O, and washed with 10 mL 20% ethanolic sodium iodide (NaI) 
(Sigma-Aldrich). Residual CTAB was removed by extending the washing step to 3 days at 
RT with mechanical stirring. Solutions were centrifuged at 7,500 x g for 40 min at RT and 
the resulting pellets were washed with EtOH to remove NaI. Samples were lyophilised to 
obtain a water soluble white powder (Figure 3.5). 
 
 
Fig. 3.5 Lyophilised Splachnidium rugosum fucoidan after salt extraction. 
 
3.2.3) Chemical composition of fucoidan 
 
3.2.3.1) L-fucose assay 
 
Fucoidan was assessed for L-fucose oligosaccharide content by a method developed by 
Dische and Shettles (1948). This method was modified by down-scaling the assay to 
microtitre plate volumes. Firstly, 200 µL of 1 mg/mL fucoidan sample was added to 900 µL 
of diluted H2SO4 (95-98%) (1:7 in ddH2O). Acid hydrolysis was performed in triplicate. 
Samples were boiled at 100°C for 10 min, followed by cooling on ice for 5 min. Once 
samples reached RT, 50 µL 3% (w/v) L-cysteine HCl (Sigma-Aldrich) solution was added. 
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Each experimental sample had a sample blank without L-cysteine HCL that was used to 
calibrate the spectrophotometer (POLARstar Omega, BMG Labtech) before measuring the 
absorbance readings of experimental samples. Absorbance readings were calculated using the 
following equation:            -            to correct for the presence of hexoses, as 
methylpentoses absorbance values were the objective. Commercially procured crude fucoidan 
from F. vesiculosus (Sigma-Aldrich) was prepared in the same manner as the experimental 
samples and used as a positive control. A standard curve was constructed with L-fucose 
(Sigma-Aldrich) as a standard with a concentration range between 0.01-0.1 mg/mL (Figure 
3.6).  
 
 
Fig. 3.6. Microtitre plate assay for L-fucose content. Lane A1-C1: 10 μg/mL; Lane A2-C2: 20 μg/mL; Lane 
A3-C3:40 μg/mL; Lane A4-C4: 60 μg/mL; Lane A5-C5: 80 μg/mL; Lane A6-C6: 100 μg/mL; Lane A7-C7: 120 
μg/mL; Lane A78-C8: 140 μg/mL; Lane A9-C9: 160 μg/mL. 
 
3.2.3.2) Sulphate assay 
 
Fucoidan was assessed for sulphate (SO4
2-
) content by a method developed by Dodgson and 
Price (1962). This method was modified by performing the assay in microtitre plate volumes. 
Stock solutions included a conditioning reagent, 1 mg/mL potassium sulphate (K2SO4) 
(Sigma-Aldrich) and 3% (w/v) barium chloride dihydrate (BaCl2) (Sigma-Aldrich). The 
conditioning reagent consisted of 50 mL glycerol (Sigma-Aldrich), 30 mL HCl 32% (v/v) 
(Merck), 100 mL 2-propanol (Merck) and 250 mL 5M sodium chloride (Merck) made up to 1 
L with ddH2O. Fucoidan stock solutions of 1 mg/mL were prepared in ddH2O. Serial 
dilutions of K2SO4 standards and fucoidan samples were prepared in a 96-well flat bottom 
microtitre plate (Greiner). Standards and samples were loaded in triplicate (final volume of 
A 
B 
C 
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250 µL) as follows: K2SO4 standards (0-500 μg/mL), containing 12.5 µL of conditioning 
reagent and 25 µL of 3% (w/v) BaCl2 stock solution; 125 µL of fucoidan stock (1mg/mL) 
with 12.5 µL of conditioning reagent, 87.5 µL of ddH2O and 25 µL of 3% (w/v) BaCl2. The 
microtitre plate was agitated for 1 min at RT so that a precipitate could form (Figure 3.7). 
The resulting suspension was measured spectrophotometrically at a wavelength of 420 nm 
using a Nano spectrophotometer (BMG LABTECH). A water blank was prepared and treated 
in the same manner and was subtracted from the raw data.  
 
 
 
Fig. 3.7. Microtitre plate assay for sulphate content. Lane A1-C1: 0 μg/mL; Lane A2-C2: 50 μg/mL; Lane 
A3-C3; 100 μg/mL; Lane A4-C4: 200 μg/mL; Lane A5-C5: 300 μg/mL; Lane A6 C6: 400 μg/mL; Lane A7-C7: 
500 μg/mL. 
 
3.2.3.3) Uronic acid assay 
 
Fucoidan was assessed for uronic acid contamination by a method that was first developed by 
Dische (1947) and later optimised by Cesaretti et al. (2003). This method was further 
modified by boiling the samples in microcentrifuge tubes (Eppendorf) before transferring to 
microtitre plates. Reagents included 25mM sodium tetraborate reagent (Na2B4O7) prepared in 
concentrated H2SO4 (Sigma-Aldrich) and 0.125% (w/v) carbazole (C12H9N) reagent prepared 
in absolute ethanol. D-Glucuronic acid (Sigma-Aldrich) standards were prepared from a 
1 mg/mL stock solution in 2 mL heat-resistant microcentrifuge tubes (Eppendorf) to 
concentrations ranging from 25-150 µg/mL in a final volume of 50 µL. This was performed 
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in triplicate. Ten-fold serial dilutions were prepared from 1 mg/mL fucoidan samples, to a 
final volume of 50 µL, in 2 mL heat-sensitive microcentrifuge tubes. This was conducted in 
triplicate and followed by the addition of 200 µL of 25 mM Na2B4O7. Samples were boiled at 
100°C for 10 min. After cooling on ice for 10 min, 50 µL of C12H9N was added and the 
samples were boiled at 100°C for 10 min. After cooling on ice, 250 µL aliquots of the 
standards, samples and blanks were transferred to a 96-well flat bottom microtitre plate 
(Greiner) and measured spectrophometrically (POLARstar Omega, BMG Labtech) at a 
wavelength of 550 nm (Figure 3.8). Blanks contained ddH2O instead of fucoidan sample and 
were used to zero the spectrophotometer before measuring the absorbance readings of the 
experimental samples. 
 
 
Fig. 3.8. Microtitre plate assay for uronic acid content. Lane A1-C1: 0 μg/mL; Lane A2-C2: 25μg/mL; Lane 
A3-C3; 50 μg/mL; Lane A4-C4: 75 μg/mL; Lane A5-C5: 100 μg/mL; Lane A6-C6: 125 μg/mL; and Lane 
A7-C7: 150 μg/mL. 
 
3.2.3.4) Protein assay 
 
The Bradford Assay (Bradford, 1976) was used to quantify protein concentration (mg/mL) in 
96-well microtitre plates. Protein standards were prepared using Bovine serum albumin 
(BSA) (Sigma-Aldrich) over a concentration range of 0.2-1.2 mg/mL. Samples of unknown 
concentration were prepared within an approximate range of the protein standards. A volume 
of 5 μL of protein standard, blank, or unknown sample was added to respective wells, 
followed by the addition of 250 μL Bradford Reagent (Sigma-Aldrich). Samples were mixed 
A 
B 
C 
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and incubated at RT for 30 min and the absorbance determined at a wavelength of 595 nm. 
The net absorbance versus the protein concentration of the standards was plotted and the 
protein concentration of the unknown samples was determined by correlating the net Abs 595 
nm against the standard curve (Figure 3.9). 
 
 
Fig. 3.9. Microtitre plate assay for protein content. Lane A1-C1: 0 μg/mL; Lane A2-C2: 200 μg/mL; Lane 
A3-C3: 400 μg/mL; Lane A4-C4: 600 μg/mL; Lane A5-C5: 800 μg/mL; Lane A6-C6: 1000 μg/mL; Lane 
A7-C7: 1200 μg/mL. 
 
3.2.4) Acid hydrolysis of fucoidan  
 
E. maxima, L. pallida and S rugosum samples were dried at 40°C for 2-3 days. Fucoidan was 
extracted with a hot water method (Section 3.2.2.1). A 1 mg/mL stock of fucoidan was 
prepared by dissolving the lyophilised biomass in ddH2O. Fucoidan extracts were acid 
hydrolysed for 2 hours at 100°C in 0.5 mL of 5M HCl. Samples were reconstituted in ddH2O 
to a concentration of 1 mg/mL. Native and acid-hydrolysed samples were assayed for 
sulphate content by the turbidimetric precipitation in BaCl2 as previously described (Section 
3.2.3.2). For sulphate content analysis, 0.5 mL of 1 mg/mL fucoidan stock was used. A 
water-blank was prepared and treated in the same manner by adding 0.5 mL of ddH2O to 0.5 
mL of 5M HCl, and incubated at 100°C for 2 hours. 
 
3.2.5) High Performance Liquid Chromatography analysis of fucoidan 
 
Molecular weight of crude fucoidan tissue extracts and irradiated fucoidan precipitated from 
mucilage were run as a service and determined by High Performance Liquid 
A 
B 
C 
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Chromatography (HPLC) on an Agilent 1200 series HPLC instrument. A volume of 50 µL 
of 1 mg/mL fucoidan samples were injected into the HPLC, and run on Shodex 804/805 
columns in series for 30 min with a flow rate of 1 mL/min. The buffer used for HPLC, 10 
mM phosphate buffered saline (PBS), was equilibrated to pH 7.0.  
 
3.2.6) Gas chromatography mass spectrometry  
 
3.2.6.1) Sample preparation for gas chromatography mass spectrometry analysis 
 
Chemical characterization of crude and purified fucoidan was conducted by GC-MS that was 
run as a service, with specifications and parameters used described below. Polysaccharides 
were hydrolysed into monomeric units before being subjected to GC-MS analysis by a 
modified method described by Goubet et al. (2002). Internal standard was prepared by 
resuspending/dissolving 20 ng/mL of adonitol (ribitol) (Sigma-Aldrich) in 70% (v/v) aqueous 
methanol (Sigma-Aldrich). Approximately 0.2-1 mg of polysaccharide was deposited into 2 
mL screw cap tubes (Eppendorf)  and resuspended into 1 mL of 70% (v/v) methanolic 
adonitol solution and vortexed until homogeneity. Monosaccharide sugars used as reference 
standards were prepared in the same manner but were not subjected to hydrolysis. 
Monomeric sugar standards (Sigma-Aldrich) included L-fucose, galactose, glucose, fructose, 
mannose, rhamnose, and xylose were prepared to 1mg/mL in UV-treated ddH2O. Screw caps 
were pierced before hydrolysis to ensure that the tubes did not explode during built up 
pressure. Polysaccharides were hydrolysed by boiling at 100°C in 5M trifluroacetic acid 
(TFA) (Sigma-Aldrich) for 2 hours. Hydrolysates were dried in a SpeedVac (Labconco) and 
washed with 0.5 mL methanol (MeOH). After vigorous mixing by vortex, samples were dried 
in the SpeedVac and the washing step repeated.  
Hydrolysates were derivatized by adding 80 µL of 20 mg/mL methoxyamine hydrochloride 
in pyridine for 90 min at 30 °C. Samples were silyated by adding 80 μL 
N-Methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA) (Sigma-Aldrich) for 30 min at 
37°C. Samples were injected into a Agilent DB5ms column of a mass spectrometer (Agilent 
Technologies Network Gas Chromatograph 7890) and run under the following parameters: 
helium gas mobile phase, constant flow of 1.3928 mL/min; temperature gradient of 70 °C for 
 
 
 
 
  
69 
 
0.5 min; ramp at 30 °C/min to 150 °C; ramp at 5 °C/min to 220 °C; run time of 32.267 min. 
Mass spectrometric scans were acquired as single quadrupole scans between 0 and 1000 m/z 
(mass to charge ratio) on an Agilent 7000A triple quadrupole mass spectrometer. 
 
3.2.7) Statistical analysis 
 
Significant differences between polysaccharide extraction techniques were determined by 
one-way analysis of variance (ANOVA). Statistically significant differences were assessed 
using Tukey‘s honest significant difference (HSD) or Student t-test. ANOVA and Student t-
test were performed with Microsoft
®
 Office Excel 2010 Version 14.0.7153.500 and Tukey‘s 
HSD by GraphPad Prism 6 Version 6.01. 
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3.3)  Results  
 
3.3.1) Colorimetric analyses 
 
Fucoidan extracts were assessed by several colorimetric tests to determine yield, basic 
chemical composition and purity. Fucoidan was hydrolysed into oligosaccharide units and 
assayed for L-fucose content. L-fucose is the building block of the skeletal structure of 
fucoidan (Dische and Shettles, 1948). Sulphate content was assessed by the turbidimetric 
precipitation of SO4
2-
 ions in a BaCl2 solution (Dodgson and Price, 1962). Hydrolysed and 
native fucoidan were assessed for SO4
2-
 content. Fucoidan is a sulphated polysaccharide that 
contains sulphate groups on varying positions of the L-fucose backbone. The positioning and 
concentration of SO4
2-
 have a direct correlation to the compound‘s bioactivity (Jiao et al., 
2011). Purity of fucoidan was assessed by determining uronic acid and protein content. 
Uronic acid is a major component of alginate (alginic acid) which is abundant in brown 
macroalgae and is easily co-extracted with fucoidan (Ale et al., 2013). Uronic acid 
contamination was assayed by the carbazole sulphuric acid reaction (Cesaretti et al., 2003). 
Protein content was determined with the Bradford (1976) assay. 
 
3.3.1.1) Fucoidan extraction from Ecklonia maxima 
 
Three methods were employed to assess the suitability of extraction technique of fucoidan 
from Ecklonia maxima. The hot water extraction technique yielded highest (p < 0.05) 
concentration of L-fucose (63 ± 6.7 µg/mL), followed by extraction with HCl (26 ± 5.2 
µg/mL) and salt (i.e. CaCl2) (3 ± 0.4 µg/mL) (Figure 3.10, Table 3.1). Acid extraction with 
HCl yielded highest (p < 0.05) sulphate content (136 ± 43.9 µg/mL), followed by extraction 
with water (44 ± 5.0 µg/mL) and salt (32 ± 5.5 µg/mL). Acid and salt extraction techniques 
removed all protein, while the hot water extraction method removed most protein with only 9 
± 14.2 µg/mL protein remaining after extraction. Uronic acid contamination was assessed 
spectrophometrically in a 96-well microtitre plate. The salt extraction technique yielded 
samples with the lowest (p < 0.05) uronic acid content (42 ± 13.3 µg/mL), followed by 
extraction with water (77 ± 24.1 µg/mL) and acid (102 ± 21.3 µg/mL). The molecular weight 
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of E. maxima fucoidan was estimated by HPLC (Section 3.2.5) to be approximately 470 kDa 
(Figure 3.11). 
 
 
Fig. 3.10. Chemical profile of fucoidan extracted from Ecklonia maxima using hot water, acid or salt. 
Fucoidan compounds were assessed for L-fucose, sulphate, uronic acid and protein content. Mean ± standard 
error (SE) (n = 3).  
 
Table 3.1. Fucoidan profile of brown seaweed extracts. 
Species Extraction method L-fucose 
(µg/mL) 
Sulphate 
(µg/mL) 
Uronic acid 
(µg/mL) 
Protein 
(µg/mL) 
      
E. maxima Hot water 63 ± 6.7 44 ± 5.0 77 ± 24.1 9 ± 14.2 
      
 Acid 26 ± 5.2 136 ± 43.9 102 ± 21.3 0 
      
 Salt 3 ± 0.4 32 ± 5.5 42 ± 13.3 0 
      
L. pallida Hot water 51 ± 5.5 29 ± 9.5 22 ± 7.1 8 ± 2.5 
      
 Acid 33 ± 5.9 55 ± 17.2 69 ± 27.7  0 
      
 Salt 2 ± 0.7 15 ± 3.2 32 ± 2.8 0 
      
S. rugosum Hot water 265 ± 49.2 157 ± 6.7 50 ± 9.6 36 ± 0.4 
      
 Acid 220 ± 13.4 226 ± 40.2 83 ± 14.7 0 
      
 Salt 12 ± 4.8 96 ± 29.9 19 ±8.1 0 
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Fig. 3.11. Chromatogram of molecular weight estimation of intact and fractionated fucoidan compounds analysed by HPLC (Section 3.2.5). B. Commercially 
procured fucoidan from F. vesiculosus (Sigma-Aldrich) C. Non-irradiated untreated control (0 kGy) of S. rugosum fucoidan D. S. rugosum fucoidan γ-irradiated at 10 kGy E. 
S. rugosum fucoidan γ-irradiated at 30 kGy F. S. rugosum fucoidan γ-irradiated at 50 kGy. I. E. maxima crude hot water extracted fucoidan J. L. pallida crude hot water 
extracted fucoidan. Fucoidan was prepared to 1 mg/mL in ddH2O before being run on HPLC. 
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3.3.1.2) Fucoidan extraction from Laminaria pallida 
 
Three methods were assessed to extract fucoidan from Laminaria pallida. The hot water 
extraction technique yielded highest (p < 0.05) amounts of L-fucose with 51 ± 5.5 µg/mL, 
followed by the HCl extraction technique with 33 ± 5.9 µg/mL, and the CaCl2 salt extraction 
technique with the lowest yield at 2 ± 0.7 µg/mL (Figure 3.3; Table 3.1). The hot water 
extraction technique also yielded lowest (p < 0.05) uronic acid at 22 ± 7.1 µg/mL, followed 
by the salt extraction technique with 32 ± 2.8 µg/mL, and the acid extraction technique with 
69 ± 27.7 µg/mL. The HCl method yielded highest (p < 0.05) sulphate content 
55 ± 17.2 µg/mL, followed by water method at 29 ± 9.5 µg/mL, with the salt method yielding 
the lowest at 15 ± 3.2 µg/mL (Figure 3.12). The acid and salt methods removed all protein, 
while the hot water extraction technique yielded a low protein content of 8 ± 2.5 µg/mL 
(Figure 3.12, Table 3.1). The molecular weight of L. pallida was estimated by HPLC (Section 
3.2.5) to be approximately 197 kDa (Figure 3.11). 
 
 
Fig. 3.12. Chemical profile of fucoidan isolated from Laminaria pallida using hot water, acid, or salt. 
Fucoidan compounds were assessed for L-fucose, sulphate, uronic acid and protein. Mean ± SE (n = 3).  
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3.3.1.3) Fucoidan extraction from Splachnidium rugosum 
 
Three methods were assessed to extract fucoidan from S. rugosum. The hot water extraction 
technique yielded the highest (p < 0.05) amount of L-fucose with 265 ± 49.2 µg/mL, 
followed by the HCl extraction technique with 220 ± 13.4 µg/mL, and the CaCl2 salt 
extraction technique had the lowest yield at 12 ± 4.8 µg/mL (Figure 3.13; Table 3.1). The 
acid extraction technique yielded the highest (p < 0.05) sulphate content of 226 ± 40.2 
µg/mL, followed by the hot water extraction technique with 157 ± 6.7 µg/mL, and the salt 
extraction technique with the lowest yield of 96 ± 29.9µg/mL. The salt extraction technique 
produced the lowest content of uronic acid with 19 ±8.1 µg/mL, followed by the hot water 
extraction technique with 50 ± 9.6 µg/mL, and the acid extraction technique with 83 ± 14.7 
µg/mL. The HCl and CaCl2 salt technique completely removed protein from S. rugosum 
fucoidan, whereas the hot water extraction technique yielded a low protein content of 
36 ± 0.4 µg/mL. Molecular weight of S. rugosum could not be determined by HPLC and was 
not displayed on chromatogram (Sample A, Figure 3.11). 
 
 
Fig. 3.13. Chemical profile of fucoidan isolated from Splachnidium rugosum using hot water, acid, or salt. 
Fucoidan compounds were assessed for L-fucose, sulphate, uronic acid protein. Mean ± SE (n = 3).  
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3.3.1.4) Assessing acid hydrolysed vs non-hydrolysed brown macroalgal fucoidan 
 
Fucoidan was extracted from seaweed samples with the hot water method and analysed for 
sulphate content before and after acid hydrolysis with HCl (Figure 3.14). The highest 
sulphate content was measured in S. rugosum polysaccharide extracts, 42 ± 9.1 µg/mL and 
72 ± 6.6 µg/mL, respectively, in native and hydrolysed samples. E. maxima extracts and 
hydrolysates contained 19 ± 1.9 µg/mL and 44 ± 5.0 µg/mL sulphate, respectively. Sulphate 
content in L. pallida was the lowest at 5 ± 0.8 µg/mL and 29 ± 9.5 µg/mL, respectively, in 
native and hydrolysed samples.  
 
 
 
Fig. 3.14. Sulphate content of native and acid hydrolysed fucoidan from several brown macroalage. 
Fucoidan compounds were extracted from S. rugosum, E. maxima, and L. pallida tissue using a hot water 
extraction method. Fucoidan compounds were assessed for sulphate content by turbidimetric barium chloride 
method before and after hydrolysis with HCl. Mean ± SE (n = 3). 
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3.3.2) Fucoidan compositional analysis by gas chromatography mass 
spectroscopy   
 
Fucoidan was extracted from several samples of brown seaweeds using a hot water extraction 
method and analysed by GC-MS. Samples included commercially procured fucoidan from 
F. vesiculosus as well as crude and purified extracts from S. rugosum, E. maxima and 
L. pallida (Table 3.2). S. rugosum crude extracts consisted mainly of L-fucose and galactose, 
with trace amounts of glucose, mannose and xylose. E. maxima crude fucoidan extracts 
consisted mainly of L-fucose and glucose, with trace amounts of xylose, mannose, galactose 
and rhamnose. L. pallida extracts consisted mainly of L-fucose, a fair amount of galactose, 
and small amounts of xylose, mannose, rhamnose and glucose. The F. vesiculosus positive 
control fucoidan consisted mainly of L-fucose, a fair amount of galactose, and trace amounts 
of xylose, mannose and rhamnose.
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Table 3.2. Monosaccharide composition of hot water fucoidan extracts by GC-MS analysis.
a
 
Sample 
code 
Species Quality Biological  
replicate 
b
Fucose 
% 
b
Fructose 
% 
b
Galactose 
% 
b
Glucose 
% 
b
Mannose 
% 
b
Rhamnos
e 
% 
b
Xylose 
% 
           
A S. rugosum Crude 1 79.39 - 18.86 
 
0.87 
 
0.87 - - 
           
B S. rugosum Crude 2 92.83 - 0.98 
 
4.24 
 
- - 1.94 
           
C S. rugosum Crude 3 97.74 
 
- - 1.03 
 
- - 1.23 
           
D S. rugosum Purified 1 78.20 13.55 
 
- 1.40 
 
- - 6.85 
           
E S. rugosum Purified 2 79.37 
 
15.04 
 
- 1.95 
 
- 0.85 
 
0.85 
           
F S. rugosum Purified 3 84.85 
 
6.58 
 
- - - - 8.58 
           
G 
c
F. vesiculosus  
 
Crude 1 86.18 - 1.95 
 
- 5.08 
 
2.27 4.52 
           
H L. pallida Crude 1 73.72 
 
- 11.86 
 
2.66 
 
4.69 
 
1.24 
 
5.83 
           
I E. maxima Crude 1 26.36 5.32 
 
3.25 
 
60.35 
 
3.77 
 
- 0.95 
a
Fucoidan samples extracted from several samples of brown seaweeds were analysed by GC-MS. The values listed above represent baseline corrected peak area (converted to %): the total 
number of ions that hit the detector during the time the peak was eluting, minus the baseline count.  
b
Monosaccharide constituent found within the sample and expressed as % abundance. 
c
Commercially procured fucoidan from Sigma-Aldrich used as a control in this study.
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3.4) Discussion 
 
3.4.1) Fucoidan extraction from brown seaweeds  
 
Fucoidan has been extracted from seaweeds with a myriad of different techniques, most of 
which use water, mild to concentrated acids, or salts. Good quality fucoidan consists of high 
levels of L-fucose, a high degree of sulphation, and low levels of contaminants such as uronic 
acid and protein (Ale et al., 2011; Ale et al., 2013). Moreover, it is important to retain the 
native structure of fucoidan as it is often structural characteristics that confer bioactive 
properties in higher biological systems. The extraction methodology is pivotal to preserving 
the structural integrity of fucoidan. Other factors are linked to the host, which include species 
biogeography, sampling season, climate and age of organism when sampled.  
Fucoidan was extracted from South African brown seaweed species, S. rugosum, E. maxima 
and L. pallida, using hot water, mild HCl solution, or CaCl2. Extracts were assessed by 
colorimetric assays to determine fucoidan yield, sulphate content and purity (Table 3.1). 
Samples were hydrolysed into oligosaccharide units and assayed for L-fucose content. The 
hot water method delivered extracts with highest concentration of L-fucose, suggesting 
highest fucoidan yield. L-fucose is the building block of the skeletal structure of fucoidan 
(Dische and Shettles, 1948). Highest sulphate content was obtained with HCl extraction 
compared to methods using hot water and salt. This was not surprising as more sulphate may 
be liberated from fucoidan polysaccharides with acid hydrolysis. Fucoidan is a sulphated 
polysaccharide that contains sulphate groups at varying positions of the L-fucose backbone. 
The positioning and concentration of SO4
2-
 have a direct correlation to the compound‘s 
bioactivity (Jiao et al., 2011). Fucoidan has been extracted using acetic acid, HCl, and H2SO4 
ranging from dilute, mild, to highly acidic conditions (Ale et al., 2011). HCl is preferred 
since H2SO4 may interfere with sulphate analysis. Purity of fucoidan extracts were assessed 
by determining uronic acid and protein content. Acid extraction resulted in highest uronic 
acid contamination. Uronic acid is a major component of alginate (alginic acid) which is 
abundant in brown macroalgae and is easily co-extracted with fucoidan (Ale et al., 2013). 
HCl and CaCl2 methods yielded extracts free of protein; hot water extracts contained very 
low levels 0-9 µg/mL) which was considered pure, with the exception of S. rugosum extract 
that contained 36 µg/mL of protein. 
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This is the first study reporting on the presence of fucoidan in E. maxima, a species endemic 
to South Africa. The L-fucose content in hot water extracts was similar to the content 
reported for water extracts from Ecklonia cava, a species from the Northern Hemisphere (Lee 
et al., 2012). Extraction with CaCl2 yielded samples with the lowest levels of contaminants 
such as protein and uronic acid. Low uronic acid content in extracts suggests low 
contamination with alginate. L-fucose content, and therefore fucoidan yield, was however 
also very low. Extraction of fucoidan with CaCl2 is therefore not recommended for 
E. maxima. This method has however been successfully used to extract copious amounts of 
fucoidan, relatively free of contaminants, from other brown algal species such as Undaria 
pinnatifida (Mak et al., 2013). 
In L. pallida extracts, the hot water technique yielded highest L-fucose content and lowest 
uronic acid levels (Table 3.1). The L-fucose content was however significantly lower 
compared to E. maxima and S. rugosum. Fucoidan may be present at lower abundance in cell 
walls of this species. Lowest sulphate content in acid hydrolysed samples may be attributed 
to lower fucoidan yield. This is the first study reporting on the presence of fucoidan in 
L. pallida, a species endemic to South Africa.  
The S. rugosum L-fucose yield, by hot water extraction, was more than five times higher than 
that of E. maxima and L. pallida. However, E. maxima fucoidan, as seen in acid hydrolysed 
samples, contained the most sulphate. The fucose-to-sulphate ratio for E. maxima was 
approximately 1:5, the highest reported fucose-to-sulphate ratio to date. The ratios for 
S. rugosum and L. pallida were approximately 1:1 and 1:2, respectively (Table 3.1). 
Fucoidan‘s bioactivity has been correlated to the sulphation pattern and the sulphate-
to-fucose ratio (Morya et al., 2012). Cho et al. (2010) conducted a study on the effects of 
sulphation levels in low and high molecular weight fucoidan compounds on in vitro 
anti-cancer activity. Fucoidan has been partially hydrolysed under mild acid conditions to 
yield low molecular weight fucoidan and fractionated by membrane ultrafiltration. High 
(>30 kDa) and low (5-30 kDa) molecular weight fucoidan were oversulphated. The sulphate 
content increased from 36 to 57% and 32 to 41% for >30 kDa and 5-30 kDa fucoidan, 
respectively. Cho et al. (2010) found that their oversulphated fucoidan displayed greater (15-
30%) anti-cancer activity.  
Harden et al. (2009) extracted fucoidan from sporophytes of S. rugosum harvested from New 
Zealand coastline. Two techniques tested acid (HCl and H2SO4) and the third relied on CaCl2. 
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All methods yielded sulphated fucans with anti-viral activity against HSV-1 and HSV-2. 
Assessing the bioactivity of S. rugosum from this study and comparing it to bioactivity 
profiles from fucoidan across the world could aid in elucidating if biogeography is a 
determining factor in the chemical composition of fucoidan polysaccharides (Mak et al., 
2014). Wozniak et al. (2015) extracted fucoidan from sporophytes of S. rugosum from New 
Zealand using three different extraction techniques. HCl extraction recovered 34.6% fucose 
compared to 32.5% with H2SO4 and 35.5% with CaCl2. Uronic acid recovery was noted as 
1%, 2% and 0%, respectively. They have shown that anti-viral activity was directly correlated 
with the degree of sulphation.  
Fucoidan from S. rugosum was selected for further characterization because of its appealing 
chemical profile including high yields and purity. The hot water method was preferred as 
fucoidan‘s native structure and chemical composition were preserved (Kawamoto et al., 
2006). Acid extraction and associated acidolysis may result in unwanted degradation of 
functional groups attached to fucoidan backbone. 
 
3.4.2) Sulphate content in native and acid-hydrolysed fucoidan 
 
Fucoidan hydrolysis can be achieved by the following methodologies: enzymatic digestion; 
acetic-, hydrochloric- or sulphuric acid treatment; gamma-irradiation; or by microwave- and 
ultrasound-assisted extraction (Ale et al., 2011; Rodriguez-Jasso et al., 2011; Hahn et al., 
2012). Acid hydrolysis is considered the most reliable method to degrade fucoidan into 
mono- and oligomeric units (Lim et al., 2015). Fucoidan was extracted from brown seaweed 
in its native high molecular weight form by using the hot water method. Extracts were 
analysed for changes in sulphate content following acid hydrolysis. Higher sulphate content 
was measured in hydrolysed samples compared to non-hydrolysed (native) fucoidan (Figure 
3.14). Dodgson and Price (1962) have shown that the ester sulphate content of 
polysaccharides can be estimated by measuring SO4
2-
 liberated by acid hydrolysis. Sulphate 
content measured in native fucoidan polysaccharides prior to acid hydrolysis was however 
significant (Figure 3.14). Sulphate groups are attached to the backbone of the fucoidan 
polymer, but may be accessible for analysis. The liberation of L-fucose by acid hydrolysis 
allows for better assessment of more readily accessible inorganic sulphate. Since the degree 
of sulphation of fucoidan is critical to the compound‘s bioactivity, reliable measurement is 
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crucial. Our results show that acid hydrolysis is required for quantitative analysis of fucoidan 
sulphate content. Conversely, Xue et al. (2001) showed that a water extract from brown 
seaweed Laminaria japonica treated to mild H2SO4 hydrolysis resulted in liberation of 
L-fucose while the ester sulphate content barely increased. 
 
3.4.3) Fucoidan compositional analysis by gas chromatography mass 
spectroscopy 
 
Compositional analysis of fucoidan compounds was performed by GC-MS. GC-MS is used 
to identify and quantify organic compounds in a volatile (i.e. gaseous) state or mixture (Kind 
and Fiehn, 2010). The affinity of a compound (based on its physiochemical properties) to the 
stationary phase (i.e. the solid support with a particular coating) enables the separation of 
consortium of samples into their constituent parts. GC-MS has a longstanding history of 
successful compositional analysis of small to large biological molecules (Koek et al., 2011a). 
These molecules include antibiotics, carbohydrates, polysaccharides, proteins and peptides 
(Koek et al., 2011b). The general GC-MS workflow involves injecting a liquid sample into a 
hot inlet which converts the sample into a gaseous volatile phase (Banerjee and Mazumdar, 
2012). Thereafter, an inert gas transports the volatile compounds through a capillary column 
(usually of coated glass). This coated column, also known as the stationary phase, passes the 
sample through the column to a detector over a certain period, referred to as the retention 
time. Based on the compounds affinity to the stationary phase, the retention time is used to 
identify the analyte of interest compared to a reference standard. Structural modification of 
anionic polysaccharides, such as fucoidan, is commonly altered to aid in characterization of 
these compounds by analytical chemical techniques (Jiao et al., 2011). For example, fucoidan 
compounds are commonly oversulphated, desulphated, acetylated, or benzylated, in an 
attempt to develop more effective derivatives to be analysed by mass spectroscopy (Nishino 
and Nagumo, 1992; Soeda et al., 1993; Soeda et al., 1994; Teruya et al., 2007; Wang et al., 
2009).  
S. rugosum crude fucoidan was isolated by hot water to preserve its native structure and 
analysed by GC-MS. The polysaccharide consisted mainly of L-fucose (79.4-97.7%) and 
galactose (0-18.9%) with trace amounts of xylose, mannose, and glucose (Sample A-C, Table 
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3.2). Algal fucoidan consisting of mainly L-fucose, galactose, and xylose is considered of 
good quality as these monosaccharides are building-blocks of the fucoidan structure (Ale et 
al., 2011). The low abundance of trace monosaccharides suggests that the S. rugosum 
fucoidan extract was highly pure. Trace monosaccharides may constitute the building blocks 
of other algal polysaccharides that are easily co-extracted. Conversely, fucoidan structure is 
highly heterogeneous and monosaccharides such as galactose, glucose, and mannose may be 
legitimate substitutions on the fucoidan compound (Ale et al., 2013). Heterogeneity adds to 
the difficulty in correctly assessing the molecular structure of fucoidan compounds using 
analytical techniques. GC-MS data supports the results obtained with colorimetric assays, 
suggesting that fucoidan was successfully extracted from S. rugosum and that the extracts 
were relatively free of contaminants. Wozniak et al. (2015) sampled S. rugosum from the 
New Zealand coastline and reported a similar neutral monosaccharide composition by 
GC-MS. Fucoidan extracts consisted mainly of L-fucose (86-88%) and trace amounts of 
rhamnose, arabinose, xylose, mannose galactose and glucose (0.2-8%). Inter-species variation 
in fucoidan composition, i.e. between the same species in different geographic locations, is 
governed by intrinsic factors such as maturity, age and reproductive cycle (Skriptsova et al., 
2012; Maina et al., 2014; Wozniak et al., 2015). 
E. maxima crude fucoidan analysed by GC-MS consisted mainly of glucose (60.4%) and 
L-fucose (26.4%), with low abundance of fructose (5.3%), galactose (3.3%), mannose (3.8%) 
and xylose (1.0%) (Sample I, Table 3.2). High glucose content could be an indication of 
alginate co-extraction. Glucose and mannose are building-blocks of uronic acids, a major 
constituent of alginate, abundantly found in the cell walls of brown macroalgae. GC-MS data 
may explain comparatively low L-fucose content of E. maxima extracts as determined by the 
colorimetric assays (Table 3.2). E. maxima hot water fucoidan extracts appeared to be 
contaminated by alginate as indicated by high uronic acid and glucose content. A similar 
composition has been presented by Cao et al. (2014) for sulphated fucans extracted from 
E. cava, a Northern Hemispheric brown seaweed. Fucoidan has been extracted with 0.01N 
HCl and consisted mainly of L-fucose (36.1%) and glucose (26.2%), while galactose 
(15.7%), mannose (11.8%), and small amounts (1-7%) of rhamnose, arabinose and xylose 
were also present. Conversely, Lee et al. (2012) presented data of hot water extracted E. cava 
crude fucoidan with mainly L-fucose (45.2%), galactose (18.2%) and xylose (14.4%). Only 
small amounts (0.2-10%) of glucose, rhamnose, arabinose and mannose were present. 
Distinct fucoidan structures can be isolated by different extraction methods (Ale et al., 2013). 
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Slight modifications in parameters or a condition in the isolation process enhances the 
variability of chemical composition and subsequent analysis. 
L. pallida crude fucoidan analysed by GC-MS consisted mainly of L-fucose (73.7%) with a 
fair amount of galactose (11.9%) and trace amounts of glucose (2.7%), mannose (4.7%), 
rhamnose (1.24%) and xylose (5.8%) (Sample H, Table 3.2). GC-MS data supports results 
obtained with colorimetric assays, suggesting that fucoidan extracts were relatively free of 
contaminants. Xue et al. (2001) extracted fucoidan from a Northern Hemispheric kelp 
Laminaria japonica with hot water. Compositional analysis by GC-MS has shown that the 
presence of L-fucose (52.8%) and galactose (27.4%) are dominant with small amounts 
(1-6%) of mannose, glucose, rhamnose, xylose and arabinose. Conversely, Xue et al. (2004) 
have reported that a hot water extract from the L. japonica consisted mainly out of galactose 
(57.4%), mannose (15%), L-fucose (12%) and small amounts (2-5%) of glucose, rhamnose, 
xylose and arabinose were also present. L. pallida has a much higher L-fucose ratio than that 
of its Northern Hemispheric neighbour, L. japonica. 
Commercially procured crude fucoidan from F. vesiculosus (Sigma-Aldrich) (Sample G) was 
used as a positive control for compositional analysis by GC-MS. F. vesiculosus fucoidan 
consisted mainly of L-fucose (86.2%) with low abundance of galactose (5.7%), mannose 
(1.4%), rhamnose (2.3%) and xylose (4.5%) (Sample G, Table 3.2). This polysaccharide was 
extracted with a method using an acid of which the details are not fully disclosed by the 
supplier. Mak et al. (2013) have reported a similar profile for F. vesiculosus fucoidan 
(Sigma-Aldrich), mainly L-fucose (87%) with low abundance of galactose, glucose, mannose 
and xylose (1-6 %). Results obtained with F. vesiculosus control are a confirmation that 
compositional analyses of brown seaweed extracts reported in this study was correct. 
L-fucose ratio of fucoidan extracts presented in this study was highest in S. rugosum 
(79-98%) and F. vesiculosus (86.2%). 
Intra-variations (within the same species in the same location) of fucoidan content has been 
reported before and it has been inferred that maturity of the alga, the age of the alga, 
reproductive state, biogeography and seasonality are determining factors (Lee et al., 2006; 
Skriptsova et al., 2012). Inter-variations (between different/same species in different 
locations) of fucoidan have also been shown to be a contributing factor to fucoidan 
composition. The Northern and Southern Hemispheres have different environmental factors 
such as nutrient content and cycling, light exposure, tidal conditions, and other climate 
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conditions. To conclude, many variables may affect the heterogeneity of fucoidan compounds 
but biogeography and extraction methodology are the primary contributors.  
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3.5) Conclusion 
 
Fucoidan was extracted from three species of South African brown seaweed, Ecklonia 
maxima, Laminaria pallida and Splachnidium rugosum. Three different methods were used 
to extract fucoidan in an effort to determine the influence of various extraction parameters on 
the heterogeneity of fucoidan. The hot water extraction method yielded highest L-fucose 
content, while the calcium chloride salt extraction method yielded fucoidan with lowest 
uronic acid contamination. Extracts obtained with hydrochloric acid extraction yielded 
highest uronic acid contamination and sulphate content. High sulphate content may be 
explained by the liberation of sulphate from fucoidan polymers as a result of acid hydrolysis. 
All extracts were considered free of protein (<0.01%). 
Fucoidan is typically subjected to acid hydrolysis before sulphate assessment. The barium 
sulphate turbidimetric reaction was used to analyse liberated sulphate. This study has shown 
that it is possible to comparatively analyse sulphate content of fucoidan extracts without 
hydrolysis; however, quantitative analysis of sulphate content relies on acid hydrolysis. A 
drawback of the acid method includes higher alginate co-extracts (as assessed by uronic acid 
content), whilst fucoidan yield was very low with the salt method. Instead of using one 
extraction method, a better approach might be to extract fucoidan with hot water to retain its 
structure in its most native form, apply mild acid hydrolysis to yield lower molecular weight 
compounds with potentially higher bioactivity and use a salt step to bind and remove cationic 
contaminants such as alginate, thereby increasing purity. The extraction method for fucoidan 
and other fucose-containing-sulphated-polysaccharides is critical in maintaining structural 
integrity and therefore bioactivity. However, the significance of this concept is often 
overlooked. Splachnidium rugosum tissue yielded more than five times more fucoidan than 
Ecklonia maxima and Laminaria pallida. Monosaccharide analysis furthermore revealed 
highest L-fucose ratio. There were only minor compositional differences between fucoidan 
extracted from the same species. Inter-species variation between Splachnidium rugosum from 
South Africa and New Zealand was more prominent and may be explained by differences in 
e.g. climate, tidal, and geochemical conditions. The fucose-to-sulphate ratio of fucoidan from 
Ecklonia maxima (1:5) is the highest reported to date. The degree of sulphation is the primary 
contributor to fucoidan‘s bioactive properties in mammalian systems. While fucoidan from 
Splachnidium rugosum generated in this study was fractionated and purified (Chapter 4), and 
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assessed for anti-oxidant and anti-cancer properties (Chapter 5), future studies should also 
include bioactivity assays with Ecklonia maxima extracts. 
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Chapter 4. Fractionation and purification of 
fucoidan 
 
 
Abstract 
 
Fucoidan is a heavily sulphated anionic polysaccharide, found mainly in seaweeds, that 
exhibits numerous bioactive properties including anti-cancer activity. Bioactivity has been 
correlated with sulphate-to-fucose ratio and lower molecular weight forms. Crude hot water 
and acid extracts from Splachnidium rugosum tissue were fractionated and purified by 
anionic ion exchange chromatography. In water extracts, ion exchange chromatography 
resulted in close to 90% decrease in L-fucose, sulphate and uronic acid, while protein levels 
increased by 57%. Similar results were reported for acid extracts; however protein content 
did not change significantly. Purified hot water extracts contained 25.235 ± 1.981 µg/mL 
L-fucose, 11.512 ± 2.352 µg/mL sulphate, 3.897 ± 1.621 µg/mL uronic acid and 
82.117 ± 7.186 µg/mL protein. Comparatively, L-fucose yield in purified acid extracts were 
almost half and sulphate content was ~4-fold lower. Uronic acid content was higher 
(~1.7-fold), while protein content was not significantly different. These results show that 
method of extraction may affect the composition of fucoidan post-purification. Hot water 
extraction is recommended due to higher fucoidan yield, as reflected by L-fucose content, 
and higher sulphate-to-fucose ratio. High protein content after ion exchange chromatography 
was however of concern. Since mucilage in Splachnidium rugosum thallus had no detectable 
protein present, fucoidan was precipitated from mucilage with ethanol. Fucoidan yield of 
mucilage was >15-fold higher than in purified hot water extracts with a sulphate-to-fucose 
ratio of ~1:1. The average molecular weight of native fucoidan in mucilage was estimated to 
be 2367 kDa. The polysaccharide was hydrolysed by gamma-irradiation levels of 10-50 kGy 
to fractions ranging between 60 and 15.5 kDa. It is recommended that the dosage of gamma-
irradiation should not exceed 50 kGy, considering the drastic drop in molecular weight at 
higher levels.  
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4.1) Introduction 
 
Fucoidan is a heavily sulphated anionic polysaccharide with an L-fucose backbone (Ale et 
al., 2013). Extracts from seaweed are of highly heterogeneous structure with different 
branching patterns and a variable molecular weight (Fitton et al., 2015). Structure and size 
are impacted by species, origin, extraction method and downstream processing (Ale et al., 
2013). Fucoidan can be classified into three groups based on size (Senthilkumar et al., 2013). 
HMWF is >10,000 kDa, MMWF ranges between 10-10,000 kDa, and LMWF is usually <10 
kDa. Fucoidan is often fractionated by acid hydrolysis, irradiation, an enzyme cocktail, or by 
microwave- and ultrasound-assisted extraction (Ale et al., 2011; Rodriguez-Jasso et al., 2011; 
Hahn et al., 2012). Numerous studies have reported that the bioactivity of fucoidan in 
mammalian systems is both compound size- and dosage-dependent (Yumi et al., 2009; Cho 
et al., 2011; Lee et al., 2012; Morya et al, 2012; Kimura et al., 2013; Zhang et al., 2013; 
Kwak, 2014). Recent studies have reported that LMWF possesses different bioactive 
characteristics to that of HMWF (Choi and Kim, 2013). HMWF has been shown to have a 
low affinity in vitro as a bioactive compound, possibly due to low solubility (attributed to its 
large size) which hinders its use as a drug. It has been shown that LMWF is an effective 
anti-oxidant, anti-coagulant and a cellular proliferator of healthy cells. Conventionally, 
LMWF is obtained by acid hydrolysis of the polymer or by enzymatic degradation (Lee et al., 
2012; Ale et al., 2013; Pielesz, 2014). The disadvantages of acidolysis include uneven size 
distribution and unwanted removal of sulphate groups, while enzymatic degradation requires 
a complex metabolic process. No universal fucoidan hydrolysing enzyme (i.e. fucoidanase or 
fucanase) has been identified (Wu et al., 2011).  
Gamma (γ)-irradiation is a commonly used security measure to kill food borne pathogens and 
remove contaminants from food products processed for long term storage (Choi et al., 2014). 
Gamma-irradiation has been shown to effectively reduce the size of fucoidan (Choi and Kim, 
2013; Lim et al., 2015), resulting in increased anti-oxidant and cytotoxic bioactivities in 
mammalian systems (Lee et al, 2009; Sung et al., 2009; Abad et al., 2013). Increasing 
radiation dosages, measured in kGy, has been shown to cleave high molecular weight 
(HMW) polysaccharides into low molecular weight (LMW) monosaccharide or 
oligosaccharide sugars (Byun et al., 2008; Choi et al., 2009a). The main advantage of 
γ-irradiation is that sugars are fractionated at glycosidic bonds, and not at random bonds and 
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functional groups which may alter the structural integrity of the compound (Choi et al., 
2009b, Sung et al., 2009).  
Ion exchange chromatography (IEC) separates compounds based on net surface charge. 
Interaction with a charged chromatography medium depends on a molecule‘s overall charge, 
charge density and surface charge distribution. In the IEC process, ions or polar molecules 
are separated based on their affinity for the ion exchanger, i.e. the column. Analyte molecules 
are retained on the column due to a physical phenomenon known as columbic interactions. 
The surface of the stationary phase (i.e. the fixed medium that makes up the column) contains 
the functional groups (R-X) that interact with analyte ions of opposite charge. An IEC 
medium comprises a matrix of spherical particles substituted with ionic groups that are 
negatively (cationic) or positively (anionic) charged. As fucoidan is a heavily sulphated 
polysaccharide its overall charge is negative. As IEC separates compounds based on charge, 
fucoidan, an anionic polysaccharide, would bind to a positively charged ligand (CTAB) 
attached to the column medium (Celite
®
).  
Literature has shown that by refining fucoidan into a more purified compound, the bioactivity 
of fucoidan could be increased, especially the potency of the compound as an in vitro drug 
candidate (Gerwick and Moore, 2012). Conversely, crude algal extracts may possess 
synergistic activities in biological systems (Michalak and Chojnacka, 2015). This study 
aimed to purify fucoidan, assess the bioactivity of low molecular weight, crude, and purified 
fucoidan extracted from brown macroalgal species of South Africa by exploiting the 
physicochemical properties of the polysaccharide.  
 
4.1.1) Aims and objectives of this chapter 
 
The aim of this Chapter was to develop an effective purification and fractionation strategy for 
fucoidan compounds extracted from S. rugosum. This aim was further broken down into two 
objectives: 
(1.) Development of an effective fucoidan fractionation method which has minimal 
effects on the structural integrity of fucoidan. Commonly used fractionation 
techniques, γ -irradiation and anionic exchange chromatography, were evaluated. 
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(2.) Development of a novel purification protocol for fucoidan compounds extracted 
from S. rugosum.  
 
 
 
 
 97 
 
4.2)  Methods and material 
 
4.2.1) Fucoidan samples and compositional analysis 
 
Crude fucoidan was extracted from S. rugosum whole algal tissue (thallus fingers) by using 
hot water or acid extraction. Methods were described in Section 3.2.2. The clear viscous gel 
or ―mucilage‖ was separated from tissue by cutting off the tip of thallus fingers and 
squeezing out the gel (Figure 4.1). Mucilage was stored at -80°C for analysis by γ-irradiation. 
For L-fucose analysis, mucilage and empty thallus tissue were dried, followed by a hot water 
extraction and ethanol precipitation (Section 3.2.2 and 4.2.3 respectively). 
Colorimetric analysis of L-fucose, sulphate and uronic acid content was determined with the 
cysteine sulphuric acid, barium salt and carbazole sulphuric acid methods, respectively 
(Section 3.2.3). Protein content was analysed by the Bradford assay (Section 3.2.3).  
 
A.  B.   
 
Fig. 4.1. Splachnidium rugosum mucilage isolated from algal tissue. A. Wild S. rugosum sporophyte 
photographed at Grotto Bay, Western Cape, South Africa (33.5014° S, 18.3192° E). B. Mucilage squeezed out 
of S. rugosum thallus (left), empty thallus (centre), and whole alga tissue (right).  
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4.2.2) Anion exchange/silica column chromatography 
 
4.2.2.1) Creating and packing the column 
 
Glass wool (Sigma-Aldrich) was inserted into the bottom of a 50 mL syringe (DuraSyringe
®
) 
to act as a plug for the column slurry. The syringe was mounted vertically to a retort stand 
(Figure 4.2). A fucoidan-CTAB complex was formed by adding 20 mL of 10 mg/mL crude 
S. rugosum fucoidan extracts (Section 3.2.2), prepared in 25mM sodium acetate (NaOAc: 
Sigma-Aldrich), to 20 mL of 10% (w/v) CTAB. The solution was vortexed for 30 min and 
precipitated at RT for 30 min. The fucoidan-CTAB complex was mixed with ~40-50 mL of a 
30% (w/v) Celite
®
 (Sigma-Aldrich) solution (1:2), forming a fucoidan-CTAB-Celite slurry. 
The slurry was left to settle for 1 hour at RT, the supernatant was removed (~20-30 mL), and 
the slurry was packed into the syringe column.  
 
 
Fig. 4.2. Fucoidan purification columns. Crude fucoidan extracts from S. rugosum algal tissue (n=3) were 
purified by IEC. The syringe column (stationary phase) was packed with a fucoidan-CTAB-Celite slurry (solid 
adsorbent). A range of mobile phases were passed over the column to elute fractions containing different 
concentrations of fucoidan-salts. Gravity and external pressure (i.e. a peristaltic pump) were applied. 
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4.2.2.2) Washing and eluting fucoidan salts off the column 
 
Once the column had settled and dried the following wash and eluent buffers were passed 
through the column to elute fucoidan-CTAB salts: 2x column vol 0.05% CTAB (w/v) 
prepared in 0.05M NaOAc, 3x column vol 30% (w/v) EtOH prepared in 0.05M NaOAc, 3x 
column vol 60% (w/v) EtOH in 0.05M NaOAc, and 3x column vol 100 % (w/v) EtOH in 
0.05M NaOAc. Eluted fractions were captured and assessed colorimetrically for L-fucose 
content by a modified cysteine sulphuric acid method developed by Dische and Shettles 
(1948) (Section 3.2.3.).  
 
4.2.2.3) Dialysis of fucoidan salts 
 
Fractions containing highest concentrations of L-fucose were pooled and dialysed against two 
buffers. Firstly, the fucoidan-CTAB alcoholic fractions (60-90 mL) were added to 230 mL 
Slide-A-Lyzer
™
 Dialysis Flasks 3.5K MWCO (Thermoscientific) and dialysed against 1-2 L 
of 0.2M NaCl buffer (10-20x vol dialysis buffer) overnight at 4°C. Dialysis displaced CTAB 
and created a fucoidan-Na
+
 complex. The complex was dialysed against 1-2 L of UV-treated 
autoclaved ddH2O buffer (10-20x vol dialysis buffer) overnight at 4°C. Na
+ 
was displaced 
with H2O, thereby creating a homogenous fucoidan solution in water. The fucoidan solution 
was lyophilised at -50°C in a freeze-dryer (Labconco FreeZone
1
 Benchtop Freeze-dryer) for 
3-5 days until a dry white powder was formed.  
 
4.2.3) Gamma-irradiated fucoidan mucilage 
 
4.2.3.1) Gamma-irradiation  
 
S. rugosum mucilage was transferred into 50 mL glass Schott bottles and subjected to 
γ-irradiation at High Processing Energy Cape (Pty) (Ltd) (HEPRO), Montague Gardens, 
Western Cape Province, South Africa (-33.871105, 18.525371). Mucilage was γ-irradiated at 
ambient temperature at 10, 30, 50, and 80 kGy with a cobalt 60 irradiator. Dosimetry was 
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conducted with a B3 DoseStix® dosimeter and measured with a Genesys G20 
spectrophotometer. Non-irradiated mucilage (0 kGy) was used as the untreated control. 
Samples were maintained at 4°C after irradiation. This experiment was conducted as an 
initial trial experiment (n=1).  
 
4.2.3.2) Ethanol precipitation  
 
Fifty mL samples of S. rugosum untreated and γ-irradiated mucilage were precipitated 
overnight at 4°C in 5x vol of 96% (v/v) technical ethanol (Sigma-Aldrich). Alcoholic 
mucilage solutions were pelleted at 7,000 x g at 4 °C for 10 min. Supernatant was discarded 
and pellets were dried at 40°C for 24-48 hours. Dried pellets were macerated in a mortar and 
pestle to a fine powder. 
 
4.2.4) Matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry  
 
Matrix-assisted laser desorption/ionization time-of-flight (MALDI TOF) mass spectrometry 
(MS) of irradiated fucoidan was run performed using an UltrafleXtreme MALDI ToF/ToF 
system (Bruker Daltonics, Bremen, Germany) with instrument control through Flex control 
3.4. Samples were physically spotted onto an MTP 384 Ground steel MALDI target. Spectra 
were acquired in a linear negative mode with an ion source 1 of 20 kV, ion source 2 of 18.88 
kV and with a lens of 7 kV. A number of 250 laser shots were summed up at a scan range of 
m/z = 500-2200. Spectra were also acquired in positive reflector mode between a scan range 
of m/z 500-2000 Da. 
Matrices used were α-Cyano-4-hydroxycinnamic acid (CHCA) and sinapinic acid (SA). A 
combinatorial approach was conducted whereby various matrix:sample ratios were prepared 
since there is no set standard for fucoidan preparation for analysis on MALDI-TOF MS. 
Therefore, optimization was conducted with matrix type, sample to matrix ratio, ionization 
sources, and both linear and positive modes of ionization.  
 
 
 
 
 101 
 
4.2.5) Statistical analysis 
 
All results presented (excluding γ-irradiation) were from three independent replicate 
experiments and each seaweed sample came from three biological sources. For each 
biological repeat, three technical repeats were performed. Standard error was calculated using 
Microsoft
®
 Office Excel 2010 Version 14.0.7153.500. Significant differences between 
chemical composition of crude fucoidan extracts and of purified compounds were assessed by 
Student t-test. The assessment was determined using Microsoft
®
 Office Excel 2010 Version 
14.0.7153.500 and GraphPad Prism 6 Version 6.01. 
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4.3) Results  
 
4.3.1) Assessing ion exchange eluate fractions for fucoidan content 
 
Crude hot water and acid extracts from S. rugosum tissue were loaded separately onto 
columns for purification by IEC. Fractions eluted by IEC were assessed for L-fucose content. 
L-fucose containing fractions were pooled to ensure maximum recovery of FCSPs. The hot 
water extraction method yielded FCSPs that were most efficiently eluted with 60% (w/v) 
EtOH in 0.05M NaOAc buffer (p < 0.05), yielding an L-fucose content of 0.176 ± 0.023 
mg/mL (Figure 4.3). With the acid extraction method, no significant differences (p > 0.05) in 
elution efficiency were recorded in an EtOH concentration range of 30-100% (Figure 4.4). 
Eluates obtained with the 60% EtOH buffer (hot water extracted fucoidan) and the 100% 
EtOH buffer (acid extracted fucoidan) were subjected to dialysis and further purification.  
 
 
Fig. 4.3. L-fucose content of fucoidan extracted from Splachnidium rugosum tissue with a hot water 
method. CTAB:fucoidan salts were eluted from an IEC column using an ethanol concentration gradient and 
L-fucose content was determined by a cysteine sulphuric acid method. Samples were assessed for significant 
differences by a Student t-test with a 95% confidence interval. Mean ± SE (n = 3). 
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Fig. 4.4. L-fucose content of fucoidan extracted from Splachnidium rugosum tissue with an acid method. 
CTAB:fucoidan salts were eluted from as IEC column with an ethanol concentration gradient. L-fucose content 
was determined by a cysteine sulphuric acid method. Samples were assessed for significant differences by a 
Student t-test with a 95% confidence interval. Mean ± SE (n = 3). 
 
4.3.2) Compositional analyses of crude fucoidan extracts before and after ion 
exchange chromatography 
 
Crude hot water and acid extracts from S. rugosum tissue were subjected to IEC. Chemical 
composition was compared before and after IEC (Figure 4.5). Yield differences are presented 
in Table 4.1 as percentage change. For crude water extracts, IEC resulted in more than 90% 
decrease in L-fucose, sulphate and uronic acid, while protein content increased by 57% (p < 
0.05). Similar results were reported for acid extracts; however the protein content did not 
change significantly (p > 0.05).  
Fucoidan extracted by the hot water method contained 25.235 ± 1.981 µg/mL L-fucose and 
11.512 ± 2.352 µg/mL sulphate. Acid extraction yielded significantly (p < 0.05) less L-fucose 
and sulphate, 13.976 ± 0.164 µg/mL and 2.963 ± 0.787 µg/mL, respectively. Hot water 
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µg/mL in acid extracts (p < 0.05). Water and acid extracts contained 82.117 ± 7.186 µg/mL 
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and 51.450 ± 18.449 µg/mL protein, respectively. The difference in protein content obtained 
with different extraction methods was not statistically significant (p > 0.05). 
 
 
Fig. 4.5. Chemical profile of Splachnidium rugosum fucoidan extracts. Crude water and acid extracts were 
purified by IEC and all samples analysed for L-fucose, sulphate, uronic acid, and protein content. Samples were 
assessed for significant differences by a Student t-test with a 95% confidence interval. Mean ± SE (n = 3).  
 
Table 4.1. Yield of fucoidan constituents gained (+) or lost (-) after ion exchange chromatography.  
Species 
Fucoidan 
sample 
L-fucose 
% 
Sulphate 
% 
Uronic acid 
% 
Protein 
% 
S. rugosum 
Purified water 
extract 
-89.4% -86.9% -87.5% +43.9% 
S. rugosum 
Purified acid 
extract 
-88.6% -98.7% -90.4% -5.6% 
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4.3.3) Gamma-irradiated fucoidan 
 
4.3.3.1) Splachnidium rugosum fucoidan content in mucilage and cellular tissue 
 
S. rugosum mucilage was removed and dried alongside the empty thallus tissue, followed by 
a hot water extraction and ethanol precipitation (Section 3.2.2). The mucilage contained 
0.072 ± 0.0063 µg/mL L-fucose (17% yield), while the tissue contained 0.210 ± 0.0382 
µg/mL (49.6% yield) (Figure 4.6). 
 
 
Fig. 4.6. L-fucose content of fucoidan in Splachnidium rugosum mucilage and cellular tissue. S. rugosum 
algal tissue was divided into mucilage and cellular tissue. Fucoidan was extracted from dried samples with the 
hot water method, precipitated by ethanol, and assessed for L-fucose content. Mean ± SE (n = 3). 
 
4.3.3.2) Assessment of γ-irradiated fucoidan  
 
Mucilage was removed from S. rugosum thalli and fucoidan was precipitated by ethanol. 
Fucoidan were exposed to γ-irradiation, and concentrated again by ethanol precipitation. 
Increasing dosages of γ-irradiation (kGy) fractionated fucoidan into LMW compounds 
ranging from 60 to 15.5 kDa (Figure 4.7). Native fucoidan extracted from the untreated 
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control (0 kGy) was estimated at 2367 kDa. At 10 kGy of γ-irradiation, L-fucose content 
increased 1.5-fold, from 0.390 to 0.607 mg/mL (Figure 4.8). At a dosage of 30 kGy, L-fucose 
concentration dropped drastically to 0.157 mg/mL, followed by a steady increase at higher 
dosages reaching 0.495 mg/mL at 80 kGy. The sulphate content of native fucoidan 
(148 µg/mL) steadily rose with an increase in radiation (Figure 4.9). The highest sulphate 
content (685 µg/mL) was measured at 80 kGy. Mucilage was free of protein (results not 
presented). Uronic acid content remained constant at ~55 µg/mL up to 50 kGy, but dropped 
to 19 µg/mL at 80 kGy (Figure 4.10). All data are comparatively presented in Figure 4.11 to 
depict effects of different doses of γ-irradiation on yield and purity. 
 
 
Fig. 4.7. Molecular weight of gamma-irradiated fucoidan. Fucoidan was precipitated from S. rugosum 
mucilage with ethanol and exposed to increasing dosages of γ-irradiation (kGy). Molecular weight was 
determined by HPLC. 
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Fig. 4.8. L-fucose content of gamma-irradiated and non-irradiated fucoidan. Fucoidan was precipitated 
from S. rugosum mucilage with ethanol. Fucoidan was exposed to increasing dosages of γ-irradiation (kGy) to 
break down the polysaccharide into oligosaccharide units. L-fucose content was determined by a cysteine 
sulphuric acid method. 
 
 
Fig. 4.9. Sulphate content of gamma-irradiated fucoidan. Fucoidan was precipitated from S. rugosum 
mucilage with ethanol. Fucoidan was exposed to increasing dosages of γ-irradiation (kGy) to break down the 
polysaccharide into oligosaccharide units. Sulphate content was determined by turbidimetric barium salt 
method.  
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Fig. 4.10. Uronic acid content of gamma-irradiated fucoidan. Fucoidan was precipitated from S. rugosum 
mucilage with ethanol. Fucoidan was exposed to increasing dosages of γ-irradiation (kGy) to break down the 
polysaccharide into oligosaccharide units. Uronic acid content was determined by a sulphuric acid carbazole 
method.  
 
 
Fig. 4.11. Comparative profile of Splachnidium rugsoum gamma-irradiated fucoidan. Fucoidan was 
precipitated from S. rugosum mucilage with ethanol. Fucoidan was exposed to increasing dosages of 
γ-irradiation (kGy) to break down the polysaccharide into oligosaccharide units. L-fucose, sulphate, uronic acid 
contents were comparatively assessed. No protein was detected. 
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4.3.3.3) Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry 
analysis of gamma-irradiated fucoidan 
 
Gamma-irradiated fucoidan was subjected to MALDI-TOF MS to further elucidate molecular 
structure. Several matrices and sample mixtures were assessed in both linear and positive 
modes of ionization. Spectra produced by MALD-TOF did not present clear definitive peaks, 
and ions of interest could not be confidently identified under current parameters and 
conditions.  
 
4.4) Discussion 
 
Chapter 3 assessed the suitability of various fucoidan extraction methods from a range of 
brown seaweed species of South Africa. Crude S. rugosum extracts yielded 5-7 times more 
L-fucose, irrespective of method of extraction. This chapter presents the fractionation and 
purification of crude water and acid extracts from S. rugosum tissue, as well as from 
S. rugosum mucilage. This chapter also assessed the chemical profiles presented by all 
purified and fractionated fucoidan extracts. 
 
4.4.1) Assessing ion exchange eluates for fucoidan content 
 
Fucoidan is a heavily sulphated water-soluble polysaccharide with a net negative charge. Its 
anionic nature allows for purification by IEC. In this study, a differential precipitation 
process was utilised which is commonly used to purify pathogenic bacterial 
lipopolysaccharides for vaccine development. Positively charged CTAB was added to 
negatively charged fucoidan, thereby forming a CTAB:fucoidan complex. This complex (or 
polysaccharide salt) is insoluble in water but soluble in ethanol (EtOH). Celite
®
 (0.02-0.1 mm 
pore size), which acts as filter trap, was added and mixed into the solution thereby capturing 
and retaining most insoluble impurities. The Celite:CTAB:fucoidan slurry was packed into a 
column and allowed to settle. The CTAB:fucoidan complex was eluted by washing the 
column with a concentration gradient of ethanolic buffers. The eluates (containing the 
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CTAB:fucoidan) were dialysed against sodium chloride (NaCl) to remove the CTAB 
(CTAB
+
 was displaced with Na
+
), thereby forming a Na:fucoidan complex. The Na:fucoidan 
salt is insoluble in alcoholic solution and hence precipitated. Following centrifugation, the 
supernatant was discarded and the pellet that contained water-soluble fucoidan was dissolved 
in water. The Na:fucoidan salt was dialysed against ddH2O to displace Na
+
 and lyophilised. 
Fractions eluted by IEC containing L-fucose were pooled to ensure maximum recovery of 
FCSPs. Eluent buffers prepared in different concentrations of alcoholic solvents have been 
shown to elute polysaccharides of different molecular weight and chemical composition 
(Gardell, 1957; Bouveng et al., 1963; Zhan et al., 2011; Han et al., 2014). The hot water 
extraction method yielded FCSPs that were most efficiently eluted with 60% (w/v) EtOH in 
0.05M NaOAc buffer (p < 0.05), yielding an L-fucose content of 0.176 ± 0.023 mg/mL 
(Figure 4.3). Similarly, Zvyagintseva et al. (1999) reported that a concentration gradient of 
ethanolic buffers could elute various types of water-soluble polysaccharides from brown 
seaweeds. However, with the acid extraction method, no significant difference in elution 
efficiency was recorded at different concentrations of ethanol (Figure 4.4). Eluates obtained 
with the 60% EtOH buffer (hot water extracted fucoidan) and the 100% EtOH buffer (acid 
extracted fucoidan) were subjected to dialysis and further purification.  
 
4.4.2) Assessment of fucoidan purity 
 
Crude hot water and acid extracts from S. rugosum tissue were fractionated and purified by 
anionic IEC. IEC resulted in close to 90% decrease in L-fucose and sulphate content of both 
extracts (Table 4.1). This decrease is not unexpected, as the sulphate groups are attached to 
the L-fucose backbone of the fucoidan polysaccharide. Higher sulphate content in crude acid 
extract (Figure 4.5) is explained by liberation of sulphate by acid hydrolysis during 
extraction. Once purified, sulphate content was however ~4-fold lower than in water extracts, 
while L-fucose content was about 2-fold less. Liberated sulphate was likely removed by the 
IEC column. Since bioactivity of fucoidan correlates positively with sulphate content, or 
more specifically, to sulphate-to-fucose ratio (Jiao et al., 2011), extraction with hot water is 
recommended. Chapter 5 will delve into the efficacy of the crude versus purified fucoidan 
compounds as potential anti-oxidants and anti-cancer agents. 
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The extraction method employed may alter fucoidan‘s chemical composition on an ionic 
level, which may explain the drastic drop in fucoidan yield, as reflected by L-fucose content, 
after purification by IEC. This could be attributed to the negative charge of the sulphate 
groups attached to the L-fucose backbone which is the primary contributor to the compound‘s 
overall negative charge (Ponce et al., 2003; Mak et al., 2013). A similar phenomenon has 
been reported by Ale et al. (2012) with fucoidan extracts from Sargassum species. The 
sulphate-to-fucose ratio of fucoidan molecules after acid extraction was dependent on 
concentration of acid, time of extraction, and concentration of ethanol during precipitation. 
Mabeau et al. (1990) showed that fucans extracted with acid from brown seaweeds Pelvetia 
canaliculata, Fucus vesiculosus, Sargassum muticum and Laminaria digitata, and 
precipitated by EtOH, could be solubilized by Triton X-100 (a surfactant similar to CTAB). 
Once purified by anion IEC, these fucans displayed a different ionic composition to its crude 
form. Lee et al. (2012) reported that purification of a hot water extract from Ecklonia cava by 
anion IEC yielded FCSPs with varying ionic compositions. Our study confirmed that the 
method of extraction can affect the composition of fucoidan post-purification.  
Significantly higher uronic acid content in crude and purified acid extracts may be explained 
by co-extraction of alginate. Uronic acid is the primary component of alginate, a cell wall 
polysaccharide commonly found in brown seaweeds (Lee and Mooney, 2012). Considering 
that uronic acid often contaminates fucoidan as a co-extract during the isolation process (Ale 
et al., 2013), its content may be a good indication of fucoidan purity. Conversely, uronic acid 
is not always a contaminant but may be attached to the fucoidan compound as discrete short 
branches (Ale et al., 2013). Uronic acid content of crude extracts (water and acid) decreased 
by close to 90% after IEC (Table 4.1), suggesting that uronic acid is not an integral part of 
S. rugosum fucoidan structure. Saboural et al. (2014) included a calcium acetate step in their 
purification protocol, as the calcium ions bind to uronic acid which can be precipitated out at 
a later stage. However, in the present study the addition of calcium chloride resulted in only a 
10% decrease in uronic acid content of S. rugosum fucoidan (data not shown).  
While IEC resulted in ~90% decrease in fucoidan yield, no protein was lost, raising questions 
as to the efficacy of the purification method. Zvyagintseva et al. (2003) also reported high 
protein content of water-soluble polysaccharides extracted from brown seaweeds after 
purification. The authors hypothesised that purified FCSPs may be a glycoconjugate for 
proteins and therefore has a high binding affinity for protein. They also reported on high 
protein content of water-soluble polysaccharides from brown macroalgal Laminaria and 
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Fucus species separated chromatographically based on hydrophobic affinities. Proteins were 
removed from a Fucus evanescens fucoidan fraction, containing the largest amount of protein 
(12%), with the Sevag method (1934). It entailed chloroform and n-butanol treatment, 
followed by polysaccharide precipitation with 80% aqueous EtOH and an acetone wash step. 
As a result, the molecular weight decreased from 200-500 kDa to 20-30 kDa and a UV 
spectra peak at 285 nm disappeared. The authors concluded that fucoidan may have formed a 
complex with protein. High protein content in IEC purified S. rugosum extracts may therefore 
support the notion that fucoidan can exist as glycoconjugates to proteins.   
 
4.4.3) Fucoidan content of Splachnidium rugosum mucilage 
 
Gamma-irradiation is common practice for sterilization and decontamination in the food 
sector (Farkas, 1998; Howard, 2010). Gamma rays released by radiation are of a high 
ionizing nature and are therefore hazardous, disrupting genetic and cellular mechanisms of 
bacteria and pests. Gamma-irradiation has been utilised as a safe means to hydrolyse algal 
polysaccharides into LMW fractions without disrupting structural or chemical integrity (Choi 
et al., 2013). This was accomplished by exposing algal material to high-energy photons 
emitted from an isotope source (e.g. Cobalt 60), thereby disrupting electrons in the product 
by ionization. This form of ionization can disrupt glycosidic bonds that hold polysaccharides 
together and degrade them into LMW oligosaccharides (Abad et al., 2013). This study 
investigated the use of γ-irradiation to fractionate fucoidan. From a range of endemic brown 
algal species screened, S. rugosum was selected as a model organism for this trial experiment 
due to highest fucoidan content, irrespective of extraction method utilised (Chapter 3, Table 
3.2). Fucoidan forms part of the intracellular mucilage of numerous brown seaweed species, 
and has been shown to be present in the extracellular mucilage of L. digitata fronds and on 
the fruiting tips of Ascophyllum nodusum (Black, 1954). Thalli of S. rugosum are uniquely 
filled with a clear sticky viscous gel. Considering the difficulties in extracting pure fucoidan 
from cellular matter, we assessed the presence and purity of fucoidan in clear thalli mucilage. 
S. rugosum mucilage was removed and dried alongside the rest of the algal tissue, followed 
by a hot water extraction and ethanol precipitation. The mucilage contained L-fucose 
(0.072 µg/mL), albeit in lower L-fucose concentration than fucoidan extracted from cellular 
tissue of empty thallus (0.210 µg/mL) (Figure 4.6). The mucilage was however free of 
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cellular debris and protein (results not shown), yielding fucoidan in a comparatively pure 
form as assessed by chemical profiling. This is the first account of S. rugosum fucoidan 
extraction and assessment from different anatomical parts of the alga.  
 
4.4.3.1) Assessment of gamma-irradiated fucoidan  
 
Mucilage was removed from S. rugosum thalli and fucoidan was precipitated with ethanol. 
Native fucoidan in unexposed (0 kGy) mucilage was estimated at 2367 kDa (Figure 4.7). 
Gamma-irradiation (10, 30 and 50 kGy) fractionated fucoidan into LMW compounds of 60.0, 
16.8 and 15.5 kDa, respectively (Figure 4.7). Cleavage of glycosidic bonds in the polymer 
was successfully achieved with increasing dosage of irradiation. In a study by Choi et al. 
(2009a), F. vesiculosus fucoidan was similarly hydrolysed by γ-irradiation from 217 kDa to 
37, 15, and 10 kDa at 10, 30, and 50 kGy, respectively. Other polysaccharides from brown 
seaweeds such as β-glucan, laminaran and alginate have also been hydrolysed into low 
molecular weight by γ-irradiation (Nagasawa et al., 2000; Byun et al., 2008; Choi et al, 
2013). The dosage of γ-irradiation is not recommended to exceed 50 kGy, considering the 
drastic drop in molecular weight at higher levels (Figure 4.7). Factors such as molecular 
weight and chemical composition are determining variables in fucoidans bioactivities. Choi et 
al. (2009a) have shown that an increase in dosages of γ -irradiation and associated decrease in 
molecular weight was directly correlated with an increase of carbonyl groups and double 
bonds in fucoidan, as well as bioactivity.  
At 10 kGy of γ-irradiation, L-fucose content increased ~1.5-fold, from 0.390 to 0.607 mg/mL 
(Figure 4.8). Colorimetric determination of L-fucose content included an acid hydrolysis step 
to liberate L-fucose from the fucoidan polysaccharide. An increase in L-fucose content upon 
irradiation may be explained by an increase in L-fucose liberation and other monosaccharide 
sugars upon fractionation. Interestingly, at a dosage of 30 kGy, liberated L-fucose 
concentration dropped drastically to 0.157 mg/mL, followed by a steady increase at higher 
dosages reaching 0.495 mg/mL at 80 kGy.  
Sulphate content was assessed by a turbidimetric barium salt assay, as described in Chapter 3 
(Section 3.2.3), which does not include an acid hydrolysis step. Data presented are therefore 
an indication of sulphate liberated by fractionation. Irradiation increased sulphate content 
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>3-fold and concentration remained constant up to 50 kGy (Figure 4.9). At 80 kGy, sulphate 
content was increased ~4.6-fold compared to unexposed control. Fractionation by irradiation 
may expose and liberate sulphate groups attached to the backbone of the fucoidan polymer. 
Results furthermore confirmed high sulphate content of S. rugosum fucoidan as determined in 
Chapter 3. Sulphate content has been shown to be a key determinant in fucoidan‘s 
bioactivities, especially in its anti-viral activity against encapsulated viruses (Fitton, 2011). 
Further research needs to be conducted in vitro to test if the sulphation level of fucoidan from 
S. rugosum plays a pivotal role in its bioactivity. 
Uronic acid was determined colorimetrically by a sulphuric acid carbazole assay described in 
Chapter 2 (Section 3.2.3). Uronic acid content did not appear to be affected by irradiation 
below 80 kGy (Figure 4.10). All samples were free of protein as determined by Bradford 
assay. 
 
4.4.4) Matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry analysis of gamma-irradiated fucoidan 
 
 MALDI-TOF is a soft ionization technique - along with electrospray ionization (ESI) - that 
is extensively and effectively utilized in analytical chemistry for the analysis of fragile 
biological macromolecules such as DNA, protein, polysaccharides and glycoconjugates (Sato 
et al., 2007), as conventionally MS methodologies tend to fragment fragile macromolecules 
(Schiller et al., 2004). MALDI and ESI allow for less harsh retrieval of ions from large 
biomolecules in a gaseous phase (Gross and Strupat, 1998). 
No standardised protocol for MALDI-TOF MS analysis of fucoidan samples has been 
published due to the heterogeneity of fucoidan compounds. Optimisation with regards to 
sample concentration, matrix type, matrix to sample ratio, and ionization source selection 
were necessary. The following MS steps (reviewed by Mann and Talbo, 1996; Karas and 
Krüger, 2003) were followed: (i) fucoidan samples were mixed with appropriate matrix and 
applied to a metal MALDI plate (―spotting‖); (ii) the spotted sample-matrix mixture was 
irradiated by a pulsed laser, ablation was initiated (i.e. removal of matrix material on a 
surface by an erosive process, e.g. vaporization)  followed by sample desorption; (iii) analyte 
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molecules were ionized by protonation or deprotonation in the hot plume of the ablated glass; 
and (iv) accelerated ions were analysed by MS. 
Matrices used for this analysis were α-Cyano-4-hydroxycinnamic acid (CHCA) and sinapinic 
acid (SA). Various matrix:sample ratios were analyzed since there is no set standard for 
fucoidan analysis by MALDI-TOF MS. Limited literature is available on MALDI-TOF MS 
analysis of fucoidan extracted from seaweed species. Therefore, optimization was conducted 
with matrix type, sample to matrix ratio, ionization sources, and both linear and positive 
modes of ionization. 
The choice and usage of matrix materials in MALDI-TOF MS improves the desorption and 
ionization processes, thereby allowing for the assessment of non-volatile thermally accessible 
molecules (Sze et al., 1998). The precise mechanism of matrix enhancement is not fully 
understood, but it has been reported that matrices such as 2,5-dihydroxybenzoic acid (DHB) 
and CHCA yield respectable reproducibility and sensitivity for the analysis of biomolecules. 
Generally, sample preparation includes a dilution of a small quantity of analyte 
(approximately 1-10 pmol) within a bigger molar excess of matrix solution, followed by 
drying the resultant mixture to produce a solid deposit on the metal matrix plate. The 
analyte-matrix mixture is deposited into the mass spectrometer and analysed by laser pulse of 
large intensity. The laser desorption of solid analyte-matrix deposits presents several 
disadvantages including low shot-to-shot reproducibility, short sample longevity, and an 
excessive dependence on sample preparation methods. The problem of shot-to-shot 
reproducibility is generally caused by laser-based modifications of the surface structure of the 
analyte-matrix deposit, and the heterogeneity of the solid deposit. The latter variable is also 
attributed to the variation in mass spectra obtained from different regions of a sample. Over 
the last few years numerous novel sample preparation methodologies have been developed to 
enhance the homogeneity of the analyte-matrix deposit. These methods include vacuum 
drying, co-crystallization of analyte and matrix molecules by the addition of a ―seed‖ layer, 
and precoating a matrix substrate for deposition of analytes, and rapid evaporation of matrix 
followed by an application of the analyte solution in a matrix insoluble solvent. 
Spectra were achieved but identification of the peaks could not be defined due to the complex 
nature of FCSPs, as no database has been established to verify peaks (data not shown). 
Anastyuk et al. (2009) reported the successful analysis of fucoidan from the brown seaweed 
F. evanescens by MALDI-TOF and tandem ESI-MS. However, their samples were 
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depolymerized by solvolysis, not γ-irradiation, and a DHB matrix was employed. To date, 
there are only a few matrices reported that can detect polysaccharides with molecular weights 
larger than 3000 Da by MALDI MS (Hsu et al., 2007). Hsu et al. (2007) reported that 
2,4,6-trihydroxyacetophenone (THAP) is a good matrix for MALDI-TOF MS analysis of 
polysaccharides with a broad mass range. They reported that large polysaccharides, dextrans, 
glycoproteins and polysialic acids can be successfully detected by MALDI-TOF MS using a 
THAP matrix. 
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4.5)  Conclusion 
 
Crude fucoidan extracted from Splachnidium rugosum whole thalli tissue, with hot water or 
acid, was purified and fractionated by anionic ion exchange chromatography. This is the first 
study incorporating a novel hexadecyltrimethylammoniumbromide/Celite
®
 strategy for 
fucoidan purification. Low fucoidan yield and high protein content after purification was of 
concern but may be improved with further optimisation. Conversely, purified 
fucose-containing-sulphated-polysaccharides may have a high binding affinity for protein as 
a large amount of protein was purified with fucoidan. Previous studies have shown fucoidan 
can be a glycoconjugate for proteins. Mucilage from Splachnidium rugosum thallus was 
found to be free of protein and cellular debris. Fucoidan was precipitated from mucilage with 
ethanol at relatively high yield and purity, and had an average molecular weight of 2367 kDa. 
The polysaccharide was hydrolysed by gamma-irradiation to fractions ranging between 60 
and 15.5 kDa. Further research needs to be conducted to determine whether fractionated and 
purified fucose-containing-sulphated-polysaccharides from Splachnidium rugosum have an 
increased bioactivity over that of its crude and high molecular weight counterparts. The 
establishment of a database for fucose-containing-sulphated-polysaccharides or similar 
sulphated sugars would aid in the detection and elucidation of fucoidan compound‘s 
structural architecture by matrix assisted laser desorption/ionization time-of-flight mass 
spectroscopy. 
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Chapter 5. Bioactivity of fucoidan 
 
 
Abstract 
 
Fucoidan is a promising marine-derived agent that holds enormous potential for the 
pharmaceutical industry because of its organic nature, bioactive properties, and opportunities 
for sustainable harvesting from seaweeds. Hot water crude fucoidan extracts from Ecklonia 
maxima, Laminaria pallida, and Splachnidium rugosum were assessed for anti-oxidant 
activity by measuring the ability to scavenge free radicals and the capacity to reduce copper 
ions using the 2,2-Diphenyl-1-picrylhydrazyl and Cupric Reducing Antioxidant Capacity 
assays, respectively. Ecklonia maxima crude fucoidan displayed the highest anti-oxidant 
activity and capacity, having the potential to scavenge reactive oxygen species as well as the 
capacity to reduce copper to less toxic forms in mammalian systems. Splachnidium rugosum 
showed the weakest anti-oxidant activity and lowest reducing capacity (chelating activity). 
Crude fucoidan extracts from algae tissue were fractionated and purified by anionic ion 
exchange chromatography (Chapter 4). Fucoidan was also precipitated from Splachnidium 
rugosum mucilage with ethanol and fractionated by gamma-irradiation. In this study we 
assessed the anti-cancer activity of crude and purified hot water Splachnidium rugosum 
extracts, as well as non-irradiated (native) and gamma-irradiated fucoidan, and commercially 
procured fucoidan for anti-cancer activity against MCF-7 breast cancer cells by the WST-1 
cell viability assay. Fucus vesiculosus fucoidan displayed highest half maximal inhibitory 
concentration of 0.25 mg/mL. Splachnidium rugosum crude and purified fucoidan displayed a 
half maximal inhibitory concentration of 0.7 mg/mL and 0.029 mg/mL, respectively. Low 
cytotoxicity of Splachnidium rugosum crude and purified fucoidan against non-cancerous 
breast epithelial cell line, MCF-12A was reflected by half maximal inhibitory concentration 
values of 2 mg/mL of 0.663 mg/mL, respectively. The cancer specific selectivity of purified 
Splachnidium rugosum fucoidan was therefore much higher as reflected by selectivity indices 
of 22.86 compared to 2.86. Native and low molecular weight gamma-irradiated fucoidan also 
showed bioactive properties including anti-cancer activity as seen by the reduction of cell 
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proliferation in vitro, the ability to scavenge free radicals, and the capacity to reduce copper 
ions.  
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5.1)  Introduction 
 
Natural products have been used as therapeutic agents for centuries in folk and traditional 
medicines (Imhoff et al., 2011; Edwards, 2015). Communities located along coastlines or 
along neighbouring towns depend on marine derived products for food, medicines, and 
economic exports. Marine organisms have been shown to contain a number of biologically 
active compounds, including polysaccharides displaying therapeutic effects in humans and 
other mammalian systems (Michalak and Chojnacka, 2015). Fucoidan is a marine derived 
sulphated polysaccharide that possesses numerous bioactivities, including, anti-bacterial 
(Kandasamy et al., 2015), anti-coagulant (Jiao et al., 2011), anti-inflammatory (Chen et al., 
2008), anti-oxidant (Wang et al., 2010), anti-viral (Ponce et al., 2003), anti-protozoal (Torres 
et al., 2014), anti-cancer (Zhang et al., 2011), anti-angiogenic (Ustyuzhanina et al., 2014) and 
immunomodulatory activities (Ale et al., 2011). Bioactivity is governed by molecular weight, 
charge distribution, degree of sulphation, and chemical affinity to other biomolecules such as 
proteins and viral epitopes (Wozniak et al., 2015). Fucoidan of macroalgal origin is diversely 
branched compared to that of marine invertebrates (Ale et al., 2013). Algal fucoidan consists 
of a backbone of α (1-3)-L-fucopyranose residues or of alternating α (1-3) and α (1-4)-linked 
L-fucopyranosyls, which in either case may be substituted with sulphate or acetate. Side 
branches contain fucopyranoses or other glycosyls such as uronic acid. To further add to 
heterogeneity of algal fucoidan, the branching pattern of monomeric units and functional 
groups appear different in each species of brown algae. The complex chemical and molecular 
structure of fucoidan has not yet been fully elucidated (Ale et al., 2012). Fucoidan has been 
reported to have cytotoxic effects against several human cancerous cell lines, reducing the 
proliferation of tumour growth, angiogenesis, and metastasis (Ustyuzhanina et al., 2014). 
Anti-cancer activity is displayed in a dosage- and size-dependent manner (Cho et al., 2011). 
The anti-cancer properties of fucoidan have been examined in vitro and in vivo, and clinical 
trials have recently been initiated in human patients (Kimura et al., 2013). Despite its wide 
range of biological activities, fucoidans mode of action remains to be elucidated. 
There are many types of free radicals, but those of most concern in biological systems are 
derived from oxygen, and are known collectively as ROS. Oxidative phosphorylation is a 
vital part of the respirative cycle in eukaryotes, whereby nutrients are oxidized into adenosine 
triphosphate (ATP) for energy (Dean and Allikimets, 1995). ROS are released as a 
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by-product, such as oxygen ions and peroxides, and are essential in maintaining cellular 
homeostasis and signalling (Wang et al., 2010). However, when ROS is heavily accumulated 
due to environmental stress, it can have devastating long term effects on biological 
macromolecules (Franco et al., 2008). ROS may oxidize cellular proteins and cleave DNA 
which could cause genetic mutagenesis, cardiovascular disease, cancerous tumour formation 
and senescence (aging) (Halliwell and Aruoma, 1991; Halliwell and Gutteridge, 2006). This 
phenomenon is known as oxidative stress. Diets rich in food containing natural containing 
anti-oxidants are the most common prescribed method to combat oxidative stress (Finkel and 
Holbrook, 2000; Roberts et al., 2002). Anti-oxidants are molecules that can scavenge and 
neutralise free radicals which may offer a natural alternative as a cancer therapeutic, opposed 
to chemically synthesised drugs with harmful side-effects. The food industry incorporates 
synthetic anti-oxidants in their products to prevent lipid peroxidation caused by ROS (Wang 
et al, 2010). Some of these anti-oxidants such as butylates hydroxyanisole (BHA), 
butylatedhydroxytoluene (BHT) and tertiary butyl hydroquinone (TBHQ) may be 
carcinogenic or toxic to human health (Ito et al., 1989). To overcome health issues, numerous 
MNPs have been tested for anti-oxidant activity and potential application in food industry or 
in biological systems (Rupérez et al., 2002).  
Biogeography is an important factor in fucoidan chemistry and may therefore influence 
fucoidan bioactivity. This study reports on the anti-cancer and anti-oxidant activities of 
fucoidan compounds extracted and purified from South African brown macroalgae. 
 
5.1.1) Aim and objectives of this chapter 
 
The aim of this Chapter was to assess the bioactivity of fucoidan extracted from brown 
macroalgae of South Africa. The aim was broken down into three objectives: 
1. Assessment of anti-cancer activity of crude, purified, and γ-irradiated fucoidan in the 
breast cancer cell line MCF-7, using cell viability assays. 
2. Assessment of cytotoxicity of crude, purified, and γ-irradiated fucoidan in the non-
cancerous breast epithelial cell line MCF-12A, using cell viability assays . 
 
 
 
 
 128 
 
3. Assessment of anti-oxidant activity of crude fucoidan by measuring the ability to 
scavenge free radicals, and anti-oxidant capacity by measuring copper chelating 
ability.  
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5.2)  Methods and material 
 
5.2.1) Fucoidan samples 
 
Crude hot water fucoidan extracts (Section 3.2.2) from whole algae material of E. maxima, 
L. pallida, S. rugosum, as well as commercially procured fucoidan (Sigma-Aldrich) (Section 
3.2.3) from F. vesiculosus were assessed for anti-oxidant activity. FCSPs were assessed for 
anti-cancer activity and cytotoxicity. These included crude water extracts and fractions 
purified by IEC (Section 4.2.2), as well as high molecular weight (native) fucoidan 
precipitated from S. rugosum mucilage and 10 kGy γ-irradiated lower molecular weight 
fractions (Section 4.2.3). 
  
5.2.2) Anti-oxidant screening 
 
5.2.2.1) 2,2-Diphenyl-1-picrylhydrazyl assay 
 
Crude hot water fucoidan extracts were tested for anti-oxidant activity by measuring the 
radical scavenging ability of 2,2-Diphenyl-1-picrylhydrazyl (DPPH) free radicals. This was 
achieved by the DPPH assay described by Mensor et al. (2001) and Mak et al. (2013), with 
minor modifications. The assay was performed in triplicate. Fucoidan samples were diluted to 
0.05-4 mg/mL in ddH2O. Fucoidan (100 µL) was mixed with 250 µL methanolic 0.3mM 
DPPH (Sigma-Aldrich). In sample blanks, DPPH was substituted for ddH2O. Ascorbic acid 
(Vitamin C: Sigma-Aldrich) was included in assays for comparative analysis. A negative 
control was prepared that consisted of 100 µL methanol (Sigma-Aldrich) and 250 µL 
methanolic DPPH (0.3mM). Reactions were incubated at RT for 30 min, and the absorbance 
was measured at 518 nm in a 96-well microtitre plate (Greiner) with a microtitre plate reader 
(Nano spectrophotometer: BMG LABTECH). The following equation was used to calculate 
antioxidant activity, as described by Mensor et al. (2001): 
                     ( )       
(                         )    
(                   )
] 
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5.2.2.2) Cupric Reducing Antioxidant Capacity assay 
 
Crude hot water fucoidan extracts were assessed in triplicate for anti-oxidant capacity by 
Cupric Reducing Antioxidant Capacity (CUPRAC) assay, which measures the reducing 
power of copper as described by Mak et al. (2013) and Apak et al. (2008). Fucoidan samples 
were diluted to 0.5-3 mg/mL in ddH2O and 100 µL was added to a solution containing 100 
µL 0.01M copper chloride (CuCl2: Sigma-Aldrich), 100 µL 1M ammonium acetate (NH₄Ac: 
Sigma-Aldrich) (pH 7.0), 100 µL 0.075M neocuproine (in EtOH) and 10 µL ddH2O. In 
blanks, samples were substituted for ddH2O. The reaction was incubated at RT for 10 min, 
and the absorbance measured at 450 nm in a 96-well microtitre plate (Greiner) with a 
microtitre plate reader (Nano spectrophotometer: BMG LABTECH, USA). An increase in 
absorbance is indicative of an increase in copper reducing ability. 
 
5.2.3) Anti-cancer and cytotoxic screening 
 
5.2.3.1) Culturing (seeding) cell lines 
 
Immortalized Homo sapiens  breast cancer cell line MCF-7 (ATCC
®
) and non-cancerous 
human breast epithelial cell line MCF-12A (ATCC
®
) were aseptically cultured in vitro at the 
Animal Cell Culture Laboratory of the Department of Biotechnology, University of the 
Western Cape. All reagents and media were removed from storage and allowed to reach RT. 
A vial containing 2 mL of cryopreserved MCF-7 cells was removed from a -150°C cryogenic 
storage freezer (Cryo Freezer Conquerer -150°C, OPERON Co., Ltd,) and partially thawed. 
Cells were resuspended in 9 mL Dulbecco's Modified Eagle's Medium and Ham's F-12 
Nutrient Mixture (DMEM/F12: GIBCO
®
 Life Technologies) supplemented with 10% (v/v) 
fetal bovine serum (FBS: Biochrom The Scientific Group) and 100 U/mL 
penicillin-streptomycin (PENSTREP) (Lonza WhiteSci). Cells were pelleted by 
centrifugation (2,500 rpm for 3 min) and resuspended in 10 mL DMEM/F12. The suspension 
was transferred to 25cm
2
 flasks (Greiner) and incubated in a humidified atmosphere inside a 
water-jacketed incubator (Labtech) at 37°C with 5% carbon dioxide (CO2). Growth rate of 
cells were manipulated with 1:5, 2:5, or 3:5 dilution with media. Cells were cultured to 70-
80% confluency (Fig 4.1) and inspected visually under a light microscope (Nikon TMS).  
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MCF-12A cell line was cultured under the same conditions with the following modification: 
DMEM/F12 (GIBCO
®
 Life Technologies) was supplemented with 10% (v/v) FBS 
(Biochrom), 100 U/ml PENSTREP (Lonza), 20 ng/mL LONG
®
 human epidermal growth 
factor (EGF: SAFC Biosciences), 0.01 mg/ml bovine insulin (Roche) and 500 ng/mL 
hydrocortisone (Sigma-Aldrich). 
 
A.  B.  
Figure 5.1. Confluent culture of  cells visualized and captured by light microscope (200X magnification). 
A. Confluent MCF-7 cells B. Confluent MCF-12A. 
 
5.2.3.2) Maintaining cells in culture 
 
All reagents and media were removed from storage and allowed to reach RT. Cells in culture 
were inspected daily under a light microscope to determine cell confluency. Twenty four 
hours after seeding a culture, 5 mL of culture medium was replaced with fresh medium. This 
process was subsequently repeated every 48 hours until a desired confluency was reached.  
 
5.2.3.3) Sub-culturing (“splitting”) cell lines 
 
Once cells had reached a desired confluency, used culture medium was discarded and the 
flask was rinsed with 10 mL 1X phosphate-buffered saline (PBS: Biochrom). Monolayers of 
attached cells were enzymatically dissociated from the flask by trypsinization. Cells were 
trypsinized by adding 3 mL 0.25% (v/v) trypsin containing 0.02% (v/v) 
ethylenediaminetetraacetic acid (trypsin-EDTA) and incubated at 37°C with 5% CO2 for 2-5 
min. Flasks were microscopically examined to ensure complete detachment of cells and 
reincubated if necessary. Three mL of culture medium was added to the cell suspension to 
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inactivate trypsin, and the suspension was transferred to a 15 mL centrifuge tube (Greiner). 
Cells were pelleted by centrifugation (2,500 rpm for 3 min) and resuspended in 10 mL fresh 
culture medium. Appropriate aliquots of suspension were transferred to 25cm
2
 flasks and 
incubated at 37°C with 5% CO2. 
 
5.2.3.4) Cryopreservation of cells 
 
Cells at 70-90% confluency that were not required for immediate usage were preserved 
at -150°C. Firstly, cells were detached from flasks by trypsinization and pelleted by 
centrifugation (as described in Section 5.2.3.3). Cell pellets were resuspended in 10 mL fresh 
culture medium containing 10% (v/v) dimethyl sulfoxide (DMSO) (Sigma-Aldrich), 
transferred to 1.5 mL cryovials (SPL Life Sciences) and stored in a cryogenic freezer. 
 
5.3.3) Assay for cellular proliferation  
 
5.3.3.1) Cell counting and viability analysis 
 
All reagents and media were removed from storage and allowed to reach RT. Cells at desired 
confluency were seeded into a 96-well flat bottom microtitre plate (Greiner). Once attached 
to the surfaces of the microtitreplate, cells were assayed for cell viability, cell proliferation, 
and cytotoxicity. Firstly, cells were trypsinized (Section 5.2.2.3) followed by mixing a 10 µL 
aliquot of cell suspension with 10 µL of trypan blue dye (Invitrogen). Thereafter, 10 µL of 
the mix was transferred to a Countess Chamber Slide (Invitrogen). Cell count or cell viability 
was recorded on a Countess ™ automated cell counter (Invitrogen). Cells were seeded into a 
96-well microtitre plate at densities of 2 000 cells/mL to 50 000 cells/mL (in a final volume 
of 100 µL/well), and incubated for 24, 48 and 72 hours at 37°C with 5% CO2. Optimal 
conditions were selected for subsequent experiments after analysis of the absorbance spectra 
(Section 5.3.3). 
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5.3.3.2) Drug compound preparation and administration 
 
Stock solutions of FCSPs (10 mg/mL) were prepared in UV-treated ddH2O or media as 
diluent. Cells at desired confluency were treated with 100 µL of drug mix (70 µL diluent: 30 
µL drug) to final concentrations ranging from 0.03125 to 4 mg/mL per well. To administer 
the drug dosages, spent media was removed and wells were washed twice with 100 µL of 1X 
PBS. Thereafter, 100 µL of the drug-dosage-mix was added to the well and the plate was 
incubated for 24, 48, and 72 hours at 37°C with 5% CO2. Optimal conditions were selected 
for subsequent experiments after analysis of the absorbance spectra (Section 5.3.3). 
 
5.3.3.3) Bioactivity assay 
 
An aliquot of the cell proliferation reagent 4-[3-(4-Iodophenyl)-2-(4-nitrophenyl)-2H-5-
tetrazolio]-1,3-benzene disulfonate (WST-1: Roche) was removed from storage and allowed 
to thaw in the dark. Ten µL of WST-1 was added to each well of a microtitreplate, which 
contained controls, blanks, or samples. Plates were incubated at 37°C for 1, 2, and 4 hours. 
Absorbance were spectrophotometrically analysed against a background control used as a 
blank with a microtitre plate reader (Nano spectrophotometer: BMG LABTECH) between 
420-480 nm. A reference absorbance was measured at 610 nm. Once analysis of the 
absorbance spectra was completed, optimal conditions were selected for subsequent 
experiments.  
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5.3)  Results  
 
5.3.1) Anti-oxidant activity of fucoidan  
 
Hot water crude fucoidan extracts and a commercially procured sample were assessed for 
anti-oxidant activity. The ability of seaweed extracts to scavenge free radicals was measured 
by the DPPH assay (Table 5.1).  
 
Table 5.1. Anti-oxidant activity of seaweeds as defined by ability to scavenge free radicals. 
Family Seaweed species Anatomy 
a
EC50 ± SD (mg/ml) 
Fucaceae 
b
Fucus vesiculosus n/a 4.2 ± 1.4 
Splachnidiaceae Splachnidium rugosum Whole algae 3.0 ± 0.4 
Laminariaceae Laminaria pallida Whole algae 2.7 ± 0.9 
Lessoniaceae Ecklonia maxima Whole algae 2.5 ± 1.5 
n/a 
c
Vitamin C n/a 1.3 ± 0.7 
aValues obtained from regression lines with a 95% confidence level. EC50 is defined as the half maximal effective 
concentration of DPPH. Standard deviation (SD) is calculated from the mean of three independent experiments 
bCommercially procured crude fucoidan from Sigma-Aldrich 
cVitamin C was used as a positive control 
*n/a = not applicable  
 
The CUPRAC assay assessed anti-oxidant capacity by measuring the ability of the test 
compound to reduce copper ions. E. maxima crude fucoidan displayed the highest (p < 0.05) 
reducing ability, almost 5-fold higher than S. rugosum (Figure 5.2). 
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Fig. 5.2. Anti-oxidant capacity of crude fucoidan extracts as measured by the CUPRAC assay. 
 
 5.3.2) Anti-cancer and cytotoxicity screening of fucoidan 
 
FCSPs from S. rugosum were assessed for in vitro anti-cancer activity and cytotoxicity 
against MCF-7 and MCF-12A cell lines, respectively. Commercial crude fucoidan from 
F. vesiculosus was used as a control. Optimal conditions for the WST-1 cell viability assay 
are presented in Table 5.2. Fucoidan displayed anti-cancer activity in a dose-dependent 
manner (Figure 5.3). IC50 is defined as the fucoidan concentration that inhibits 50% of cell 
growth. Compared to crude water extracts, IEC purified S. rugosum fucoidan possessed 
lowest IC50 values of 0.029 mg/mL and 0.663 mg/mL against MCF-7 and MCF-12A cells, 
respectively (Table 5.3). Purified fucoidan however displayed the highest cancer specific 
selectivity index of 22.86.  
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Table 5.2. Optimal WST-1 assay conditions for cytotoxicity screening of fucoidan from this study. 
Cell seeding density Drug exposure time WST-1 incubation time Absorbance wavelength 
5 × 10
4
 cells/mL 24 hours 2 hours 430 nm 
 
 
 
Fig. 5.3. MCF-7 cell viability after 24 hr treatment with Splachnidium rugosum fucoidan. Commercially 
available fucoidan (Sigma-Aldrich) was used as a control. Graph represents cell viability (%) after assessment 
with WST-1 cell proliferation reagent (Roche).  
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Table 5.3. IC50 values and selectivity index of fucoidan compounds against various cell lines.  
Cell line Cellular 
origin 
Cell type Compound origin Molecular 
weight 
(kDa) 
a
IC50 
(mg/ml) 
b
Selectivity 
index (SI) 
   Crude tissue 
extract 
   
       
MCF7 Human 
(breast) 
Epithelial 
(cancerous) 
 
F. vesiculosus 20.5 0.25 nd
c
 
 
   Crude tissue 
extract 
   
       
MCF7 Human 
(breast) 
Epithelial 
(cancerous) 
S. rugosum  0.70  
    nd
c 
 2.86 
MCF12A Human 
(breast) 
Epithelial (non-
cancerous) 
S. rugosum  2.00  
       
   IEC purified 
tissue extract 
   
       
MCF7 Human 
(breast) 
Epithelial 
(cancerous) 
S. rugosum  0.03  
22.86 
    <3.5  
MCF12A Human 
(breast) 
Epithelial (non-
cancerous) 
S. rugosum  0.66 
      
   Mucilage 
Precipitate 
   
       
MCF7 Human 
(breast) 
Epithelial 
(cancerous) 
S. rugosum  
2367 
2.00  
2.00 
      
MCF12A Human 
(breast) 
Epithelial (non-
cancerous) 
S. rugosum  4.00 
      
   γ -Irradiated (10 
kGy) mucilage 
   
       
MCF7 Human 
(breast) 
Epithelial 
(cancerous) 
S. rugosum 60 4.00 nd 
 
      
 
       
aIC50 is defined as the fucoidan concentration that inhibits 50% of cell growth. Results are the mean of three independent 
experiments. 
bSelectivity indices were calculated by dividing the IC50 mean of non-cancerous cell line divided by the mean of the 
cancerous cell line. 
cnot determined
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5.4)  Discussion 
 
5.4.1) Anti-oxidant activity of fucoidan by 2,2-Diphenyl-1-picrylhydrazyl assay 
 
Crude and commercial fucoidan samples were tested for antioxidant activity by measuring 
the radical scavenging ability using the DPPH assay. The principle of the assay is described 
below. DPPH is a stable free radical that possesses an extra electron that delocalizes the orbit 
of the entire molecule (Szabo et al., 2007). This delocalization allows DPPH to appear as a 
dark purple coloured substance in a methanolic solvent. When DPPH is added to a solution 
containing a hydrogen atom donor (H-A) (such as an anti-oxidant), a non-radical form of 
DPPH is formed (DPPH-A) (Brand-Williams et al., 1995). That is, the free radicals are 
scavenged by anti-oxidant, which in turn causes a colour shift from deep purple to pale 
yellow (Mak et al., 2013). The equation below depicts the colorimetric reaction that occurs 
when an anti-oxidant scavenges the overly protonated DPPH-H molecule (purple) to the 
neutralised DPPH molecule (yellow):  
 
(           )  (   )               (  )  
 
The half maximal effective concentration (EC50) is a pharmacological term used to represent 
the concentration of a bioactive compound that induces a response halfway between the 
baseline and maximum after a specified exposure time (Sebaugh, 2011), in other words, the 
concentration where 50% of its maximal effect is observed. Vitamin C is a natural 
anti-oxidant (Liu et al., 2008) and was used as a positive control in this study. Vitamin C 
displayed the strongest anti-oxidant activity as indicated by lowest EC50 of 1.3 ± 0.7 mg/mL 
(Table 5.1). Ayoola et al. (2008) reported an EC50 of 0.054 mg/mL for Vitamin C. Vitamin C 
is an efficient free radical scavenger, and therefore an ideal positive control in DPPH assays. 
The anti-oxidant activity of all fucoidan samples as determined by the DPPH assay were 
dosage-dependent (Table 5.1). F. vesiculosus commercial fucoidan displayed weakest 
anti-oxidant activity seen by highest EC50 value of 4.2 ± 1.4 mg/mL (Table 5.1). The 
commercial sample is sold as a crude acid extract from F. vesiculosus. In contrast, all South 
African seaweed samples were extracted with hot water to retain native polysaccharide 
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structure, which may explain higher anti-oxidant activity at lower doses. S. rugosum crude 
fucoidan displayed anti-oxidant activity with an EC50 of 3.0 ± 0.9. There is no published 
literature on the assessment of S. rugosum fucoidan anti-oxidant activity. L. pallida crude 
fucoidan displayed the second strongest anti-oxidant activity with an EC50 of 2.7 ± 0.9. 
Activity furthermore appears to be stronger than its Northern Hemispheric neighbour 
L. japonica. Wang et al. (2010) have reported EC50 values were in the range of 3.6-3.7 
mg/mL for several LMW fucoidan derivatives extracted from L. japonica. E. maxima crude 
fucoidan displayed the strongest anti-oxidant activity as seen by lowest EC50 of 2.5 ± 1.5. 
Kuda et al. (2007) have extracted water-soluble polysaccharides (including fucoidan and 
alginate) from Ecklonia stolonifera and Ecklonia kurome. Water extracts have shown a 
stronger anti-oxidant scavenging ability than alcoholic extracts from the same species, due to 
the presence of large concentrations of phlorotannin and phenolic compounds. Maina et al. 
(2014) reported that E. maxima possess an abundance of phlorotannins, a natural anti-oxidant 
found in brown macroalgae. Phlorotannins may be contained within crude fucoidan extracts 
from E. maxima, which could aid in the compound‘s effectiveness as an anti-oxidant. The 
ability of an anti-oxidant to neutralise the free radical DPPH has been accredited to several 
mechanisms including protonation, radical scavenging, chain inhibition, and deterrence of 
constant hydrogen abstraction (Wang et al., 2009). Strong anti-oxidant activity of fucoidan 
may be due to the hydrogen-donating ability of fucoidan to form a stable DPPH-H molecule 
(Wang et al., 2010). The presence of sulphate groups may activate the hydrogen atom of the 
anomeric carbon. The sulphate content as well as the sulphate-to-fucose ratio may influence 
anti-oxidant activity of fucoidan.  
 
5.4.2) Anti-oxidant capacity of fucoidan by Cupric Reducing Antioxidant 
Capacity assay 
 
Crude and commercial fucoidan samples were assessed for anti-oxidant capacity with the 
CUPRAC assay (Apak et al., 2008). The principle of the assay works by reducing Cu(II) to 
Cu(I) where absorbance is recorded at a maximum wavelength of 450 nm. Cu(II)-Nc acts as 
the chromogenic oxidising reagent, which reacts with an electron reductant antioxidant 
(A-OH). This gives rise to the CUPRAC chromophore, copper(I)-neocuproine (Cu(I)-Nc) 
chelate (Güçlü et al., 2006). The reaction formula is illustrated below: 
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  (  ) 
                      (    )
    (  ) 
                            (   )     
 
Crude fucoidan extracts (3 mg/mL) reduced Cu
2+ 
to Cu
+ 
in a dosage-dependent manner 
(Figure 5.2). A higher absorbance measurement at a wavelength of 450 nm indicates a 
stronger CUPRAC anti-oxidant capacity. E. maxima showed the strongest ability to reduce 
copper. The anti-oxidant properties of F. vesiculosus and L. pallida were similar (p > 0.05). 
S. rugosum displayed weakest capacity, ~4.3-fold lower than E. maxima.  
 
5.4.3) Anti-cancer and cytotoxicity screening of fucoidan 
 
FCSPs were assessed for in vitro anti-cancer activity and cytotoxicity against MCF-7 and 
MCF-12A cell lines, respectively. The WST-1 cell viability assay was chosen for anti-cancer 
and cytotoxic analyses due to its robustness, stability, user-friendliness, sensitivity, accuracy, 
and proven track record of success (Berridge and Tan, 1998). The principle of this assay is 
based on the conversion of stable water-soluble tetrazolium salts (WST) into soluble 
formazan by cellular enzymes, namely mitochondrial dehydrogenases (Figure 5.4). 
Tetrazolium salts are cleaved to formazan by the succinate-tetrazolium reductase system 
which belongs to the respiratory chain of the mitochondria, and is only active in 
metabolically intact cells. Dehydrogenases are released extracellularly, and the colorimetric 
conversion takes place at the cell surface. Living cells produce NAD(P)H by glycolysis, 
which is essential for the conversion of WST-1 (slightly red) to formazan (dark red). Dead 
cells will appear light red to yellow (depending on the colour of the culture medium). The 
formazan dye content is quantitated colorimetrically and correlates to the number of 
metabolically active cells in the culture medium. 
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Fig. 5.4. Schematic illustrating the conversion of WST-1 to formazan. EC = electron coupling reagent, RS = 
mitochondrial succinate-reductase system (Taken from Roche protocol: https://pim-
eservices.roche.com/LifeScience/Document/c4c412ae-96ed-e311-98a1-00215a9b0ba8) 
 
Fucoidan from S. rugosum species was selected for bioactivity studies, as the polysaccharide 
could be extracted at the highest yield and purity compared to extracts from other species 
(Chapter 3). The anti-cancer activity of S. rugosum crude fucoidan was compared with 
activity of commercially procured crude fucoidan from F. vesiculosus. Bioactivity increased 
with an increase in fucoidan concentration in a dosage-dependent manner (Figure 5.3). 
F. vesiculosus fucoidan displayed higher activity with an IC50 of 0.25 mg/mL. Mak et al. 
(2014) reported a similar IC50 for commercially procured F. vesiculosus. S. rugosum crude 
and purified fucoidan displayed an IC50 of 0.7 mg/mL and 0.029 mg/mL, respectively (Table 
5.3). Higher efficacy of purified fucoidan compared to crude is likely due to low molecular 
weight (<3.5 kDa). Factors such as molecular weight and chemical composition are 
determining variables in fucoidans bioactivities. Choi et al. (2009) have shown that an 
increase in dosages of γ -irradiation and associated decrease in molecular weight was directly 
correlated with an increase of carbonyl groups and double bonds in fucoidan, as well as 
bioactivity. Low cytotoxicity of S. rugosum crude and purified fucoidan against non-
cancerous breast epithelial cell line MCF-12A was reflected by IC50 values of 2 mg/mL and 
0.663 mg/mL, respectively. The cancer specific selectivity of purified S. rugosum fucoidan 
was therefore much higher as reflected by an almost 10-fold increase in selectivity index (SI), 
22.86 compared to 2.86. Prayong et al. (2008) have presented that plant extracts with SI 
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values greater than 3 for cancer cell lines are considered high selectivity. Low cytotoxicity 
have of fucoidan has also been reported for non-cancerous cell lines such as HDFb (derma 
fibroblast), HUVEC (umbilical vein), and HEK-293 (embryonic kidney).  
Native fucoidan (2367 kDa) has been precipitated from S. rugosum mucilage with EtOH and 
fractionated into low molecular weight compounds using γ–irradiation (Chapter 4). Exposure 
to 10, 30 and 50 kGy has yielded fractions of 60.0, 16.8 and 15.5 kDa, respectively. Native 
and 60 kDa fractions were assayed for activity against MCF-7, with no difference in 
inhibition profile (results not shown). Native fucoidan and 60 kDa fraction displayed an IC50 
value of 2 mg/mL and 4 mg/mL respectively against MCF-7 breast cancer cells (Table 5.3). 
Anti-cancer activity in mucilage was furthermore considerably less than IEC purified 
samples, which may be explained by low molecular weight of purified polysaccharide (<3.5 
kDa). Future studies should include comparative analysis of the lower molecular fractions 
obtained at higher doses of γ -irradiation. Choi and Kim (2013) showed that 10 kGy gamma 
irradiated fucoidan (38 kDa) from F. vesiculosus (Sigma-Aldrich) showed a greater 
cytotoxicity to cancer cell lines AGS, MCF-7, and HepG-2 (IC50 values of 2-4 mg/mL), 
compared to its native counterpart (217 kDa). The authors presented similar chemical and 
bioactive profiles to that of γ -irradiated fucoidan from S. rugosum.  
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5.5)  Conclusion  
 
Fucose-containing-sulphated-polysaccharides from brown macroalgae displayed high 
anti-oxidant activity and may have potential as a natural dietary supplement. The health 
implications of natural anti-oxidants are significant as these compounds have the ability to 
quench ROS under oxidative stress environments. This is the first study assessing fucoidan 
from S. rugosum for anti-cancer activity. Fucoidan extracts often consist of carbohydrate 
polymer mixtures, the composition of which is influenced by the method of extraction. 
Bioactivity not only depends on purity of the extract, but also on chemical structure of 
fucoidan polysaccharide, which is governed by species and biogeography. An anti-cancer 
drug should be effective at low concentrations, and possess little or no cytotoxicity to non-
cancerous cells, characteristics displayed by S. rugosum purified fucoidan. Further studies 
aim to elucidate structure-function relationships of South African fucoidan compounds by in 
depth profiling of compounds using more analytical techniques such as nuclear magnetic 
resonance, as well as in vivo fucoidan bioactivity studies in animal models. 
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Chapter 6. General Conclusion 
 
 
Fucoidan was extracted from three species of South African brown seaweed, Ecklonia 
maxima, Laminaria pallida and Splachnidium rugosum. Three different methods were used 
to extract fucoidan in an effort to determine the influence of various extraction parameters on 
the heterogeneity of fucoidan. Extraction methods employed water, acid or salt. The hot 
water extraction method yielded highest L-fucose content, while the calcium chloride salt 
method yielded fucoidan with lowest uronic acid contamination. Extracts obtained with 
hydrochloric acid extraction yielded highest uronic acid contamination and sulphate content. 
High sulphate content may be explained by the liberation of sulphate from fucoidan polymers 
as a result of acid hydrolysis. All extracts were considered free of protein. Fucoidan is 
typically subjected to acid hydrolysis before sulphate assessment. The barium sulphate 
turbidimetric reaction was used to analyse liberated sulphate. This study has shown that it is 
possible to comparatively analyse sulphate content of fucoidan extracts without hydrolysis. 
However, quantitative analysis of sulphate content relies on acid hydrolysis. A drawback of 
the acid method includes higher alginate co-extracts (as assessed by uronic acid content), 
whilst fucoidan yield was very low with the salt method. Instead of using one extraction 
method, a better approach might be to extract fucoidan with hot water to retain its structure in 
its most native form, apply mild acid hydrolysis to yield lower molecular weight compounds 
with potentially higher bioactivity, and use a salt step to bind and remove cationic 
contaminants such as alginate, thereby increasing purity. The extraction method for fucoidan 
and other fucose-containing-sulphated-polysaccharides is critical in maintaining structural 
integrity and therefore bioactivity. However, the significance of this concept is often 
overlooked. Splachnidium rugosum tissue yielded >5 times more fucoidan than Ecklonia 
maxima and Laminaria pallida. Monosaccharide analysis furthermore revealed highest 
L-fucose ratio. There were only minor compositional differences between fucoidan extracted 
from the same species. Inter-species variation between Splachnidium rugosum from South 
Africa and New Zealand was more prominent and may be explained by differences in e.g. 
climate, tidal, and geochemical conditions. The fucose-to-sulphate ratio of fucoidan from 
Ecklonia maxima (1:5) is the highest reported to date. Degree of sulphation is the primary 
 
 
 
 
 149 
 
contributor to fucoidan‘s bioactive properties in mammalian systems. While fucoidan from 
Splachnidium rugosum generated in this study was fractionated and purified, and assessed for 
anti-oxidant and anti-cancer properties (Chapter 4), future studies should also include 
bioactivity assays with Ecklonia maxima extracts. 
Crude fucoidan extracted from Splachnidium rugosum whole thalli tissue, respectively with 
hot water and acid, was purified and fractionated by anionic ion exchange chromatography. 
This is the first study incorporating a novel Celite
®
 column for fucoidan purification. Low 
fucoidan yield and high protein content after purification were of concern but may be 
improved with further optimisation. On the other hand, purified fucose-containing-sulphated-
polysaccharide may have a high binding affinity for protein. Mucilage from Splachnidium 
rugosum thallus proved free of protein and cellular debris. Fucoidan was precipitated from 
mucilage with ethanol at relatively high yield and purity and an average molecular weight of 
2367 kDa. The polysaccharide was hydrolysed by gamma-irradiation to fractions ranging 
between 60 and 15.5 kDa. Further research needs to be conducted to determine whether 
fractionated and purified fucose-containing-sulphated-polysaccharide from Splachnidium 
rugosum have an increased bioactivity over that of its crude and high molecular weight 
counterparts. The establishment of a database for fucose-containing-sulphated-polysaccharide 
or similar sulphated sugars would aid in the detection and elucidation of fucoidan 
compound‘s structural architecture by matrix assisted laser desorption ionization time-of-
flight mass spectroscopy. 
Fucose-containing-sulphated-polysaccharides from brown macroalgae displayed high 
anti-oxidant activity and may have potential as a natural dietary supplement. The health 
implications of natural anti-oxidants are significant as these compounds have the ability to 
quench reactive oxygen species under oxidative stress environments. This is the first study 
assessing fucoidan from Splachnidium rugosum for anti-cancer activity. Fucoidan extracts 
often consist of carbohydrate polymer mixtures, the composition of which is influenced by 
method of extraction. Bioactivity not only depends on purity of extract, but also on chemical 
structure of fucoidan polysaccharide, which is governed by species and biogeography. An 
anti-cancer drug should be effective at low concentrations, and possess little or no 
cytotoxicity to non-cancerous cells, characteristics displayed by Splachnidium rugosum 
purified fucoidan. Further studies aim to elucidate structure-function relationships of South 
African fucoidan compounds by deeper profiling of compounds using more analytical 
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techniques such as nuclear magnetic resonance, as well as assessing fucoidan bioactivity in in 
vivo animal models. 
 
 
 
 
